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Eukaryotic protein synthesis is a sophisticated multistep process, which requires an
extensive biological machinery and several control mechanisms. Translation regulation
mainly occurs at the level of initiation. One of the key control mechanisms is the
phosphorylation of translation initiation factors. Although phosphorylation of ribosomes
has been known for decades, there is still very limited knowledge on translation regulation
by phosphorylation of the translation machinery itself, the ribosome.
In this study a large-scale phosphoproteomic survey of Saccharomyces cerevisiae ribosomal
proteins resulted in the identification of 279 ribosomal phosphorylation sites. In a second
quantitative phosphoproteomics approach, Stable Isotope Labelling with Amino Acids in
Cell Culture (SILAC) was used to assess changes in the phosphorylation pattern in response
to a stress-induced shut-down of translation and to – hopefully – identify functional relevant
phosphorylation sites. Here, changes in the phosphorylation pattern of 17 ribosomal
phosphosites were determined.
Subsequently, a mutational analysis of selected ribosomal phosphorylation sites was
performed to assess their function in protein synthesis. Out of the 25 phospho-deficient
alanine mutations analyzed so far, twelve showed an altered translation activity in in vitro
translation active extracts. Interestingly, two phosphorylation sites on proteins of the small
ribosomal subunit, Rps5 T38 and Rps12 T23, play a role in translation initiation. The
phospho-deficient alanine mutants of these two phosphorylation sites showed a defect in
canonical translation initiation. Specifically, Rps5 T38 phosphorylation is important for
efficient 48S initiation complex formation and context dependent start codon recognition
whereas the phosphorylation of Rps12 T23 functions in initiation complex formation and
scanning processivity. Moreover, the two mutations affect growth under specific conditions
demonstrating a physiological relevance of these phosphorylation sites.
Taken together, eukaryotic ribosomes are highly phosphorylated and change their
phosphorylation pattern in response to stress. In this study the first two ribosomal
phosphorylation sites are reported to be important for translation initiation suggesting
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The biological complexity of eukaryotic cells cannot simply be explained by the number
of protein encoding genes, but is regulated by a number of multilayer and interconnected
mechanisms. The transcription of DNA into RNA by RNA polymerase II (Svejstrup, 2004)
and the cotranscriptional splicing of the mRNA takes place in the nucleus (Black, 2003;
Chen and Manley, 2009). After export of the mature mRNAs to the cytoplasm (Kohler and
Hurt, 2007), mRNAs are translated into proteins that can be further modified by a diversity
of posttranslational modifications (Walsh et al., 2006). Both mechanisms, alternative
splicing and posttranslational modifications, enable the cell to expand the coding capacity
to generate a much more complex and diverse proteome.
Besides covalent cleavage of the protein backbone by protein proteases or autocatalytic
cleavage and covalent alkylation, there exists an extensive array of highly dynamic and
reversible posttranslational modification (PTMs). The current literature reports more than
200 different PTMs (Mann and Jensen, 2003). Some PTMs like disulfide bridge formation
or glycosylation are relatively stable and crucial for protein folding and maturation of
nascent proteins. In contrast, PTMs including protein phosphorylation, ubiquitylation and
acylation are readily reversed and thus suitable for regulatory functions and intracellular
signaling (Deribe et al., 2010). Proteins cannot only be modified by different types of PTMs
or at multiple sites with the same PTM but also in a sophisticated manner separated in time
and occurring sequentially. PTMs alter the properties of a protein. The coupling of PTMs
with corresponding recognition motifs of interacting partners creates a decoding mechanism
for relaying and reacting to changing environmental conditions, thereby initiating signaling
pathways and other feedback regulatory mechanisms, e.g. in transcription and translation
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(Hunter, 2000; Sims and Reinberg, 2008; Avraham and Yarden, 2011).
1.2 Phosphorylation as Posttranslational Modification in
Cellular Pathways
Protein phosphorylation is one of the key PTM in regulatory mechanisms and was one of the
first PTMs being described (Fischer and Krebs, 1955; Walsh et al., 1968). Most processes in
living cells including the cell cycle, receptor mediated signal transduction, differentiation,
proliferation and the metabolism of the cell are regulated by phosphorylation (Hunter,
2000). The interplay of two enzyme classes, protein kinases transferring the γ-phosphate
of ATP to hydroxyamino acids (mainly S, T and Y in eukaryotes) and phosphatases
removing the phosphate, continuously regulate substrate modification (Krebs and Beavo,
1979). Kinases represent one of the largest families of genes in eukaryotes, for instance,
1.7 % of the human genome encode kinases (Manning et al., 2002). Furthermore, about
30 % of all cellular proteins were estimated to be phosphorylated on at least one residue
and 50 % to possess at least one potential phosphorylation site (Cohen, 2000). Actually,
Olsen et al. showed that in HeLa S3 cells 70 % of the cellular proteins are phosphorylated
(Olsen et al., 2010).
The addition of a phosphoryl group to an amino acid residue confers properties
which can have profound effects on protein conformation and function. Under
physiological conditions, the phosphate is double-negatively charged and can form
extensive hydrogen-bond networks. These properties play an important role in inter- and
intramolecular interactions of phosphorylated residues with other amino acids resulting in
attractive or repulsive electrostatic effects. However, there is no universal response that
allows to predict a general mechanism for regulation by phosphorylation, but a range of
different responses to posttranslational modifications (Johnson and Lewis, 2001).
The binding affinity of a protein towards potential interaction partners can be altered
drastically by reversible phosphorylation. For instance, the binding of the epidermal
growth factor (EGF) to the EGF receptor (EGFR), which is a protein tyrosine kinase,
induces a multisite autophosphorylation at the cytoplasmic domains of the EGFR, thereby
2
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recruiting key regulatory proteins via their SH2 (Src homology 2) domain to the activated
homodimer (Jorissen et al., 2003). In the EGFR signal transduction cascade these
downstream signaling proteins initiate diverse cellular answers by activating signaling
pathways such as MAPK (Mitogen-activated protein kinase), PI3K (Phosphatidylinositol
3-kinases) or mTOR (mammalian target of rapamycin). Thereby, the mTOR pathway
is the major nutrient sensing pathway (Martin and Hall, 2005; Wullschleger et al.,
2006). The EGF signaling pathway is only one impressive example of the crucial role of
phosphorylation in biological processes.
1.3 Mass Spectrometry Based Phosphoproteomics
Analysis of protein phosphorylation is still a very challenging task, although breakthrough
developments of the past decade now enable the identification and relative quantification
of thousands of phosphorylation sites from complex biological samples. Considering that
the phosphorylation of proteins is not only a very common, but also a reversible and
dynamic process, the dynamic range of the phosphoproteome is similar to that of the
proteome itself. However, phosphoproteomics based on mass spectrometry is a powerful
tool to analyze and quantify cellular protein phosphorylation events at a global level (Ong
and Mann, 2005; Nita-Lazar et al., 2008; Macek et al., 2009).
In the first large scale analysis of the yeast Saccharomyces cerevisiae in 2002, a total of
216 peptide sequences defining 282 phosphorylation sites were identified from whole cell
lysate in a single experiment (Ficarro et al., 2003). Some of the identified phosphoproteins
were ribosomal proteins of the large and the small ribosomal subunits (Rpl12a, Rpl24a,
Rpl25, Rpl3, Rpl7a/b, Rps31 and Rps6a).
More recent phosphoproteomic studies have not only the objective to determine
phosphorylation sites, but also to profile levels of phosphorylation in different cellular
states. The two most frequently used methods for quantitative phosphoproteomics are
based on stable isotope labeling: (i) the metabolic labeling by SILAC (Stable Isotope
Labeling with Amino Acids in Cell Culture) in which two populations of cells are
cultivated in media containing either the normal amino acids or amino acids labeled with
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stable (non-radioactive) heavy isotopes (Ong et al., 2002) and (ii) the chemical labeling
method iTRAQ (isobaric Tag for Relative and Absolute Quantitation) which is based on
the covalent labeling of the N-terminus and side chain amines of peptides with tags of
varying mass (Ross et al., 2004).
Gruhler and co-workers combined SILAC with phosphoproteomic methods to investigate
and quantify pheromone-induced changes in protein phosphorylation in yeast. They
identified more than 700 unique phosphorylation sites in about 500 different yeast proteins
that are pheromone regulated (Gruhler et al., 2005). Another study applied SILAC
and phosphoenrichment to quantify global phosphorylation changes and site-specific
phosphorylation dynamics in EGF stimulated HeLa cells (Olsen et al., 2006). The
application of high end mass spectrometry in combination with phosphotyrosine
immunoprecipitation and SILAC enabled the time-dependent analysis of the tyrosine
phosphorylation cascade in the insulin signaling pathway (Kru¨ger et al., 2008). Thus,
quantitative phosphoproteomics provide new insights into protein-kinase mediated
signaling networks (Choudhary and Mann, 2010; Kosako and Nagano, 2011).
In summary, these applications demonstrate the impressive capabilities of
phosphoproteomics to identify phosphorylation sites, to elucidate dynamic signaling
pathways, and due to its unbiased nature, to reveal new biological connections.
1.4 Translation and Its Regulation
Protein synthesis is the last step of gene expression and one of the most important processes
in all living cells. Translation of an mRNA into a protein can be subdivided into four
stages: initiation, elongation, termination and recycling. In eukaryotes initiation is a highly
sophisticated and dynamic process that results in an elongation competent 80S ribosomal
complex with the initiator tRNA (Met-tRNAi) for the first amino acid residue positioned
at the start codon (AUG) of the mRNA. During elongation the ribosomes assemble in large
complexes termed polysomes and the polypeptide chain encoded by the open reading frame
(ORF) of the mRNA emerges from the ribosomes. As soon as the ribosomes encounter a
stop codon translation is terminated and the polypeptide chain released. After recycling
of the ribosomal subunits a new cycle of translation can begin (Fig. 1.1, adapted from
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Melnikov et al. (2012)).
Figure 1.1: The translation cycle (adapted from Melnikov et al. (2012)). Translation can be divided into
translation initiation, elongation, termination and ribosome recycling. Each step is assisted by certain factors –
initiation factors (eIFs), elongation factors (eEFs), release factors (eRFs) and recycling factors. During the
multistep process of translation initiation an elongation competent 80S complex is loaded onto the mRNA and
positioned at the start codon. In elongation, the ribosomes assemble in large complexes termed polysomes and
the nascent polypeptide chain emerges from the polysomes. Termination occurs when the ribosomes encounter
a stop codon and the polypeptide chain is released. During recycling the ribosomes are split into their subunits




1.4.1 Eukaryotic Translation Initiation
Translation initiation is a complex process in eukaryotes requiring the ribosomal subunits to
act in concert with the 12 eukaryotic translation initiation factors. Thereby, an elongation
competent 80S complex with the Met-tRNAi in the peptidyl (P-)site of the ribosome is
positioned at the correct start codon of the mRNA. Translation initiation starts with the
assembly of the 43S pre-initiation complex (PIC) with the ternary complex (TC) containing
eIF2, GTP and Met-tRNAi bound to the 40S P-site. 43S PIC formation is assisted by the
initiation factors eIF1, 1A, 3 and 5. In yeast eIF1, 3 and 5 together with the TC form
a multifactor complex (MFC) which is then recruited to the 40S subunit (Asano et al.,
2000). Subsequently, the 43S PIC is recruited to the 5’ end of the capped mRNA by
the eIF4F complex consisting of the cap-binding eIF4E, the scaffold protein eIF4G, the
helicase eIF4A with its auxiliary factor eIF4B and the poly(A) binding protein (Pab1).
The 43S complex scans along the 5’ UTR of the mRNA until it recognizes the start codon
by perfect complementarity of the Met-tRNAi anticodon with the AUG in the P-site of
the 40S subunit. Release of eIF1 and hydrolysis of GTP bound to eIF2 assisted by the
GTPase-activating protein eIF5 results in a stable 48S PIC. After release of eIF2-GDP and
eIF3, the 60S subunit joins mediated by eIF5B to form an 80S initiation complex (IC).
Hydrolysis of eIF5B-bound GTP and displacement of the remaining initiation factors leave
an elongation competent 80S ribosome on the mRNA. Subsequently, eIF2B catalyzes the
GDP exchange on eIF2 to recycle eIF2 for a new round of translation initiation (Lorsch
and Dever, 2010; Hinnebusch, 2011; Aitken and Lorsch, 2012). The process of eukaryotic
translation initiation is illustrated in Fig. 1.2 (adapted from Hinnebusch (2011)).
Although the scanning model was proposed by Kozak three decades ago, the details of the
scanning mechanism remain fragmentary (Kozak, 1978). Scanning is a complex process
comprising the unwinding of structured mRNA, ribosomal movement along the mRNA,
rejection of mismatches between noncognate codons and the Met-tRNAi anticodon and
finally selection of the right start codon in the ribosomal P-site. Generally, the first AUG is
the site for translation initiation (‘First AUG rule’). But the sequence context surrounding
the start codon has a drastic influence on start site selection, to the point that ribosomes
bypass the first AUG, so called leaky scanning (Kozak, 1986). In yeast, the consensus
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sequence is biased for As with a strong preference for the -3 position upstream of the AUG
(Shabalina et al., 2004). Substitution of the -3 A has substantial effects on translation
rates (Martin-Marcos et al., 2011).
eIF1 and eIF1A bind cooperatively to the 40S subunit and are crucial for a scanning
competent 43S PIC (Maag et al., 2006, 2005; Mitchell and Lorsch, 2008). eIF1 and eIF1A
act synergistically in promoting an open scanning competent conformation of the 43S
initiation complex (Passmore et al., 2007). Upon start codon recognition a conformational
change (closed state) is induced moving eIF1 and eIF1A apart from each other and
triggering the release of eIF1 (Maag et al., 2005). eIF1 and eIF1A have opposing effects
on start codon recognition. eIF1 promotes scanning and impedes the tight binding of the
Met-tRNAi to the P-site at non-AUG codons by stabilizing the open-scanning competent
conformation of the 40S subunit. Although the C-terminus of eIF1A acts together with
eIF1 to stabilize the open conformation of the mRNA channel with the TC in a mode
that prevents full accommodation of the Met-tRNAi in the P-site (Passmore et al., 2007),
its N-terminus promotes the closed conformation by releasing eIF1 and full binding of the
tRNA in the P-site (Fekete et al., 2007). The release of eIF1 is crucial for start codon
selection as in the scanning competent conformation the codons entering the P-site are
controlled for perfect base pairing with the Met-tRNAi anticodon without tight binding.
Upon perfect matching triggering the conformational change and eIF1 release the mRNA
is locked in the closed conformation. eIF1 release is stimulated by eIF5, which competes
for its binding site on the 40S (Nanda et al., 2009) and stabilizes the closed conformation of
the 40S subunit (Maag et al., 2006). Since eIF2 delivers the Met-tRNAi to the 40S subunit
and the hydrolysis of GTP and dissociation of eIF2-GDP releases the initiator tRNA into
the P-site, eIF2 is a key player in start site selection (Hinnebusch, 2011). Its α subunit is
supposed to be directly involved in start codon context selection as was crosslinked to the
important -3 position upstream of the AUG codon (Pisarev et al., 2006). eIF3 as scaffold
for initiation factors stimulates many steps in translation initiation and therefore is also
involved in scanning and start codon recognition (Hinnebusch, 2006, 2011).
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Figure 1.2: The mechanism of cap-dependent eukaryotic translation initiation (adapted from Hinnebusch
(2011)). Initiation starts with the assembly of the 43S PIC comprising the 40S and the MFC components
followed by the recognition and recruitment of the 5’ capped mRNA, the process of 5’ UTR scanning and 60S
subunit joining and resulting in the formation of an elongation competent 80S ribosome at the start codon. For
details see text. 80S ribosome and 40S subunit are depicted as blue silhouettes with location of aminoacyl-tRNA
(A), peptidyl (P) and exit (E) site labeled in the 40S subunit; initiation factors (eIFs) are labeled by number;
GTP and GDP are depicted as green or red balls, respectively; MFC: pre-assembled multifactor complex.
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1.4.2 Eukaryotic Elongation, Termination and Ribosome Recycling
After translation initiation, the Met-tRNAi is positioned at the P-site of the ribosome
with the A-site open for the next aminoacyl-tRNA (aa-tRNA) encoded by the mRNA.
Translation elongation comprises three steps (i) positioning of the correct aa-tRNA in the
A-site, (ii) peptide bond formation leading to a transfer of the peptide from the tRNA
in the P-site to the aa-tRNA in the A-site and (iii) translocating the mRNA and tRNAs
one position further on the ribosome into the E-site and P-site clearing the A-site for the
next aa-tRNA. Translation elongation is assisted by the elongation factors eEF1 (eEF1A
and B), eEF2 and the fungi specific eEF3. eEF1A recruits the aa-tRNA in the A-site in
a GTP-dependent manner. eEF1B recycles eEF1A-GDP for a new round of elongation.
After peptide bond formation, eEF2-GTP catalyzes the translocation step (Fig. 1.1) (Dever
et al., 2007).
Termination occurs when the ribosome encounters a stop codon in the A-site. The
t-RNA mimicry release factor eRF1 recognizes the stop codon with the help of Dbp5 and
Gle1 (Baierlein and Krebber, 2010). After GTP-hydrolysis by eRF3 and its subsequent
dissociation ABCE1 (ATP-binding cassette, sub-family E, member 1) binds to the
ribosome. eRF1 catalyzes the hydrolysis of the peptidyl-tRNA bond and the release of
the polypeptide from the ribosome. Subsequently, ABCE1 triggers the ATP-dependent
ribosome splitting into subunits (Pisarev et al., 2010; Becker et al., 2012). Ribosome
recycling is coupled with re-initiation when initiation factors such as eIF3, eIF1 and
eIF1A bind to the small ribosomal subunit after ribosome recycling (Pisarev et al., 2007).
eIF3 might be recruited to the 80S ribosome directly via ABCE1 even before recycling is
completed (Jackson et al., 2010).
1.4.3 Translation Regulation by Phosphorylation of Translation
Factors
Regulation of such an intricate, multistep process as translation can occur at many
steps. Global translation regulation mainly occurs by modification of translation factors –
initiation and elongation factors – whereas mRNA specific regulation is mediated by protein
complexes that recognize particular elements of the mRNA or by small microRNAs that
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hybridize to the mRNA (Gebauer and Hentze, 2004). Most regulation is exerted at the
level of initiation.
One key mechanism to regulate translation initiation is the phosphorylation of the α
subunit of eIF2 on serine S51. Phosphorylated eIF2α acts as competitive inhibitor of
eIF2B, the recycling factor of eIF2-GDP to eIF2-GTP (Sonenberg and Hinnebusch, 2007).
eIF2B, the catalytic subunit of eIF2B, is also a phosphoprotein. Phosphorylation of
eIF2B increases or decreases eIF2B activity depending on the site of phosphorylation
(Dever, 2002). A second regulated step in translation initiation is 5’ cap recognition by
the eIF4F complex. The assembly of eIF4F is suppressed by the eIF4E-binding proteins
(4E-BPs). Upon phosphorylation of 4E-BPs, their interaction with eIF4E is disrupted and
eIF4E is released to bind the cap and activate the mRNA during translation initiation.
Phosphorylation of eIF4B, the auxiliary factor of the RNA helicase eIF4A, results in a
better interaction with eIF3, and thus together with phosphorylation of 4E-BPs increases
translation initiation (Pierrat et al., 2007).
During elongation, the eukaryotic elongation factor eEF1A and subunits of eEF1B are
targets of phosphorylation. However, the effects of these phosphorylation events on
translation still have to be shown. Phosphorylation of elongation factor eEF2 impairs
interaction with the ribosome, and thus inactivates translation (Proud, 2007).
The two major pathways signaling to the translation machinery in response to stress,
starvation or mitogen and growth factor stimulation, are the PI3K/Akt/mTOR1 and
Ras-MAPK2 signaling pathways (Proud, 2007; Sonenberg and Hinnebusch, 2009). The
serine-threonine kinase mTOR directly phosphorylates the 4E-BPs and the S6 kinases
(S6Ks) which in turn phosphorylate eIF4B and the eEF2 kinase. eIF4E and eIF4B are
phosphorylated in a Ras-MAPK pathway dependent manner. eIF2α is phosphorylated
by a number of kinases, which are activated under different conditions such as stress
or starvation, including HRI (Heme-regulated eIF2α kinase), PKR (Protein kinase R),
or PERK (PKR-like ER-localized eIF2α kinase) (Dever, 2002). In yeast, Gcn2 (general
control non derepressable 2) is the only eIF2α phosphorylating kinase (Hinnebusch, 2005).
The major signaling pathways that control the phosphorylation and activity of translation
initiation factors are depicted in Fig. 1.3 (adapted from Sonenberg and Hinnebusch (2007)).
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Figure 1.3: The major signaling pathways that control the phosphorylation and activity of translation initiation
factors (adapted from Sonenberg and Hinnebusch (2007)). (A) The PI3K/Akt/mTOR and the Ras-MAPK
signaling pathways regulate 5’ cap recognition by eIF4F. mTOR directly phosphorylates the 4E-BPs and S6
kinases (S6Ks), and indirectly eIF4B and eIF4G. The Ras-MAPK pathway is responsible for the phosphorylation
of eIF4E and eIF4B. (B) Under stress or starvation conditions the eIF2α kinases HRI, PKR, PERK3 or Gcn2
phosphorylate S51 of eIF2α thus inhibiting eIF2B. eIFs are labeled by number; GTP and GDP are depicted as
green or red balls, respectively; red arrows are repressing, green activating influences.
1.5 The Ribosome and Its Phosphorylation
Decoding of the message and formation of the polypeptide chain is catalyzed by large
macromolecular ribonucleoprotein complexes, the ribosomes. Ribosomes consist of two
subunits, designated as the small (40S) and the large (60S) ribosomal subunit together
forming the 80S ribosome. In Saccharomyces cerevisiae, the small subunit consists of
an 18S rRNA and 33 proteins, whereas the large subunit is composed of three rRNAs
(5S, 5.8S and 28S rRNA) and 46 proteins. The small subunit decodes the information
encoded in the ORF of the mRNA, thus controlling the correct base pairing of tRNAs with
each mRNA codon. The formation of peptide bonds is catalyzed by the large ribosomal
subunit in the so called peptidyl-transferase center. The interplay of ribosomal proteins
and rRNA is crucial for the optimal function of the translation machinery. Although the
ribosome is considered as a ribozyme (Cech, 2000), ribosomal proteins not only support the
structure of the ribosome, but are also involved in mRNA and tRNA recognition, helicase
activity, decoding, formation of binding sites for translation factors, peptidyl-transferase
activity and formation of the peptide exit tunnel (Kramer et al., 2009; Dresios et al.,
2000; Meskauskas and Dinman, 2007; Pisarev et al., 2008; Takyar et al., 2005). However,
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the function of ribosomal proteins and their role in translation regulation remains to be
elucidated.
Surprisingly little is known about translation regulation and ribosome function by PTMs, in
particular by phosphorylation of eukaryotic ribosomal proteins. In earlier studies, proteins
of the large and the small ribosomal subunit were reported to be phosphorylated in yeast
(Hebert et al., 1977; Kruiswijk et al., 1978; Campos et al., 1990). Ribosomal proteins
Rpl3, Rpl11 and Rpl14 from Saccharomyces cerevisiae were phosphorylated in vitro by a
ribosome associated kinase. Furthermore, in vivo phosphorylation of the small ribosomal
proteins Rps2 and Rps6 and the large ribosomal proteins Rpl3, Rpl9, Rpl11, Rpl24, Rpl30,
Rpl44 and Rpl45 have been shown. In two recent studies, an inventory of phosphorylation
sites of ribosomes form Escherichia coli and mammalian mitochondria was generated by
different mass spectrometry methods (Soung et al., 2009; Miller et al., 2009). It was also
shown that mammalian mitochondrial ribosomes have a decreased translation rate after in
vitro phosphorylation with different kinases, thereby hypothesizing that phosphorylation
events have a regulatory function in translation.
The most prominent ribosomal phosphoprotein is Rps6 being phosphorylated at two sites
in yeast and at least five sites in vertebrates. Several stimuli like heat shock and starvation
have been reported to affect the phosphorylation status of Rps6 and lead to a reduction in
the phosphorylation level (Ruvinsky and Meyuhas, 2006). However, the phosphorylation of
Rps6 seems to have no effect on growth in yeast as shown by mutational analysis (Johnson
and Warner, 1987). Thus, the molecular function of Rps6 phosphorylation in translation
still remains to be elucidated. Moreover, the ribosomal stalk proteins Rpp0, Rpp1 and
Rpp2 are highly phosphorylated in eukaryotes. The stalk is a protuberance of the large
ribosomal subunit which directly interacts with cytoplasmic proteins, such as translation
elongation factors. Changes in the stalk composition and phosphorylation state affect the
capacity of the ribosome to translate a specific subset of mRNAs (Ballesta et al., 1999).
Recently, our group revealed that the small ribosomal protein Rps2 is phosphorylated on
S238 by the kinase Ctk1. Rps2 is positioned at the mRNA entry tunnel and it is known
to be crucial for translation accuracy (Stansfield et al., 1998). We could demonstrate that
phosphorylation of Rps2 is important for translational fidelity (Rother and Strasser, 2007).
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1.6 Aim of the Study
Translation is an intricate and highly regulated step in gene expression. Translation
regulation mostly occurs at the level of initiation. One of the key control mechanisms
is the phosphorylation of initiation factors. Although phosphorylation of ribosomes has
been known for decades, there is still very limited knowledge on translation regulation by
phosphorylation of the translation machinery itself. The aim of this study was to generate
a comprehensive catalogue of ribosomal phosphorylation sites and to elucidate the function
of selected sites in translation.
Initially, a large-scale phosphoproteomics survey of the yeast Saccharomyces cerevisiae
ribosome resulted in the identification of new phosphorylation sites in the ribosome. In
a second approach, Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC)
was used to assess changes in the ribosomal phosphorylation pattern upon stress-induced
shut-down of translation and to identify functionally significant phosphorylation sites.
With the comprehensive survey of Saccharomyces cerevisiae ribosomal phosphorylation
sites and the quantification of changes in the ribosomal phosphorylation levels in response
to stress the challenge of this study was to determine which of the identified sites are
individually or collectively important for translation. To this end, selected phosphorylated
residues (S, T or Y) of ribosomal proteins were mutated to either the phospho-deficient A
or the phospho-mimicry D residues and subsequently assessed for their translation activity
in vitro. Twelve of the analyzed ribosomal phospho-mutants showed an effect in the in
vitro translation assay.
For two of the identified ribosomal phosphorylation sites on the small ribosomal subunit,
namely Rps5 T38 and Rps12 T23, the aim was to unravel their function in translation
initiation in more detail. This was accomplished by a combination of different in vitro
and in vivo translation assays for different steps of translation initiation ranging from
initiation complex formation through scanning processivity to context dependent start
codon recognition. Moreover, the physiological relevance of these two phosphorylation
sites was addressed by investigating the growth under different conditions.
Taken together, the aim of this study was to show that phosphorylation sites in heavily
phosphorylated ribosomes function in distinct steps of translation.
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2.1 Phosphoproteomic Analysis of Ribosomal
Phosphorylation Sites
2.1.1 Identification of Ribosomal Phosphorylation Sites
Phosphorylation of proteins is one of the major regulatory mechanisms used by the cell to
control almost all cellular processes, thus also translation. Since 50% of the proteins are
supposed to possess at least one phosphorylation site (Cohen, 2000) numerous ribosomal
proteins should be phosphorylated. To address the question which ribosomal proteins
are phosphorylated and how ribosomal phosphorylation sites are involved in translation,
ribosomal phosphorylation sites of the yeast Saccharomyces cerevisiae were mapped at
steady-state.
To this end, subsequent centrifugation steps with a sucrose density gradient as a final
purification step were used to isolate 40S and 60S ribosomal subunits, 80S ribosomes,
and polysomes from yeast whole cell extracts (WCEs) under phosphorylation conserving
conditions. A high salt wash removed more loosely associated proteins to obtain pure
ribosomes. Fractions of the sucrose gradients containing 40S, 60S, and 80S ribosomes or
polysomes, which were stabilized by cycloheximide, were pooled. The phosphoproteomic
analysis of purified ribosomes was done by Jesper V. Olsen. After in solution digestion of
proteins with the endoproteinases Trypsin and LysC the phosphopeptides were enriched
using TiO2 column and analyzed by nanoflow LC-MS/MS on an LTQ Orbitrap instrument
(Fig. 2.1). All peptides were sequenced by collision-induced dissociation with multi-stage
activation enabled for neutral loss of phosphoric acid. The resulting raw LC-MS files were
processed and analyzed with the MaxQuant software suite (www.maxquant.org) and yeast
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Figure 2.1: Purification of Saccharomyces cerevisiae ribosomes for phosphoproteomics analysis using
subsequent centrifugation steps with a sucrose density centrifugation as final purification step.
phosphopeptides identified by the Mascot search engine (www.matrixscience.com) at a
fixed false discovery rate of FDR > 0.01. (Olsen et al., 2006).
In total 66 of the 79 ribosomal proteins of Saccharomyces cerevisiae were found to be
phosphorylated on at least one phosphorylation site corresponding to 84 % of the ribosomal
proteins. This is a larger proportion than the commonly cited 30 % of the proteome
(Cohen, 2000) and even higher than the 70 % found in an in-depth study of HeLa S3
cellular proteins over the cell cycle (Olsen et al., 2010). 279 ribosomal phosphorylation
sites mainly on S (195) and T (80) and only rarely on Tyr (4) were identified – 117 on the
small ribosomal subunit, 144 on the large subunit and 18 on the ribosomal stalk proteins
(Table 2.1). On average each ribosomal protein is phosphorylated on 4.6 residues ranging
from one to 15 sites. 42 % of the phosphorylated amino acids are conserved in human and
mouse suggesting that their function – if any (see Section 2.3 and Section 2.4) – might
also be conserved. Based on the available structures (Rabl et al., 2011; Ben-Shem et al.,
2011) the majority of sites is located at the surface of the small or large ribosomal subunit
including the interface, where they are accessible to kinases and phosphatases (Fig. 3.1).
Table 2.1: Phosphorylation sites in ribosomal proteins identified in this study.
Protein Phosphosites
Rps0 T103, T112, S114, T219, T220
Rps1 S236, S245, T254
Rps2 S2, S181
Rps3 S104, T207, S221, T231
Rps4 S120, S247
Rps5 S2, T21, T38, S47, S206, T207, S208





Rps6 T15, T163, T180, S232, S233
Rps7 S30, S31, S103, T105, S106, S115, T117, T119, S187, T189
Rps8 S45, T132, S154, S155, S158, S161
Rps9 S13, T14, T161, S162, S184
Rps10 S48, T98
Rps11 S2, T3, T6, S9, T44, S52
Rps12 S2, T19, T23,
Rps13 S12, S13, S14, S19, S30, S147
Rps14 S2, S11, S12, S125, T126, S126, T127
Rps15 S2, S29, T30
Rps16 S2, S6, S15, T17, S34
Rps17 S70, S89, S94, S96, T106, S107, S120, S125
Rps18 S107
Rps19 S5, S117, T139
Rps20 S38, S39
Rps21 S84, Y85, S86
Rps23 S40
Rps24 S2, S14, S56
Rps25 S74, S93
Rps26 S54, S57, Y59, S110
Rps27 T11, S14
Rps28 S3, T5, T8, T19, S37
Rps29 S25
Rpl1 T5, S6, S7, S79, S86
Rpl2 S95, S195, S249
Rpl3 S24, S65, S101, T103, T296, S297, T301, S355
Rpl4 S53, T60, S61, S64, S85, S270, S278, S282, T283, S284, T287,
S292, S293, S297, T306
Rpl5 S9, S235
Rpl6 S12, S88, S164,
Rpl7 T8, S11, T16, S113, T115, S228









Rpl13 T144, T152, S165
Rpl14 T3, S5
Rpl15 T165, T167, T196
Rpl16 S2, S163, S178, S179, S180, S181, T184, S185, S187, S188
Rpl17 S65, S66, S141, S142, S144
Rpl18 S63, S65, S167, T168
Rpl19 S13, T29, S30, S37, T56, S59, S91
Rpl20 T16, S18, S60, S169, T170
Rpl21 S70, S142, T143
Rpl22 S20, S21, T23, T111
Rpl24 S7, S9, S26, S83, S86, S95, T153, S154
Rpl25 T28, S29, T31, S69, T71
Rpl26 T21, S24, S25, S62, S72, S94
Rpl27 S33, S94, T97, T98, S105
Rpl30 S6
Rpl32 S40, S51, S67, S69
Rpl33 S15, S97
Rpl34 T64, S66
Rpl35 S19, S40, S98
Rpl36 T18, S19, T21, S64, S79, T81, S97
Rpl37 T5, S7, T80, S82, S84
Rpp0 Y273, T281, S302
Rpp1A S62, S96
Rpp1B S58, S73, S96
Rpp2A S43, S49, S71, S79, S96
Rpp2B T65, T68, S72, S73, S100
The presented inventory of yeast ribosomal phosphorylation sites was compared to
two phosphorylation databases: PHOSIDA (www.phosida.com) (Gnad et al., 2007)
and PhosphoPep (www.phosphopep.org) (Bodenmiller et al., 2007). PHOSIDA and
PhosphoPep contain only 9.0 % and 36.6 % of the phosphosites identified by us as well
as 2.2 % and 36.6 % additional sites, respectively. Moreover, comparing the presented
inventory with UniProt (www.uniprot.org) revealed that 96 sites are reported there in
addition to 98 sites not found in this study. Taken together, the most comprehensive
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catalogue of ribosomal phosphosites in Saccharomyces cerevisiae to date is presented here
including 122 novel ones.
2.1.2 Stress-Induced Changes in the Phosphorylation Pattern of
Ribosomal Proteins Using SILAC
In a natural environment cells are exposed to a large variety of different stresses and
in order to survive they need to react and adapt to the environmental conditions. One
response to environmental stress like heat shock or nutrient deprivation is the shut-down of
global translation indicated by the accumulation of free 80S ribosomes. For instance, this
is mediated by the phosphorylation of initiation factor eIF2α leading to a decrease in TC
formation, thus inhibiting translation initiation (see Section 1.4.3). Since phosphorylation
of proteins is a broadly used control mechanism of the cell to immediately adapt to
changes in the environment, the question whether there are changes in the ribosomal
phosphorylation pattern in response to stress-induced shut-down of translation was
addressed in this study. To this end, a quantitative phosphoproteomics approach was used
to investigate stress-induced changes in the phosphorylation status of ribosomal proteins
by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) in combination with
phosphoenrichment and LC-MS/MS. A shut-down of translation was induced by heat shock
and glucose deprivation leading to a loss of heavily translating polysomes and accumulation
of free 80S ribosomes on gradient profiles (Fig. 2.2 A-C).
In the SILAC experiment two cultures were grown either in media containing light lysine
or heavy lysine and one of the two cultures was treated with either heat shock (10 min
at 42℃) or glucose deprivation (5 min in medium lacking glucose). After cell lysis, the
extracts of the two cultures were combined for further purification of ribosomes, thereby
reducing unspecific variations in the phosphorylation patterns of treated and untreated
cells caused by differences in the preparation. Ribosomal subunits and 80S ribosomes were
purified and digested with the endoproteinase LysC since only Lys was used for labeling.
The phosphopeptides were enriched and analyzed by LC-MS/MS. The amino acids with
a different phosphorylation level were determined and the phosphorylation ratio between
stressed and untreated samples calculated (Fig. 2.2 D) (Olsen et al., 2006).
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Figure 2.2: Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) to investigate changes in the
phosphorylation pattern of yeast ribosomes. (A-C) Sucrose density gradient profiles of control (A), heat shocked
(B) or glucose deprivated cells (C). WCEs were separated on 10-30 % sucrose gradients and absorption was
measured at 260 nm. 40S, 60S, 80S and polysome peaks are indicated. (D) Flow scheme of SILAC experiment.
The large majority of identified phosphorylation sites remained unchanged under heat
shock and glucose deprivation (Table A.2). Interestingly, eleven and nine ribosomal
phosphorylation sites changed their phosphorylation status in response to heat shock
and glucose deprivation, respectively (Table 2.2 Table 2.3). Importantly, the two known
Rps6 sites S232 and S233 were identified with a reduction in their phosphorylation
levels to 30 % in response to heat shock as well as glucose deprivation. Besides the
decreased Rps6 phosphorylation, two more sites Rpl24 S86 and Rpl12 S38 showed a
reduced phosphorylation status upon heat shock or glucose deprivation (Table 2.2 and
Table 2.3). Heat shock induced an increase in the phosphorylation levels of three sites on
large ribosomal proteins (Rpl12 S38, Rpl6 S12 and Rpl7 T8), two sites on the ribosomal
stalk (RPP2A T43 and T49) and two sites on small ribosomal proteins (Rps2 S2 and Rps3
T207 and S221). In response to glucose deprivation the phosphorylation sites on the large
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ribosomal subunit Rpl16 S2 and Rpl24 S9 and on the small subunit Rps7 S10 and T14,
Rps15 S2 and Rps16 S15 were increased.
Table 2.2: Phosphosites in ribosomal proteins that change in response to heat shock.
Protein Phosphosites Phosphoylation compared to normal growth
Rps2 S2 1.6 ± 0.52
Rps3 T207 1.27 ± 0.14
Rps3 S221 1.22 ± 0.16
Rps6A S232 0.32 ± 0.24
Rps6A S233 0.32 ± 0.24
RpL6A S12 1.43 ± 0.07
RpL7A T8 1.18 ± 0.2
RpL12A S38 1.91 ± 0.4
RpL24A S86 0.59 ± 0.15
Rpp2A T43 1.22 ± 0.06
Rpp2A T49 1.22 ± 0.24
Table 2.3: Phosphosites in ribosomal proteins that change in response to glucose depletion.
Protein Phosphosites Phosphoylation compared to normal growth
Rps6A S232 0.33 ± 0.05
Rps6A S233 0.33 ± 0.05
Rps7B S10 1.20 ± 0.17
Rps7B S14 1.20 ± 0.17
Rps15 S2 1.48 ± 0.29
Rps16A S15 1.40 ±0.41
Rpl12A S38 0.83 ± 0.09
Rpl16B S2 1.18 ± 0.13
Rpl24A S9 1.23 ±0.15
Thus, it could be demonstrated that ribosomal phosphorylation sites change in response
to a stress-induced shut-down of translation suggesting that phosphorylation of ribosomes
at these sites might be involved in the translational response to stress.
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2.2 Mutational Analysis of Selected Ribosomal
Phosphorylation Sites
Having identified new ribosomal phosphorylation sites as well as sites that change
significantly in response to translational impairment by stress, the aim of this study
was to demonstrate the biological significance of some of the identified phosphorylation
sites and elucidate the underlying molecular mechanism of their regulation. Therefore,
phosphorylation sites identified in the initial phosphoproteomic analysis as well as sites
that changed in the SILAC experiments were chosen for mutational analysis. Since the sites
identified in the SILAC experiments already showed a response to translational impairment,
they most probably are involved in translation regulation – at least in stress-induced control
mechanisms. In addition, sites identified in the general phosphoproteomic survey of yeast
ribosomes were chosen according to their reproducibility in the different preparations, their
intensity of their MS-signal, their position on the ribosome and their conservation in higher
eukaryotes.
The phosphorylatable amino acids (S, T and Y) of the selected phosphorylation sites were
mutated to the phospho-deficient A and subsequently to the phospho-mimicry D residues
(in the case the A mutation showed an influence on translation). The corresponding
deletion strains, either a single deletion for single copy ribosomal proteins or the double
deletion for two copy ribosomal proteins were supplemented with a wild-type or mutant
gene copy on a shuﬄe plasmid. Subsequently, the translation activity of mutated ribosomal
proteins was assessed using translation active extracts of yeast cells to translate either a
capped or a Cricket Paralysis Virus (CrPV) IRES containing luciferase mRNA in vitro
(Fig. 2.3). The capped luciferase mRNA contained the common eukaryotic 5’ UTR
structure with a 5’ m7GpppG cap and the full set of initiation factors is needed for efficient
translation initiation. In contrast, the CrPV 5’ UTR contains a so-called Internal Ribosome
Entry Site (IRES). Translation of the CrPV IRES differs from canonical cap-dependent
initiation in the direct recruitment of 80S ribosomes to the start codon by a distinct
secondary structure in the 5’ UTR without the help of any translation initiation factors
(Wilson et al., 2000; Pestova and Hellen, 2003). First, the phospho-deficient A mutants
were assessed in the in vitro translation assay to translate the 5’ capped luciferase mRNA
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Figure 2.3: Schematic representation of the mutational analysis using an in vitro translation assay with in
vitro transcribed luciferase mRNAs.
compared to the corresponding wild-type. In the case the A mutant and wild-type extracts
differed in their translation activity in vitro, cap-independent translation activity and the
translation activity of the corresponding phospho-mimicry D mutant was assessed.
So far, the in vitro translation activity of 25 phospho-deficient A mutants was analyzed
(data not shown). Thereof, twelve A mutants showed different translation activity
compared to wild-type extracts in cap-dependent translation – the majority of the analyzed
phospho-deficient A mutants showed an increase and few sites a decrease in cap-dependent
translation activity. The phospho-mimicry D mutants of these phosphorylation sites either
possessed translation activity comparable to wild-type indicating that the phosphorylation
mimicry corresponds to the wild-type situation in the cell or a decrease indicating that the
phosphorylation status might change during the translation cycle or the phospho-mimicry
failed.
Intriguingly, phosphorylation sites were identified that seem to be involved in
cap-dependent translation indicated by a defect in translating the capped, but not the
CrPV IRES containing mRNA, as well as sites that influence cap-independent translation
as the mutant affects the translation activity of both constructs. Moreover, the loss of
phosphorylation of some sites leads to increased while the loss of other phosphorylations
to a decreased translation activity indicating a specific function in translation. Two
phosphorylation sites, Rps5 T38 and Rps12 T23, showed a defect in cap-dependent
translation when mutated to the phospho-deficient A and their function in translation
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initiation was analyzed in more detail.
2.3 Function of Rps5 T38 Phosphorylation in Start Codon
Selection
The small ribosomal protein Rps5 forms part of the mRNA exit channel (Fig. 3.3 A). Rps5
belongs to a family of highly conserved ribosomal proteins also containing the prokaryotic
Rps7, archeal Rps7 and eukaryotic Rps5. Despite a conserved central core domain and
C-terminus, Rps5 proteins contain a variable N-terminus that differs in length between the
different species (Fig. 3.3 B). Recently, this N-terminus was reported to be important for
40S subunit function in translation and for efficient translation initiation (Galkin et al.,
2007; Lumsden et al., 2009). In this study, two ribosomal phosphorylation sites on the
N-terminal part of Rps5 were identified, namely Rps5 T21 and T38. Both sites were
analyzed for translation activity using the in vitro translation assay system described above
(Section 2.2). In contrast to the phospho-deficient rps5-T21A mutation that had no effect
on the translation activity in vitro the phosphorylation of Rps5 T38 is important for
translation.
2.3.1 The rps5-T38A Mutation Causes a Cap-Dependent
Translation Defect
The translation activity of phospho-deficient rps5-T38A mutant extracts to translate the
capped mRNA was reduced to around 53 % (± 11 %) of the corresponding wild-type
extracts. However, the ability to translate the CrPV IRES containing luciferase mRNA
was not affected in the rps5-T38A mutant translation active extracts compared to RPS5
wt extracts (Fig. 2.4 A) indicating that the rps5-T38A mutation causes a cap-dependent
translation defect in vitro. In contrast, the phospho-mimicry rps5-T38D mutant showed a
reduced translation activity for both capped and CrPV IRES containing mRNA reporters
to 38 % (± 10 %) of the wild-type activity (Fig. 2.4 A). Thus, the rps5-T38D mutation
causes a cap-independent translation defect in vitro.
In order to rule out that the translation defect is specific for the two exogenous mRNA
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Figure 2.4: The RPS5 phospho-mutants cause a cap-dependent translation defect. (A) Translation activity
of translation active extracts from RPS5 wild-type, rps5-T38A, and rps5-T38D mutant cells for the capped
and CrPV IRES luciferase mRNA reporters was analyzed by luciferase measurement. For both RNA constructs
the activity of the RPS5 wild-type extracts was set to 100 % (mean ± SD; n = 4; ** p < 0.001; * p < 0.05).
(B) Translation activity of in vitro translation active extracts to translate endogenous mRNAs was assessed
using [35S] methionine to label synthesized proteins in translation active extracts of rps5-T38A, rps5-T38D
and RPS5 cells. Samples were taken at the indicated time points and incorporated [35S] Met measured by
scintillation counting (mean ± SD; n = 3; p < 0.05 for t ≥ 20 min). (C) Both Rps5 phospho-mutants cause
a decrease in de novo protein synthesis compared to wild-type cells measured by incorporation of [35S] Met
into newly synthesized proteins. Samples were taken at the indicated time points and [35S] Met incorporation
measured by scintillation counting (mean ± SD; n = 4; p < 0.05 for t ≥ 10 min).
reporters, the activity to translate endogenous mRNA was assessed using [35S] methionine
to measure time-dependent protein synthesis in in vitro translation active extracts. In
the rps5-T38A mutant extracts the translation activity for endogenous mRNAs was
around 60 % of the wild-type activity (Fig. 2.4 B). The rps5-T38D mutant showed a
stronger reduction in the activity to translate endogenous mRNAs to 30 % of the wild-type
(Fig. 2.4 B). The translation defect of both RPS5 phospho-mutants is not dependent on
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Figure 2.5: In rps5-T38A mutant cells the P/M ratio is decreased. (A-C) For polysome profiles of RPS5 wt
(A), rps5-T38A (B) and rps5-T38D (C) strains, WCEs were separated on 10-50 % sucrose gradients and the
absorption at 260 nm was measured. The polysome (P) / monosome (80S;M) ratio was calculated by integrating
the area under the respective peaks after substraction of the baseline (mean ± SD; n = 4).
the mRNA used to asses the translation activity in vitro.
To corroborate the in vitro translation defect of both phospho-mutants in vivo the
incorporation of [35S] methionine into de novo synthesized proteins was assessed. After the
addition of [35S] methionine to the rps5-T38A, rps5-T38D and RPS5 wt cells, samples were
taken at the indicated time points and [35S] incorporation was analyzed by scintillation
counting of TCA precipitated proteins. For all three strains a linear increase in [35S]
incorporation was observed, but rps5-T38A and rps5-T38D mutant cells showed a reduced
translation activity to 60 % of the wild-type level for time points later than 10 min
(Fig. 2.4 C). Thus, both phospho-mutants cause a translation defect in vivo.
A defect in translation initiation results in an accumulation of free 80S ribosomes
(monosomes) and a decrease in heavily translating polysomes indicated by a reduced
polysome to monosome (P/M) ratio in polysome gradient profiles. Consistent with the
cap-dependent translation defect observed in vitro the P/M ratio in polysome gradient
profiles of the rps5-T38A mutant cells was reduced by 15 % compared to wild-type profiles
(Fig. 2.5 A, B). Interestingly, in addition to a reduced P/M ratio the rps5-T38D mutation
causes an increased 60S peak in polysome gradient profiles that might result from reduced
amount of 40S subunits (Fig. 2.5 A, C).
Taken together, both Rps5 T38 phospho-mutations cause a translation defect in vitro
as well as in vivo. Specifically, the rps5-T38A mutant showed a cap-dependent, most
likely translation initiation defect, whereas the rps5-T38D mutant has a cap-independent
reduction in translation activity.
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Figure 2.6: rps5-T38D mutation leads to lower levels of small ribosomal proteins. (A-C) Ribosomes were split
into subunits by omitting Mg2+ ions. WCEs of RPS5 wt (A), rps5-T38A (B) and rps5-T38D (C) strains were
separated on a 5-25 % sucrose gradient. The 60S/40S ratio was calculated as for the P/M ratio. (D) WCEs of
either RPS5 wt, rps5-T38A or rps5-T38D (as N-terminal 3HA fusions) were analyzed by Western blot using
antibodies against Pgk1, HA, Rpl6 and Rps8. HA, Rpl6 and Rps8 signals were normalized to the corresponding
Pgk1 signals and protein levels calculated relative to wild-type (mean ± SD; n = 4).
2.3.2 In rps5-T38D Mutant Cells 40S Subunits Are Decreased
To investigate in more detail the elevated 60S peak in the polysome gradient profiles of
rps5-T38D mutant cells (Fig. 2.5 C), ribosomes where split into their subunits to determine
the levels of 40S and 60S subunits in the cell. To this end, WCEs and sucrose density
centrifugation were performed ommiting Mg2+ ions. The 60S/40S ratio of the rps5-T38A
mutant cells equaled RPS5 wt cells (Fig. 2.6 A, B). However, the increased 60S peak in
the rps5-T38D mutant is caused by the reduced amount of 40S compared to 60S subunits
indicated by the increased 60S/40S ratio (Fig. 2.6 A, C).
This finding was corroborated using Western blot analysis to determine the levels of
HA-tagged Rps5 (wt and mutant), the small ribosomal protein Rps8 and the large
ribosomal protein Rpl6 relative to Pgk1 (Fig. 2.6 D). For the rps5-T38A mutant cells the
protein levels were similar to wild-type levels, whereas in the rps5-T38D mutant cells the
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HA-Rps5 and the Rps8 level was reduced to around 60 % of the wild-type while Rpl6 was
almost unaffected (Fig. 2.6). These results suggest that the rps5-T38D mutation causes a
ribosome biogenesis defect or affects the stability of the small ribosomal subunit whereas
the defect observed with the rps5-T38A mutation is not caused by an impaired ribosome
biogenesis or 40S stability.
2.3.3 Rps5 Phospho-Mutants Do Not Affect Translation Elongation
So far, the obtained results suggest that the rps5-T38A mutant causes a translation
initiation defect, while the rps5-T38D mutant has a cap-independent translation defect
caused by a defect in 40S ribosome synthesis or stability. To study elongation independent
of initiation a poly(U) assay was performed by Viter Marquez. This assay allows peptide
synthesis independent of canonical translation initiation using poly(U) homopolymers as
mRNA templates in in vitro translation active extracts (Leibowitz et al., 1991). The
elongation rate is determined by measuring the time-dependent incorporation of [14C]
phenylalanine into poly-F peptides (Fig. 2.7 A, left arrow). In parallel translation fidelity
can be assessed by measuring the incorporation of near-cognate [3H] leucine (Fig. 2.7 A,
right arrow). Neither rps5-T38A nor rps5-T38D mutant extracts showed an elongation or
translation fidelity defect in vitro compared to wild-type extracts (Fig. 2.7 B-E).
In order to assess whether translation fidelity is affected in vivo, different dual luciferase
reporters developed by Dinman and Bedwell were used (Hager and Dinman, 2003;
Salas-Marco and Bedwell, 2005). These reporter plasmids encode Renilla luciferase, a
linker, and firefly luciferase mRNA (Fig. 2.8A). The linker containing the L-A (−1) or
the Ty1 (+1) frameshifting signal (Fig. 2.8 Ai) only enables Firefly translation when the
ribosomes fail to maintain the correct reading frame and shift ± 1 nucleotide. The second
dual luciferase set contains point mutations of H245 to Q, R and D (Fig. 2.8 Aii) resulting
in an inactive Firefly luciferase. Only when the not cognate amino acid His is incorporated,
the Firefly is active. The readthrough frequency of stop codons can be measured with the
dual luciferase reporters containing one of the three stop codons in their linker (Fig. 2.8
Aiii). Overall, the rps5-T38A and rps5-T38D mutations did not severely affect translation
fidelity in vivo. The rps5-T38A mutant showed a slightly increased +1 frameshifting
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(Fig. 2.8 B) and readthrough frequency (Fig. 2.8 D) compared to wild-type but the
observed effect was to small to explain the translation defect observed in the previous
experiments. The same is true for the rps5-T38D mutant that also showed a minor increase
in +1 frameshifting, miscoding for H245D and readthrough of TGA and TAA stop codons
(Fig. 2.8 B-D).
Figure 2.7: RPS5 phospho-mutants have no elongation defect in vitro. (A) Schematic representation of the
poly(U) assay. Translation elongation efficiency and fidelity was determined by measuring the incorporation
of [14C] phenylalanine (F) and misincorporation of near cognate amino acids by [3H] leucine (L), respectively.
(B+C) Both RPS5 phospho-mutants do not show an elongation defect. The time dependent incorporation
of [14C] F into polypeptides in rps5-T38A (B) and rps5-T38D (C) and RPS5 wt translation active extracts
was determined by scintillation counting (mean ± SD; n = 3). (D+E) The translation defect of RPS5
phospo-mutants does not influence translation fidelity. In translation active extracts of rps5-T38A (D) and
rps5-T38D (E) mutants and RPS5 wt the incorporation of near-cognate L relative to F incorporation was
determined at the indicated timepoints (mean ± SD; n = 3).
Taken together, both RPS5 phospho-mutants do not affect translation elongation
indicating that the observed translation defect of the rps5-T38A mutant is indeed a
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translation initiation dependent defect. Since the rps5-T38D mutation has a translation
defect caused by impaired ribosome biogenesis or stability and the aim of this study was to
elucidate the function of phosphorylation sites in translation and not ribosome biogenesis,
only the rps5-T38A mutant was further analyzed in more detail.
Figure 2.8: Elongation fidelity is unaffected in RPS5 phospho-mutant cells in in vivo. (A) Schematic illustration
of different dual luciferase reporters encoding Renilla luciferase, a linker and Firefly luciferase. The linker contains
a ±1 frameshifting signal (i) or one of the tree stop codons (iii). In (ii) Firefly H245 is mutated to H245Q, H245R
or H245D resulting in an inactive luciferase to measure miscoding of near cognate amino acids. (B-D) RPS5 wt,
rps5-T38A and rps5-T38D strains harboring the frameshifting (i; B), miscoding (ii; C) and readthrough (iii,
D) plasmids were assessed for miscoding events by dual luciferase assay. The Firefly signal was normalized to
the Renilla activity and the corresponding ratios of the different reporters normalized to the ratio of a dual
luciferase reporter with a readthrough linker and active Firefly. Finally, the resulting ratios were normalized to
wild-type (mean ± SD; n = 6; ** p < 0.001; * p < 0.05)
2.3.4 Formation of 48S PICs Is Reduced in the rps5-T38A Mutant
To further elucidate the function of Rps5 T38 phosphorylation in translation initiation
an in vitro translation initiation assay was adapted from Beckmann et al. (2005). In
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this assay the incorporation of in vitro transcribed [32P] labeled RPL38 mRNA into
translation initiation complexes in translation active extracts was analyzed. The initiation
complexes were separated by sucrose density centrifugation followed by scintillation
counting of gradient fractions to determine the distribution of the radioactively labeled
mRNA. To block elongation the translation initiation reaction was incubated in the
presence of cycloheximide. GMP-PNP, a non-hydrolizable GTP analog, was added as
indicated preventing the GTP hydrolysis during 60S subunit joining and thus accumulating
48S initiation complexes at the start codon. When only elongation was inhibited by
cycloheximide, free mRNPs were accumulating and the 80S peak was significantly reduced
in rps5-T38A mutant extracts to 84 % of the wild-type extracts (Fig. 2.9 A). In the presence
of GMP-PNP, when subunit joining is blocked, the formation of 48S initiation complexes
in the rps5-T38A mutant extracts was reduced to 77 % of the wild-type while free mRNPs
accumulated (Fig. 2.9 B).
Figure 2.9: The rps5-T38A mutation causes a decreased 48S PIC formation. (A+B) Incorporation of
[32]P labeled RPL38 mRNA into initiation complexes was analyzed in initiation reactions of translation active
extracts. (A) Incorporation of RPL38 mRNA into initiation complex in the presence of cycloheximide was
assessed by sucrose density centrifugation and scintillation counting of gradient fractions. (B) Translation
initiation reaction was done in the presence GMP-PNP to accumulate 48S complexes. The fractions containing
mRNPs, 48S, and 80S complexes are indicated and the amount of mRNA in each fraction was calculated relative
to wild-type (table below; mean ± SD; n = 3).
Subsequently, the formation of initiation complexes was assessed in vivo. To this end,
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the amount of two endogenous mRNAs, RPL38 and RPL41A, associated with native 48S
initiation complexes in rps5-T38A mutant versus RPS5 wild-type cells was compared.
These two ribosomal mRNAs were chosen due to their high abundance and their relatively
short length allowing a good separation of initiation complexes. The cells were treated
with cycloheximide to block elongation and initiation complexes were separated by sucrose
density centrifugation. The amount of RPL38 mRNA, RPL41A mRNA, and 18S rRNA in
each gradient fraction was determined by quantitative reverse transcription real-time PCR
(qRT-PCR). In rps5-T38A mutant cell the ratio of RPL38 and RPL41A mRNA levels to
18S rRNA was significantly reduced to 50 % (± 16 %) and 52 % (± 21 %), respectively,
compared to wild-type cells. Moreover, the pool of free RPL38 and RPL41A mRNA in the
mutant was dramatically increased (Fig. 2.10).
Figure 2.10: In rps5-T38A mutant cells the association of RPL38 and RPL41A mRNA with 48S PICs is
decreased. WCEs of RPS5 wt and rps5-T38A mutant cells were separated by sucrose density centrifugation
and total RNA was isolated from each gradient fraction. The amount of 18S rRNA (A), RPL38 (B) and
RPL41A (C) mRNA was determined by qRT-PCR using the CT method. One representative example is shown
out of four independent experiments. (D) The amount of each mRNA associated with 48S PICs was calculated
relative to the 18S rRNA in the indicated fractions an normalized to wt (mean ± SD; n = 4).
The 48S PIC is formed during initiation by the recruitment of the mRNA to the
pre-assembled 43S complex – 40S subunit associated with eIF1A and the MFC containing
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eIF1, eIF3, eIF5 and the ternary complex (TC) – with the help of the cap-binding complex
eIF4F (see Section 1.4.1). To assess whether the interplay of all these different translation
initiation factors is affected by the loss of Rps5 T38 phosphorylation, the association
of several initiation factors with the 40S subunit and 80S/polysomes was investigated.
Whole cell extracts form RPS5 wt and rps5-T38A mutant cells were sedimented through
sucrose density gradients. To block elongation and stabilize ribosomes bound to mRNAs
cycloheximide was added prior to harvesting. The gradient fractions were subjected to
Western blot analysis using antibodies against initiation factors and ribosomal proteins as
indicated. The signal of each eIF in the 40S or 80S/polysome fractions was normalized to
the corresponding Rps8 levels and calculated relative to wild-type (Fig. 2.11). Interestingly,
all analyzed translation initiation factors showed an increased and prolonged association
with the initiating rps5-T38A mutant ribosomes compared to wild-type ribosomes. In the
rps5-T38A mutant the proper release of initiation factors seems to be impeded during
translation initiation. Thus, the phosphorylation of Rps5 T38 seems to be needed for an
efficient 48S PIC formation, either directly or indirectly via one or more initiation factors.
2.3.5 Context Dependent Start Codon Recognition Is Impaired in the
rps5-T38A Mutant
After recruitment of the 43S PIC to the 5’ cap of the mRNA, the 43S complex scans along
the 5’ UTR until it encounters a start codon in the ribosomal P-site. Here, not only the
discrimination against non-AUG codons but also the sequence context of the AUG are
crucial for efficient start codon selection (see Section 1.4.1).
First, the discrimination between AUG and non-AUG start codons was addressed using
the dual luciferase reporter pRaugFFuug encoding AUG-Renilla and UUG-Firefly luciferase
reporter mRNAs (Cheung et al., 2007). This reporter plasmid allows to assess in parallel
the initiation from AUG and UUG start codons at steady state in vivo by dual luciferase
measurement. The absolute expression levels of AUG-Renilla and UUG-Firefly luciferase
reporter were both reduced in rps5-T38A mutant cells compared to RPS5 wild-type.
Interestingly, the effect of the rps5-T38A mutation was much stronger on the AUG-Renilla
(33 ± 11 %) than on the UUG-Firefly reporter (54 ± 15 %), thus increasing the UUG vs.
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Figure 2.11: The rps5-T38A mutation alters the association of initiation factors. (A+B) RPS5 wt (A) and
rps5-T38A (B) mutant cells were treated with cycloheximide prior to harvesting. WCEs were separated by
sucrose density gradient centrifugation, and gradient fractions were subjected to Western blot analysis using
antibodies against the indicated initiation factors and ribosomal proteins. The signal of each eIF in the 40S or
80S/polysomes fractions (boxed) was normalized to the corresponding Rps8 signals. (C) The relative levels of
rps5-T38A to wild-type were calculated and plotted (mean ± SD; n = 3).
AUG ratio almost twofold (Fig. 2.12A). This finding suggests that the rps5-T38A mutation
impairs start codon recognition in vivo.
To assess the discrimination against different start codon consensus sequences SUI1-lacZ
fusion reporters were used in rps5-T38A mutant and RPS5 wild-type cells (Martin-Marcos
et al., 2011). The native poor initiation context of the SUI1 gene with -3CGU-AUG is
reported to be unfavorable and to control Sui1 expression via its own function in start codon
selection (Ivanov et al., 2010). The poor SUI1 context was modified to perfectly match the
yeast optimal consensus context of -3AAA-AUG (SUI1-opt-lacZ) and to exacerbate the poor
SUI1 context by introducing -3UUU-AUG (SUI1-UUU-lacZ) as an even more unfavorable
initiation codon context (Fig. 2.13 A) (Shabalina et al., 2004). Since the different reporters
encode lacZ fusions the context dependent initiation can be measured by β-galactosidase
assay in vivo (Miller, 1972). As expected in RPS5 wild-type cells the SUI1-opt-lacZ fusion
was expressed more than twice as much as the wild-type SUI1-lacZ fusion, whereas the
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Figure 2.12: The rps5-T38A mutation leads to increased initiation from non-AUG start codons. (A) Schematic
illustration of the dual luciferase reporter pRaugFFuug encoding AUG-Renilla (i) and UUG-Firefly (ii) luciferase.
(B) RPS5 wt and rps5-T38A mutant strains harboring the pRaugFFuug plasmid were analyzed by dual luciferase
assay. Absolute expression levels of AUG-Renilla [RLU] and UUG-Firefly [FLU] in RPS5 wt and rps5-T38A
mutant cells were plotted (graph) and normalized to wild-type (table below; mean ± SD; n = 4). (C) Ratios
of expression levels of UUG vs. AUG reporter were calculated (graph) and normalized to wild-type levels (table
below).
SUI1-UUU-lacZ was expressed at a level 4.4 times below the SUI1-opt-lacZ (Fig. 2.12 B).
Intriguingly, these differences in the expression level between optimal, poor and highly
unfavorable start codon context in SUI1-opt-, SUI1- and SUI1-UUU-lacZ, respectively,
was completely lost by the rps5-T38A mutation (Fig. 2.12 B). Thus, phosphorylation of
Rps5 at T38 is needed for the discrimination between good and poor start codon context.
A powerful assay to investigate scanning processivity was developed by Berthelot et al.
using a series of Firefly luciferase encoding constructs with 5’ UTRs that range in their
length between the 5’cap and the start codon from 43 to 607 nucleotides (Fig. 2.14 A)
(Berthelot et al., 2004). The in vitro transcribed mRNAs were translated in extracts of
RPS5 wt and rps5-T38A mutant cells. The time 40S subunits need to locate the start
codon was estimated by comparing the time courses of protein synthesis observed with
the mRNAs carrying the different length of 5’ UTR. Considering the different delay times
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Figure 2.13: The rps5-T38A mutation eliminates discrimination between different AUG context sequences in
SUI1-lacZ reporters. (A) Representation of different SUI1-lacZ reporter plasmids: (i) wild-type SUI1 context;
(ii) optimal consensus sequence SUI1-opt-lacZ and (iii) highly unfavorable context SUI1-UUU-lacZ. (B)
Expression of different SUI1-lacZ reporter plasmids depicted in (A) in RPS5 wt and rps5-T38A mutant cells was
measured by β-galactosidase activity (miller units U). Ratios of SUI1-opt-lacZ/ SUI1-lacZ or SUI1-opt-lacZ/
SUI1-UUU-lacZ were calculated (table below; mean ± SD; n = 4).
for different length eliminated the contribution of the early, undefined phase of loading
and activation of scanning competent 40S subunits (Lorsch and Herschlag, 1999). The
comparison between the time courses of luciferase synthesis in RPS5 wt and rps5-T38A
mutant translation active extracts showed that the rps5-T38A mutant ribosomes need
almost one minute longer to pass the early, undefined phase (Fig. 2.14 B). However, the
rps5-T38A mutant ribosomes have the same in vitro scanning rate as RPS5 wild-type
ribosomes of approximately 9 nucleotides per second (Fig. 2.14 B). Thus, the rps5-T38A
mutation does not confer a scanning processivity defect.
Taken together, the rps5-T38A mutation impairs context dependent start codon
recognition and increases initiation from non-AUG codons in vivo.
2.3.6 The rps5-T38A Mutation Influences Growth under Different
Conditions
Protein phosphorylation is one of the most important posttranslational modifications
and allows rapid adaptation to changing environmental conditions. To elucidate the
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Figure 2.14: In rps5-T38A mutant cells scanning processivity is unaffected. (A) Illustration of in vitro
transcribed 5’ UTR leader luciferase mRNA reporters of various lengths L0, L0.5 and L1 with respective length
in nucleotides given. (B) Time dependent analysis of luciferase generation in in vitro translation active extracts
of RPS5 wt and rps5-T38A mutant cells. The in vitro transcribed capped luciferase mRNAs depicted in (A)
were translated and luciferase activity measured at the indicated time points (5 to 9 min). One representative
example out of three independent experiments is shown. (C) Estimates of delay time of different length 5’ UTRs
and the resulting scanning rate for RPS5 wt and rps5-T38A mutant extracts are shown (mean ± SD; n = 3).
physiological relevance of the Rps5 T38 phosphorylation, the growth of rps5-T38A and
RPS5 wt cells was analyzed using microcultivation in liquid cultures in a Bioscreen C
Analyzer. The optical density was recorded every 20 min over two days. The obtained
growth curves were corrected for non-linearity at stationary phase growth and doubling
times were calculated as described by Warringer and Blomberg (2003). Under the majority
of tested growth conditions like high salinity, osmotic stress, heat and cold, unfolded protein
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Figure 2.15: In rps5-T38A mutant cells growth is affected under different conditions. Growth of rps5-T38A
and RPS5 wt cells was recorded for two days in a Bioscreen Analyzer C under different conditions: (A)
3-aminotriazol (3-AT; 100, 200, and 300 mM), (B) cycloheximide (CH; 0.1, 0.25, and 0.5 µg/ml), (C) 0.1
and 0.05 % glucose or 4 % ethanol (in SC without glucose), (D) rapamycin (rap; 0.025, 0.05, and 0.1 µg/ml).
Doubling times in hours are given in brackets. All experiments were carried out using two independent spores
in triplicates. The observed OD values were corrected for the non-linearity at higher cell densities and doubling
times were calculated according to Warringer and Blomberg (2003) (see Section 4.2.13).
response and several translation inhibitors, rps5-T38A and RPS5 wt cells showed the same
growth pattern. Interestingly, the rps5-T38A mutant cells showed a slightly increased
sensitivity to the drug 3-aminotriazole (3-AT) compared to RPS5 wt cells (Fig. 2.15 A).
3-AT inhibits the synthesis of the amino acid histidine thus starving the cells for this amino
acid.
In addition, the rps5-T38A mutation causes an increased sensitivity to the translation
inhibitor cycloheximide (CH) which inhibits translation elongation by binding to the
ribosomal E-site and blocking the translocation step (Fig. 2.15 B) (Loewith and Hall, 2011).
Moreover, growth under reduced glucose concentrations or ethanol as carbon source was
slightly impaired in the rps5-T38A mutant cells compared to RPS5 wt (Fig. 2.15 C).
Surprisingly, the rps5-T38A mutant cells were less sensitive to the drug rapamycin
(Fig. 2.15 D). Rapamycin is an inhibitor of the conserved Ser/Thr kinase TOR which
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regulates cell growth and metabolism in response to environmental causes (Wullschleger
et al., 2006; Altmann and Linder, 2010). TOR regulates translation via the kinase S6K and
the 4E-BPs. Phosphorylation of 4E-BPs by TOR leads to their dissociation from eIF4E
thus promoting cap-dependent translation initiation (see Section 1.4.3).
The rps5-T38A mutation causes a growth defect under specific conditions like reduced
availability of energy sources and amino acids or in the presence of cycloheximide blocking
translation elongation, growth is impaired compared to wild-type. In contrast, the
rps5-T38A mutant cells are more resistant to rapamycin. Concluding, the loss of Rps5
T38 phosphorylation has an influence on the growth and fitness under specific conditions,
thus providing a physiological relevance of this phosphorylation site.
2.4 Rps12 T23 Phosphorylation Affects Scanning
In the general phosphoproteomic survey of Saccharomyces cerevisiae ribosomal proteins
two sites on the small ribosomal protein Rps12 were identified, namely Rps12 T19 and
T23. So far, nothing is reported in the literature about Rps12 except its localization at the
mRNA entry channel determined recently by crystallography ((Rabl et al., 2011; Ben-Shem
et al., 2011), see also Fig. 3.4). Both phospho-deficient A mutants were assessed for their
translation activity in vitro. However, only the rps12-T23A mutation caused a translation
defect.
2.4.1 In rps12-T23A Mutant Cells Cap-Dependent Translation Is
Impaired
The translation activity of the phospho-deficient rps12-T23A mutant extracts to translate
the capped mRNA was reduced to 56 % (± 13 %) of the corresponding RPS12 wild-type
cells. In contrast, the translation activity of the rps12-T23A mutant extracts to
translate the CrPV IRES containing mRNA resembled wild-type levels indicating that
only cap-dependent translation is affected (Fig. 2.16 A).
There was no difference in the translation activity of the phospho-mimicry rps12-T23D
mutant extracts to translate the capped and the CrPV IRES containing mRNA compared
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Figure 2.16: The rps12-T23A mutation causes a cap-dependent translation defect. (A) Translation activity of
translation active extracts from RPS12 wt, rps12-T23A and rps12-T23D mutant cells for the capped and CrPV
IRES luciferase mRNA reporters was analyzed by luciferase measurement as in Fig. 2.4 A. (B) Translation activity
of translation active extracts of RPS12 wt and rps12-T23A mutant cells to translate endogenous mRNAs was
assessed in vitro using [35S] Met to label synthesized proteins. Experiment performed as in Fig. 2.4 B. (C) The
rps12-T23A mutation caused a decrease in de novo protein synthesis compared to wild-type cells measured by
incorporation of [35S] Met into newly synthesized proteins. Experiment performed as in Fig. 2.4 C.
to RPS12 wt extracts (Fig. 2.16 A). In addition to the two exogenous mRNA reporters, the
translation activity of in vitro translation active extracts to translate endogenous mRNAs
was analyzed in time-dependent protein synthesis using [35S] methionine. In rps12-T23A
mutant extracts the activity to translate endogenous mRNAs was reduced to 70 % of the
wild-type activity (Fig. 2.16 B). Thus, the translation defect of the rps12-T23A mutant is
not dependent on the mRNA used to asses the translation activity in vitro.
Using [35S] methionine labeling to measure de novo protein synthesis the rps12-T23A
mutation caused a reduced translation activity in vivo to 70 % of the wild-type whereas
the phospho-mimicry rps12-T23D showed almost wild-type levels (Fig. 2.16 C).
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Figure 2.17: The rps12-T23A mutation causes decreased P/M ratio. (A-C) WCEs of RPS12 wt (A),
rps12-T23A (B) and rps12-T23D (C) strains were separated on 10-50 % sucrose gradients and the absorption
at 260 nm was measured. The P/M ratio was calculated by integrating the area under the respective peaks
after substraction of the baseline (mean ± SD; n = 4).
As expected, the decreased cap-dependent translation activity of the rps12-T23A mutant
resulted in a slight reduction of the P/M ratio in polysome gradient profiles compared to
wild-type whereas the rps12-T23D mutant showed an even slightly increased P/M ratio
(Fig. 2.17). Importantly, the observed translation initiation defect in rps12-T23A cells was
not caused by lower levels of Rps12 itself or ribosomal subunits as was shown by Western
blot analysis of WCEs of RPS12 wt, rps12-T23A and rps12-T23D mutant cells using the
indicated antibodies (Fig. 2.18).
In summary, Rps12 T23 phosphorylation is needed for efficient translation initiation.
Figure 2.18: Both RPS12 phospho-mutants do not affect ribosomal protein levels. WCEs of either RPS12 wt,
rps12-T23A or rps12-T23D (as N-terminal 3HA fusions) were analyzed by Western blot using antibodies
against Pgk1, HA, Rpl6 and Rps8. HA, Rpl6 and Rps8 signals were normalized to the corresponding Pgk1
signals and protein levels calculated relative to wild-type (mean ± SD; n = 4).
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2.4.2 The rps12-T23A Mutation Does Not Influence Translation
Fidelity
Although the obtained data suggests that the rps12-T23A mutation causes a translation
initiation defect, elongation was assessed independent of initiation using the poly(U)
assay (performed by Viter Marquez). The elongation rate was determined by measuring
the time-dependent incorporation of [14C] phenylalanine into poly-F peptides, while
the translation fidelity was assessed by measuring the incorporation of near-cognate
[3H] leucine. There was no elongation or translation fidelity defect detectable for the
rps12-T23A mutant compared to wild-type cells in vitro (Fig. 2.19).
Figure 2.19: The rps12-T23A mutant cells have no translation fidelity defect in vitro. (A) The time dependent
incorporation of [14C] F into polypeptides in RPS12 wt and rps12-T23A mutant translation active extracts was
determined by scintillation counting (mean ± SD; n = 3). (B) In translation active extracts of RPS12 wt and
rps12-T23A mutant cells the incorporation of near-cognate [3H] L relative to F incorporation was determined
at the indicated time points (mean ± SD; n = 3).
In order to assess translation fidelity of the rps12-T23A mutant cells in vivo, different
dual luciferase reporters (see Section 2.3.3 and Fig. 2.8 A) were used to measure
frameshifting, readthrough and misincorporation rates. The rps12-T23A mutant did not
affect frameshifting and readthrough of stop codons compared to wild-type (Fig. 2.20 A, B).
Only misincorporation of near-cognate amino acids was slightly affected – with the H245Q
mutation reporter rps12-T23A cells showing a hyperacurate phenotype while the H245D
mutation caused an increased misincorporation (Fig. 2.20 C). However, the observed effect
was to small to explain the translation defect observed in the previous experiments. Thus,
the translation defect of the rps12-T23A mutant cells must be caused by a different step
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Figure 2.20: Translation fidelity is unaffected in rps12-T23A mutant cells in in vivo. (A-C) RPS12 wt and
rps12-T23A mutant strains harboring the frameshifting (A), miscoding (B) and readthrough (C) plasmids
depicted in Fig. 2.8 A were assessed for miscoding events by dual luciferase assay. The different miscoding rates
were calculated as in Fig. 2.8 (mean ± SD; n = 6; * p < 0.05).
in translation, most likely during translation initiation.
2.4.3 The rps12-T23A Mutation Causes Decreased Initiation
Complex Formation
Having first indications that Rps12 T23 phosphorylation is needed for efficient canonical
translation initiation, the step of translation initiation Rps12 T23 phosphorylation
functions in should be elucidated. To this end, the incorporation of in vitro transcribed
[32P] labeled RPL38 mRNA into initiation complexes of rps12-T23A mutant and RPS12 wt
translation active extracts was analyzed as described in Section 2.3.4. When elongation
was blocked by the addition of cycloheximide 80S initiation complexes were decreased in
extracts of the rps12-T23A mutant to 87 % (±7 %) of RPS12 wt extracts (Fig. 2.21 A).
Moreover, a reduction of 80S initiation complexes in the rps12-T23A mutant extracts to
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Figure 2.21: In rps12-T23A mutant cells the formation of 80S initiation complexes is affected. (A+B)
Translation initiation assays of RPS12 wild-type and rps12-T23A mutant translation active extracts was
performed in the presence of cycloheximide (A) and additional GMP-PNP (B) as described in Fig. 2.9.
75 % (±11 %) was also observed in the presence of GMP-PNP blocking 60S subunit joining.
48S PIC formation was not affected, but free mRNPs accumulated (Fig. 2.21 B). This result
suggests that the formation of 80S initiation complexes is affected in rps12-T23A mutant
translation active extracts in vitro.
Interestingly, in vivo the 48S PIC formation is affected by the rps12-T23A mutation.
The ratio of RPL38 and RPL41A mRNA to 18S rRNA was significantly reduced to 35 %
(±22 %) and 45 % (±34 %), respectively, comparing rps12-T23A mutant to wild-type cells
(Fig. 2.22, also see Section 2.3.4). Moreover, rps12-T23A and wild-type cells differed
in their distribution of RPL38 and RPL41A mRNA – in the mutant the amount of
mRNAs incorporated into 48S initiation complexes was diminished while free mRNPs
were increased. This difference between the in vitro initiation assay with reduced 80S
formation and the in vivo observed reduction of 48S PIC might be due to the stability
of (scanning) 43S complexes on the mRNA. It is generally believed that 43S complexes
scanning along the mRNA are only stably bound to the mRNA after start codon recognition
(see Section 1.4.1). In the in vivo experiment, the 48S complexes could fall apart during
extract preparation whereas they are formed de novo in the in vitro assay. Alternatively,
the rps12-T23A mutation leads to a defect in 48S complex formation that is not detectable
in the in vitro initiation assay or causes two independent defects in 48S as well as 80S
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Figure 2.22: The rps12-T23A mutation causes a decrease in 48S PIC formation in vivo. In RPS12 wt and
rps12-T23A mutant WCEs 18S rRNA (A), RPL38 (B) and RPL41A (C) mRNA was determined by qRT-PCR.
Experiment as in Fig. 2.10 (mean ± SD; n = 4).
formation that are detected in either assay.
In addition, an alteration in the association and release of translation initiation factors
from rps12-T23A mutant ribosomes compared to RPS12 wt ribosomes was observed using
Western blot analysis of gradient fractions and antibodies against several initiation factors
(Fig. 2.23). Components of eIF1, eIF1A, eIF3, and eIF5B are more tightly associated with
the rps12-T23A mutant 40S subunit compared to wild-type. Furthermore, eIF2α, eIF3,
eIF5 and eIF5B remain associated longer with the initiating and elongating mutant 80S
ribosomes. Thus, the rps12-T23A mutation impairs the proper release of initiation factors
during translation initiation and the formation and/or stability of translation initiation
complexes.
2.4.4 Scanning Processivity Is Reduced in rps12-T23A Mutant Cells
The decreased formation of translation initiation complexes might be due to a reduced
processivity and stability of scanning 43S complexes on the mRNA. To assess the scanning
44
2. Results
Figure 2.23: In rps12-T23A mutant cells the association of initiation factors is altered. (A+B) Gradient
fractions of RPS12 wt (A) and rps12-T23A mutant (B) were subjected to Western blot analysis using antibodies
against the indicated initiation factors and ribosomal proteins. Experiment as in Fig. 2.11. (C) The relative
levels of rps12-T23A to RPS12 wt were calculated and plotted (mean ± SD; n = 3).
rate in rps12-T23A mutant cells, the scanning processivity assay described by Berthelot et
al. (see Section 2.3.5) was used to determine the rate of scanning in vitro. The different
in vitro transcribed luciferase mRNA constructs were translated in either wild-type or
rps12-T23A mutant translation active extracts and the scanning rates of wild-type and
mutant ribosomes were estimated (Fig. 2.24). For the wild-type a delay of about 30 to
40 seconds for 300 nt was observed indicating that wild-type ribosomes have an average
scanning rate of approximately 8.6 nt per second. The rps12-T23A mutant ribosomes
need roughly one minute for 300 nt resulting in a scanning rate of around 4.7 nt per
second. Thus, the initial delay time differs between the wild-type and rps12-T23A mutant
extracts from 5.5 min to 6 min which is not only due to the slower scanning of the
mutant but might also be the result of problems in assembling and activating the scanning
competent 48S complex (Lorsch and Herschlag, 1999). In translation active extracts the
phospho-deficient rps12-T23A mutant ribosomes have a decreased scanning processivity
compared to wild-type ribosomes.
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Figure 2.24: In translation active extracts of the rps12-T23A mutant scanning processivity is reduced. (A)
Time dependent analysis of luciferase generation in in vitro translation active extracts of RPS12 wt and
rps12-T23A mutant cells. The in vitro transcribed capped luciferase mRNAs depicted in Fig. 2.14A were
translated and luciferase activity measured at the indicated time points (5 to 9 minutes). One representative
example out of four independent experiments is shown. (B) Estimates of delay time of different length of 5’
UTRs and the resulting scanning rate for RPS12 wt and rps12-T23A mutant extracts are shown (mean ± SD;
n = 4).
In order to assess other steps in translation initiation that might be affected in the
rps12-T23A mutant strain the ratio of UUG vs. AUG start codon translation was
measured using the dual luciferase reporter pRaugFFuug. The rps12-T23A mutation does
not increase the initiation from UUG start codons compared to wild-type (Fig. 2.25 A).
Furthermore, rps12-T23A mutant ribosomes were also capable to discriminate against poor
AUG context sequences in the SUI1-lacZ constructs like wild-type cells (Fig. 2.25 B).
Taken together, the inability to phosphorylate Rps12 on T23 leads to a reduced processivity
of the scanning 43S complex on the mRNA, resulting in a reduction of initiation complexes
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Figure 2.25: The rps12-T23A mutation has no effect on start codon recognition. (A) rps12-T23A mutant
and RPS12 wt cells have the same UUG/AUG ratio. RPS12 wt and rps12-T23A mutant strains harboring the
pRaugFFuug plasmid were assessed by dual luciferase assay as in Fig. 2.12. (left) Absolute expression levels of
AUG-Renilla and UUG-Firefly in the RPS12 wt and rps12-T23A cells were plotted (mean ± SD; n = 4). (right)
Ratios of expression of UUG versus AUG reporter were calculated. (B) rps12-T23A mutation discriminates
between different AUG context sequences in SUI1-lacZ reporters. Expression of reporter plasmids in RPS12
wt and rps12-T23A mutant cells was measured by β-galactosidase assay as in Fig. 2.13 (mean ± SD; n = 4).
like 48S and 80S initiation complexes that are formed at a later stage of translation
initiation.
2.4.5 In rps12-T23A Mutant Cells the Growth Is Impaired under
Specific Conditions
To investigate the physiological role of Rps12 T23 phosphorylation the growth of
rps12-T23A and RPS12 wt cells under different conditions was measured using
microcultivation in a Bioscreen C Analyzer. The rps12-T23A mutant cells grew like
RPS12 wt cells under normal growth conditions. However, the rps12-T23A mutant
cells showed a slightly increased sensitivity to the elongation inhibitor cycloheximide
and the inhibitor of the TOR signaling pathway rapamycin (Fig. 2.26 A+B). Moreover,
47
2. Results
the rps12-T23A mutant cells could not metabolize ethanol as the only carbon source as
well as RPS12 wt cells (Fig. 2.26 C). In the presence of tunicamycin, the growth of the
rps12-T23A mutant cells was more reduced in comparison to RPS12 wt cells (Fig. 2.26
D). Tunicamycin, a mixture of homologous nucleoside antibiotics, inhibits the N-linked
glycosylation of nascent proteins in the endoplasmic reticulum (ER) causing protein
misfolding and activation of the unfolded protein response (UPR). Taken together, the
growth of rps12-T23A mutant cells is more severely affected than the growth of RPS12 wt
cells under specific conditions, thus indicating that the phosphorylation of Rps12 T23 is
important under specific circumstances.
Figure 2.26: The rps12-T23A mutation influences growth under different conditions. Growth of rps12-T23A
and RPS12 wt cells was measured under the following conditions: (A) cycloheximide (CH; 0.1, 0.25, and
0.5 µg/ml), (B) rapamycin (rap; 0.025, 0.05, and 0.1 µg/ml), (C) ethanol (2 and 4 % in SC without glucose),
(D) tunicamycin (tun; 0.15, 0.3, and 0.45 µg/ml). Doubling times in hours are given in brackets. Experiment
as in Fig. 2.15.
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3.1 Phosphorylation of Ribosomal Proteins
Protein phosphorylation is one of the most important posttranslational modifications and
allows for rapid adaptation to changing environmental conditions. Almost all cellular
processes including translation are regulated by phosphorylation. However, very little is
known about the phosphorylation of ribosomal proteins and its function in translation.
Therefore it is of major interest to gain an overview of ribosomal phosphorylation and a
deeper understanding of its function in translation.
In this study, subsequent centrifugation steps under phosphorylation conserving conditions
in combination with phosphoenrichment and LC-MS/MS were used to generate a
comprehensive inventory of Saccharomyces cerevisiae ribosomal phosphorylation sites. As
expected, the majority of ribosomal proteins are phosphorylated at steady-state in vivo. In
total 279 phosphorylation sites were identified – importantly, 122 novel ones. Eukaryotic
ribosomes are highly phosphorylated with 84 % of the ribosomal proteins possessing at least
one phosphorylation site compared to 70 % of proteins being phosphorylated in Hela S3 cells
(Olsen et al., 2010). The phosphorylation sites identified in two previous phosphoproteomic
studies, summarized in the databases PHOSIDA and PhosphoPep, are partially overlapping
with the set of phosphosites identified in this study, but contain less ribosomal phosphosites.
This is most likely due to the fact that here ribosomal proteins were enriched whereas both
other approaches aimed to identify phosphosites on all cellular proteins of yeast cell extracts
(Gnad et al., 2007, 2009; Bodenmiller et al., 2007, 2008). Moreover, Bodenmiller et al. used
different peptide preparation and enrichment techniques, thus making it possible to detect
different phosphorylation sites. Since the number of identifiable phosphosites depends
on the enrichment technique and peptide preparation, most likely even more ribosomal
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Figure 3.1: Localization of ribosomal phosphorylation sites on the 80S structure. Phosphorylated amino acids
are depicted as red spheres and in the case they are not localized the last amino acid is shown as pink sphere.
Large ribosomal proteins are colored in blue, small ribosomal proteins in yellow and rRNA in gray. The structure
was taken from Ben-Shem et al. (2011).
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phosphosites remain to be discovered. Nevertheless, it could be shown that eukaryotic
ribosomes are highly phosphorylated.
The identified phosphorylation sites are located mainly on the surface of the ribosome
and/or in the intersubunit space making them accessible for potential kinases and
phosphatases during the translation cycle (Fig. 3.1). Although many of the identified
phosphorylation sites are accessible on the surface, the question arises how they might
influence ribosome function as several of them are localized on the surface and at the
back of the ribosome quite distant to the active center of the ribosome. However, there
are two possibilities: phosphorylation of a ribosomal protein might either (i) directly
influence translation by inducing conformational changes or (ii) indirectly via recruitment
of translation factors. Those phosphorylation sites identified on parts of ribosomal proteins
that are buried in the inside of the ribosome might be accessible during ribosome biogenesis
or have a more constitutive function in stabilizing the ribosome structure or be important
for ribosome biogenesis. For instance, Rps3 phosphorylation by Hrr25 and subsequent
dephosphorylation was shown to be important for efficient assembly of pre-40S subunits
(Scha¨fer et al., 2006) and phosphorylation of Rpl18 is required for folding and binding to
the 5S rRNA (Bloemink and Moore, 1999).
Taken together, a comprehensive survey of Saccharomyces cerevisiae ribosomal
phosphorylation sites is presented identifying 122 novel phosphorylation sites. Thus,
eukaryotic ribosomes are heavily phosphorylated at steady-state in vivo.
3.2 Stress-Induced Changes in the Phosphorylation
Pattern of Ribosomal Proteins
Using an unbiased quantitative SILAC approach, numerous phosphorylation sites on
ribosomal proteins were identified that change their phosphorylation status upon heat
shock and/or glucose depletion (Table 2.2 and Table 2.3). Importantly, in this study
the loss of Rps6 phosphorylation upon stress was reproduced. Hence, the applied
stress conditions indeed induce a stress response leading to specific phosphorylation and
dephosphorylation events. A second indication that the cells shut-down translation was
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Figure 3.2: Localization of ribosomal phosphorylation sites on the 80S structure changing upon stress.
Phosphorylated amino acids are depicted as red/dark green spheres and in the case they are not localized the last
amino acid is shown as pink/light green/orange sphere. In red/pink and dark/light green the phosphorylation
sites that change upon heat shock and glucose depletion, respectively, are shown. In orange is the last amino
acid of the C-term of Rps6 colored in which the two phosphorylation sites are located that responded to both
stresses. Large ribosomal proteins are colored in blue, small ribosomal proteins in yellow and rRNA in gray. The
structure was taken from Ben-Shem et al. (2011).
the increased 80S peak and loss of polysomes in gradient profiles comparing heat shocked
or glucose depleted cells to untreated control cells (Fig. 2.2 C+D). Interestingly, only four
sites, Rps6 S232/S233, Rpl24 S86 (heat shock), and Rpl12 S38 (glucose depletion), are less
phosphorylated after heat shock or glucose depletion, whereas the majority of sites showed
an increased phosphorylation. In a recent study mammalian mitochondrial ribosomes
were in vitro hyperphosphorylated by different kinases and subsequently showed decreased
translation activity in vitro (Miller et al., 2009). Therefore, it is tempting to speculate that
an increased phosphorylation of ribosomal proteins leads to decreased translation activity
as it is expected after a shut-down of translation by stress. Moreover, one of the identified
sites, Rpl12 S38, was more phosphorylated upon heat shock and less phosphorylated upon
glucose depletion, making it an especially interesting site responding differently to diverse
stresses.
In this study, the cultures in the SILAC experiment were only labeled with heavy and
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light Lys and therefore, the peptides were digested solely with LysC. For this reason,
relatively large peptides were generated and thus giving a possible explanation why only
so few and different sites were identified – 97 phosphosites compared to 279 in the general
phosphoproteomics analysis (Table A.2 and Table 2.1). Most likely there will be more
stress-induced changes in the ribosomal phosphorylation pattern which could be identified
using double labeling with heavy Lys and Arg in combination with different peptide
preparation methods (see Section 3.1).
The ribosomal proteins that change in their phosphorylation status upon stress are located
on different sites mainly on the back of the ribosome and do not cluster at any specific
region – expect for the two Rps3 sites which are in close proximity (Fig. 3.2). It is therefore
rather unlikely that one kinase and phosphatase phosphorylates and dephosphorylates,
respectively, more than one site at a time suggesting that (i) different signaling pathways
might be involved, (ii) sequential phosphorylation/dephosphorylation takes place or (iii)
several kinases of the same pathway are binding to different positions on the ribosome.
3.3 Phosphorylation Sites Have Different Effects on
Translation
The challenge of the presented project was the identification of ribosomal phosphorylation
events that are important for translation. To this end, phosphorylation sites were
selected for mutational analysis based on (i) the intensity of their MS signal, (ii) their
reproducibility in the different preparations, (iii) their accessibility on the ribosome, (iv)
their conservation in higher eukaryotes and (v) whether their phosphorylation status
changes upon stress indicating a role in translation, specificlly in stress dependent
translation control. However, it is not possible to draw conclusions from the signal
intensity for the abundance of the phosphorylation in the cell due to the characteristics
of the generated peptides for MS analysis (size, charge etc.). One attempt to assess the
abundance of ribosomal phosphorylation was to resolve ribosomal proteins on 2D gels and
stain phosphorylated proteins, unfortunately this was not conclusive and was not pursued
further (data not shown).
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Translation active extracts of phospho-deficient A and phospho-mimicry D mutant strains
were assessed for their activity to translate a 5’ capped and a CrPV IRES containing
mRNA in vitro. Out of the 25 phosphorylation sites analyzed so far twelve showed
different translation activity in vitro compared to the corresponding wild-type (data not
shown). Interestingly, there are phospho-mutants that have an increased or decreased
activity and mutants that influence cap-dependent and cap-independent translation.
Thus, phosphorylation of ribosomal proteins might be used in diverse steps of the
translation cycle. In the future, it will be fascinating to unravel for all of these functional
phosphorylation sites the step in translation they are important for and to demonstrate
their physiological relevance.
3.4 Rps5 T38 Phosphorylation Functions in Context
Dependent Start Codon Recognition
In this study strong evidence is provided that Rps5 T38 phosphorylation is important for
efficient canonical translation initiation. The phospho-deficient rps5-T38A mutation causes
a cap-dependent translation defect in vitro and a defect in de novo protein synthesis in
vivo (Fig. 2.4). Specifically, the formation of 48S initiation complexes is decreased in
rps5-T38A mutant cells compared to RPS5 wt cells (Fig. 2.9 and Fig. 2.10). Moreover, the
rps5-T38A mutation causes increased initiation from non-AUG start codons (Fig. 2.12). In
addition, the discrimination against good and poor start codon context is eliminated in the
rps5-T38A mutant cells (Fig. 2.13), indicating that Rps5 T38 phosphorylation functions
in context dependent start codon recognition.
During translation initiation first the MFC (eIF1, 3, 5 and the TC) and eIF1A bind to
the 40S subunit forming the 43S PIC. The pre-assembled 43S PIC is recruited to the
5’ cap of the mRNA and subsequently starts to scan the 5’ UTR for a start codon in
a suitable consensus context (see Section 1.4.1). The recognition of the AUG by perfect
complementarity with the Met-tRNAi anticodon in the ribosomal P-site completes scanning
followed by the release of eIF1 (Maag et al., 2005) and the hydrolysis of eIF2-bound GTP
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Figure 3.3: Localization of Rps5 T21 and T38 on the ribosome and protein sequence conservation of the
N-terminus of Rps5. (A) Phosphorylated amino acids are depicted as red spheres, Rps5 protein in green and all
other small ribosomal proteins in yellow and rRNA in gray. The 40S structure was taken form Ben-Shem et al.
(2011). (B) Multiple sequence alignment of Rps5 protein sequence (UniProt, www.uniprot.org). Colors used
are purple for S and pink for T; light - weakly, dark - highly conserved; boxed are the two sites T21 and T38.
(Huang et al., 1997; Algire et al., 2005). The recognition of the start codon and base
pairing of the Met-tRNAi anticodon with the start codon is crucial for stable 48S PIC
formation (Maag et al., 2005). Thus, the inability of rps5-T38A mutant cells to efficiently
recognize the start codon might also cause the decreased formation of 48S PICs observed
in vitro and in vivo.
Although it remains to be elucidated how the rps5-T38A mutation impedes start codon
selection, initiation factors might be involved since the rps5-T38A mutant ribosomes are
able to translate the CrPV IRES containing mRNA which does not need any initiation
factors. In addition, the release of several initiation factors is altered in rps5-T38A mutant
ribosomes (Fig. 2.11). Possible candidates are eIF1, 1A, 2, 3 and 5 since mutations in these
factors lead to a so called suppressor of initiation codon mutation (Sui-) phenotype that
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confer an increased initiation from UUG codons as observed for the rps5-T38A mutant
cells (Castilho-Valavicius et al., 1990; Fekete et al., 2007; Saini et al., 2010; Pestova
and Kolupaeva, 2002; Valasek et al., 2004; Huang et al., 1997). Moreover, the T38
phosphorylation site lies in the variable N-terminus of Rps5 and forms a part of the mRNA
exit channel (Fig. 3.3). The yeast Rps5 N-terminus is 21 aa longer than the human Rps5
N-terminus. Replacing yeast Rps5 with its human homologue altered translation fidelity
and affected the recruitment of specific mRNAs to the ribosome (Galkin et al., 2007).
Using different truncated Rps5 variants Lumsden et al. (2009) showed that the first 24 aa
only play a minor role whereas deletion of aa 1-30 and 1-46 impairs translation initiation
by affecting the association with eIF2 and eIF3. In addition, both Rps5 and eIF2α were
crosslinked to -3 thioU upstream of the AUG start codon on mRNAs in mammalian 48S
PICs (Pisarev et al., 2006, 2008), and also eIF3 locates in close proximity being crosslinked
to nucleotides -8 to -17 upstream of the AUG codon (Pisarev et al., 2008), supporting eIF2
and eIF3 as possible candidates.
In contrast, Rps5 might also be directly involved in start codon selection. First, it
crosslinked specificlly to the -3 position which is crucial for optimal AUG sequence context
in yeast (Pisarev et al., 2006) explaining the loss of discrimination against poor AUG
context in the rps5-T38A mutant. Additionally, -3 thioU also cross-linked specificlly to
the prokaryotic homologue rpS7 in prokaryotic ribosomal initiation complexes indicating a
conserved function of rps5/rps7 (La Teana et al., 1995). Second, Rps5 T38 phosphorylation
might influence the structure or conformation of initiation complexes. During start
codon recognition the 43S PIC rearranges from an open, scanning permissive to a closed
conformation mediated by eIF1 and eIF1A (Passmore et al., 2007). It is tempting to
speculate that Rps5 T38 phosphorylation might influence the transition from the open,
scanning competent conformation to the closed after start codon recognition either directly
or via interaction of initiation factors with the mRNA and the 43S during translation
initiation.
The fact that the rps5-T38D mutation causes a ribosome biogenesis or stability defect
suggests that the phosphorylation of Rsp5 T38 needs to be reversible. Provided that
the phospho-mimicry D mutation indeed resembles the phosphorylation of Rps5 at




Although the loss of Rps5 T38 phosphorylation in the rps5-T38A mutation does not lead
to a general growth defect under specific conditions – starvation of amino acids (3-AT),
inhibition of elongation (cycloheximide), low carbon or ethanol as carbon source – the
growth of rps5-T38A mutant cells is more severely affected than wild-type cells whereas
under rapamycin, inhibiting TOR signaling, the mutant cells grew better (Fig. 2.15).
Therefore, the phosphorylation and dephosphorylation of Rps5 T38 is needed for survival
under specific conditions.
Concluding, the phosphorylation of Rps5 on T38 is important for efficient 48S initiation
complex formation and context dependent start codon selection. Since Rps5 belongs to
the conserved family of Rps5/Rps7 proteins and the T38 residue is conserved in higher
eukaryotes (Fig. 3.3 B) also the function of this phosphorylation site might be conserved
in other organisms.
3.5 Rps12 T23 Phosphorylation Is Important for Scanning
Processivity
A second phosphorylation site of a small ribosomal protein, Rps12 T23, functions in
canonical translation initiation, specifically Rps12 phosphorylation on T23 is important for
initiation complex formation (Fig. 2.21 and Fig. 2.22). However, in contrast to rps5-T38A
mutation, the rps12-T23A mutant ribosomes possess a reduced scanning processivity
compared to RPS12 wild-type ribosomes (Fig. 2.24).
The reduced scanning rate observed in rps12-T23A translation active extracts might have
two reasons: (i) the ribosomes have a lower scanning speed or (ii) their processivity is
reduced due to an increased fall-off of scanning 43S from the mRNA. It is not possible
to discriminate between these possibilities based on the used in vitro translation assay to
measure the scanning activity. However, less processive 43S complexes might be less stable
explaining the decrease in 48S levels in rps12-T23A cells observed after extract preparation
in the in vivo assay (Fig. 2.22). In addition, it is generally believed that slowly scanning
ribosomes show increased initiation from non-AUG codons which was not observable in
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Figure 3.4: Localization of Rps12 T23 on the ribosome and protein sequence conservation of the N-terminal
part of Rps12. (A) The phosphorylated amino acid is depicted as red sphere, Rps12 protein in green and all
other small ribosomal proteins in yellow and rRNA in gray. The 40S structure was taken from Ben-Shem et al.
(2011). (B) Multiple sequence alignment of Rps12 protein sequence (UniProt, www.uniprot.org). Colors used
are purple for S and pink for T; light - weakly, dark - highly conserved.
the rps12-T23A mutant cells (Fig. 2.25 A), thus corroborating that 43S stability on the
mRNA is affected by the rps12-T23A mutation.
Several initiation factors have been reported to be crucial for efficient scanning. eIF1
and eIF1A promote the open, scanning competent conformation of the 43S PIC (Passmore
et al., 2007) and are important for efficient scanning together with the cap-binding complex
eIF4F, which contains the helicase eIF4A and its auxiliary factor eIF4B (Pestova and
Kolupaeva, 2002). Two additional helicases with a known and suspected function in
translation initiation are Ded1 and Dbp1, respectively (Iost et al., 1999; Jamieson and
Beggs, 1991). Interestingly, Ded1 and Dbp1 seem to be more important for scanning
processivity than eIF4A and eIF4B as could be demonstrated by Berthelot et al. (2004)
using in vivo luciferase constructs with different 5’ UTR length. The rps12-T23A mutation
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was found to influence the association and dissociation of several initiation factors to and
from the ribosomes (Fig. 2.23). Therefore, Rps12 T23 phosphorylation might either directly
function in scanning processivity or via the recruitment of one or more initiation factors.
The rps12-T23A mutation does not cause a growth defect under optimal conditions, but
there are several conditions that impair growth compared to wild-type: inhibition of
elongation (cycloheximide) or TOR signaling (rapamycin), ethanol as carbon source or
induction of the unfolded protein response (tunicamycin) (Fig. 2.26). Thus, demonstrating
the physiological relevance of the Rps12 T23 phosphorylation.
Interestingly, the residue T23 of Rps12 corresponds to an aspartate (D) in higher
eukaryotes, for instance human, mouse, and drosophila (Fig. 3.4 B). This finding suggests
that a constitutive phosphorylation of this residue is functional – if the rps12-T23D
mutation indeed resembles a phosphorylated residue – and that during evolution a
reversible phosphorylatable and ‘chargeable ’residue was replaced by a residue with an
intrinsic negative charge at a physiologic pH.
Taken together, strong evidence is provided that the phosphorylation on T23 of Rps12
functions in canonical translation initiation thus influencing initiation complex formation.
Moreover, Rps12, a ribosomal protein about which nothing was known except for its
localization in the 40S subunit (Fig. 3.4 A), is the first ribosomal protein important for
scanning processivity.
3.6 Conclusion
In this study it could be shown for the first time that two phosphosites on ribosomal
proteins of the small subunit are important for translation initiation. Specifically,
phosphorylation of Rps5 T38 is involved in context dependent start codon recognition,
whereas Rps12 T23 phosphorylation is needed for scanning processivity. In addition,
first indications for a role in translation are provided for more phosphorylation sites
comparing wild-type and phospho-mutant translation active extracts in cap-dependent
and cap-independent translation in vitro. However, the detailed step in translation they
function in and the underlying molecular mechanism remain to be elucidated.
As ribosomes are phosphorylated on many different sites it will be a challenge to determine
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which of these many sites are individually or collectively important for translation and/or
other processes such as ribosome biogenesis. It will be fascinating to unravel for each
functionally important site their role in translation, their physiological importance, and
whether they regulate the expression of specific transcripts.
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4 Materials and Methods
4.1 Materials
4.1.1 Consumables and Chemicals
Consumables and chemicals were purchased from the following companies:
Applichem (Darmstadt), Applied Biosciences (Darmstadt), Becton Dickinson (Heidelberg),
Beckman Coulter (Krefeld), Biaffin (Kassel), Biomol (Hamburg), Biorad (Munich), Biozym
(Hess. Oldendorf), Chemicon (Temecula, Canada), Eppendorf (Hamburg), Fermentas
(St. Leon-Rot), Formedium (Norwich, UK), GE Healthcare (Munich), Gilson (Bad
Camberg), Invitrogen (Karlsruhe), Kedar (Warsaw, Poland), Macherey&Nagel (Du¨ren),
Medac (Hamburg), Medigenomix (Munich), MembraPure (Bodenheim), Merck Biosciences
(Darmstadt), Millipore (Molsheim, France), Mobitec (Go¨ttingen), MP Biomedical
(Illkirch, France), NEB (Frankfurt), Neolab (Heidelberg), Nunc (Wiesbaden), Peske
(Aindling-Arnhofen), Promega (Mannheim), Qiagen (Hilden), Roche (Mannheim), Roth
(Karlsruhe), Sarstedt (Nu¨mbrecht), Semadeni (Du¨sseldorf), Serva (Heidelberg), Sigma
(Taufkirchen), Stratagene (Amsterdam, Netherlands), Thermo Scientific (Munich),VWR
(Ismaning)
4.1.2 Equipment
Table 4.1: Equipment used in this study.
Name Supplier
Beckman DU650 spectrophotometer Beckman Coulter (Krefeld)
L80 and OptimaTM L-90 K ultracentrifuge Beckman Coulter (Krefeld)
Continued on next page
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Table 4.1 (continued)
Name Supplier
SW32, SW40, Type 45Ti, TLA 110 rotor Beckman Coulter (Krefeld)
Bioscreen C Analyzer iLF bioserve (Langenau)
CO8000 Cell Density Meter WPA (Cambridge, UK)
Dissection microscope manual MSM Singer (Somerset, UK)
Electrophoresis Power Supply Consort E853 Neolab (Heidelberg)
Heidloph shaker duomax 1030 Neolab (Heidelberg)
Rotator, Vortex Genie2 Neolab (Heidelberg)
Mini-Protean II system Biorad (Munich)
Gradient machine, Fractionator Foxy Jr.,
UA-6 UV/Vis Detector
Teledyne ISCO (Lincoln, USA)
Innova 44 shaking incubator New Brunswick Scientific (Nu¨rtingen)
Liquid scintillation analyzer TriCarb 2810 TR PerkinElmer (Waltham, USA)
Lumat LB9607, Centro LB 960 Berthold technologies (Bad Wildbad)
Optimax TR developing machine MS Laborgera¨te (Dielheim)
Research Pipettes P2, P20, P200 P1000 Gilson (Bad Camberg)
Rotanda 46R, 460R Hettich (Tuttlingen)
Sorvall Evolution RC, RC 5B Plus Thermo Fisher Scientific (Munich)
SLC 6000, SW34 rotor Thermo Fisher Scientific (Munich)
StepOnePlus™Real Time PCR System Applied Biosystems (Darmstadt)
T3 Thermocycler Biometra (Go¨ttingen)
Thermomixer compact, BioPhotometer Eppendorf (Hamburg)
Eppendorf centrifuge 545D, 541R Eppendorf (Hamburg)
Universal Analytical Balance Satorius (Go¨ttingen)
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4.1.3 Commercially Available Kits
Table 4.2: Commercially available kits and reagents used in this study.
Name Supplier
Nucleobond AX PC100 Macherey&Nagel (Du¨ren)
Nucleospin Mini Macherey&Nagel (Du¨ren)
Nucleospin extract Macherey&Nagel (Du¨ren)
RNeasy MinElute Clean-Up Kit Qiagen (Hilden)
AmpliCap™SP6 High Yield Massage Maker Kit Biozym (Hess. Oldendorf)
AmpliCap-Max™T7 High Yield Massage Maker Biozym (Hess. Oldendorf)
Dual-Luciferase®Reporter Assay System Promega (Mannheim)
Power SYBR®Green PCR Master Mix Applied Biosystems (Darmstadt)
High Capacity cDNA Reverse Transcription Kit Applied Biosystems (Darmstadt)
4.1.4 Enzymes and Standards
Table 4.3: Enzymes and standards used in this study.
Name Supplier
DNA Standards, Protein Standards, Restriction




Protein Phosphatase NEB (Frankfurt)
RNasin®Plus RNase Inhibitor Promega (Mannheim)
T3 and T7 RNA Polymerase Roche (Mannheim)
VentR®DNA polymerase, λ Zymolase 20T Medac (Hamburg)
4.1.5 Radioactivity
Radioactivity was purchased from Hartmann Analytik (Braunschweig):
α-[32P]-UTP, L-[14C]-phenylalanine, L-[3H]-leucine, L-[35S]-methionine
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4.1.6 Antibodies
Table 4.4: Primary and secondary antibodies used in this study.
Antibody Source Supplier
α-eIF1 (Sui1) rabbit A.G. Hinnebusch
α-eIF1A (Tif11) rabbit A.G. Hinnebusch
α-eIF2α (Sui2) rabbit T.E. Dever
α-eIF3a (Rpg1) rabbit A.G. Hinnebusch
α-eIF3b (Prt1) rabbit A.G. Hinnebusch
α-eIF5 (Tif5) rabbit A.G. Hinnebusch
α-eIF5B (Fun12) rabbit T.E. Dever
α-Rpl6 rabbit G. Dieci
α-Rps8 rabbit G. Dieci
α-HA goat Roche (Mannheim)
α-Pgk1 mouse Invitrogen (Karlsruhe)
α-rabbit IgG-HRPO goat BioRad (Munich)
α-goat IgG-HRPO rabbit Sigma (Taufkirchen)
α-mouse IgG-HRPO goat BioRad (Munich)
4.1.7 Buffers, Solutions and Growth Media
Table 4.5: Buffers, solutions and growth media used in this study.
Buffers/Solutions/Media Components
Coomassie staining 0.25 % (w/v) Coomassie Brilliant Blue R-250; 30 % (v/v)
ethanol; 10 % (v/v) acetic acid
Coomassie destaining 30 % (v/v) ethanol; 10 % (v/v) acetic acid
DNA loading dye 6x 40 % (w/v) sucrose; 0.25 % Bromophenol Blue; 0.25 %
Xylene cyanol FF
Kinase buffer 5x 500 mM Tris-HCl,pH 7.5; 5 mM MgCl2; 5 mM EGTA
Continued on next page
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Table 4.5 (continued)
Buffers/Solutions/Media Components
KNOP buffer 10x 500 mM Tirs-HCl, pH 9.2; 160 mM (NH4)2SO4; 22.5 mM
MgCl2
KNOP Polymerase 2 U Taq; 0.56 U Vent
Luria-Bertani Broth (LB) 1 % (w/v) tryptone; 0.5 % (w/v) yeast extract; 0.5 %
(w/v) NaCl; (2 % (w/v) agar for plates)
Phosphatase Inhibitors (PhI) 10 mM NaF; 1 mM NaVO4; 5 mM β-glycerophosphate
Phosphate-buffered saline
(PBS)
137 mM NaCl; 2,7 mM KCl; 20 mM NaH2PO4; 10 mM
Na2HPO4, pH 7.5
Protease Inhibitors (PI) 100x 28 ng/ml Leupeptin; 137 ng/ml Pepstatin A; 17 ng/ml
PMSF; 0.33 mg/ml benzamidine; in 100 % EtOH p.a.
Sample buffer (SB) 4x 0.2 M Tris-HCl, pH 6.8; 40 % (v/v) glycerol; 8 % (w/v)
SDS; few grains Bromophenol Blue; 0.1 M DTT
Separation gel buffer 4x 3 M Tris; 0.4 % (w/v) SDS; pH 8.8
Stacking gel buffer 4x 0.5 M Tris; 0.4 % (w/v) SDS; pH 6.8
Solution I 10 mM Tris-HCl, pH 7.5; 1 mM EDTA; 100 mM LiOAc
Solution II 10 mM Tris-HCl, pH 7.5; 1 mM EDTA; 100 mM LiOAc;
40 % (v/v) PEG-4000
Sporulation medium (YPA) 1 % (w/v) yeast extract; 2 % (w/v) peptone; 1 % (w/v)
KOAc; (2 % (w/v) agar for plates)
Synthetic complete medium
(SC)
0.67 % (w/v) yeast nitrogen base; 0.06 % (w/v) complete
synthetic mix of aa; drop out as required; 2 % (w/v)
glucose; when required 0.1 % (w/v) 5-FOA was added;
(2 % (w/v) agar plates)
TAE 50x 2 M Tris; 100 mM EDTA, pH 8.0; 1M acetic acid
TBE 90 mM Tris-borate; 2 mM EDTA
TE 1 mM EDTA; 10 mM Tris-HCl, pH 8.0
Electrophoresis buffer 25 mM Tris; 0.1 % (w/v) SDS; 0.19 mM glycine
Continued on next page
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Table 4.5 (continued)
Buffers/Solutions/Media Components
Tris-buffered saline (TBS) 137 mM NaCl; 2.7 mM KCl; 12.5 mM Tris-HCl; when
required 0.1 % (w/v) Tween-20®was added (TBS-T)
TSNTE buffer 2 % (v/v) Triton X-100; 1 % (v/v) SDS; 100 mM NaCl;
10 mM Tris-HCl, pH 8.0; 1 mM EDTA
Wet blotting buffer 25 mM Tris; 192 mM glycine; 10 % methanol
Yeast full medium (YPD) 2 % (w/v) peptone; 2 % (w/v) glucose; 1 % (w/v) yeast
extract; (2 % (w/v) agar for plates)
4.1.8 Oligonucleotides
Oligonucleotides were purchased from Thermo Scientific (Ulm).
Table 4.6: Oligonucleotides used in this study.
Nr. Name Sequence
1 5‘NotI Rps5 GGGGCGGCCGCGACCTTTTATACAACAACACCCATATACCC
2 3‘XhoI Rps5 GGGCTCGAGCATGTGTAGATCATTTCAAGGAAACGTTACG
3 Rps5 T38A for CCAGAAGAAGTCCAACAAGCTCAAGCTGAGATTAAGTTGTTCAAC
4 Rps5 T38A rev GTTGAACAACTTAATCTCAGCTTGAGCTTGTTGGACTTCTTCTGG
5 Rps5 T21A for GTTGAAGAATTCGCTCCAGTCGTCTTGGCTACTCC
6 Rps5 T21A rev GGAGTAGCCAAGACGACTGGAGCGAATTCTTCAAC
7 Rps5 T38D for CCAGAAGAAGTCCAACAAGCTCAAGATGAGATTAAGTTGTTCAAC
8 Rps5 T38D rev GTTGAACAACTTAATCTCATCTTGAGCTTGTTGGACTTCTTCTGG
9 5’Pst1 Rps5 3HA GGGCTGCAGTCTGACACCGAAGCTCCAGTTG
10 5’NotI Rps12 GGGGCGGCCGCCTGCTTCATGTATATACGCACCTCG
11 3’XhoII Rps12 GGGCTCGAGGGCAATGAAACTTCAAATGACAACTTGC
12 Rps12 S2A for GAGAAGAAAAATGGCTGACGTTGAAGAAGTCGTTGAAGTTC
13 Rps12 S2A rev GAACTTCAACGACTTCTTCAACGTCAGCCATTTTTCTTCTC
14 Rps12 T19A for GAAGAAACTGTTGTTGAACAAGCTGCCGAAGTTACTATC
Continued on next page
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Table 4.6 (continued)
Nr. Name Sequence
15 Rps12 T19A rev GATAGTAACTTCGGCAGCTTGTTCAACAACAGTTTCTTC
16 Rps12 T23A for GAACAAACTGCCGAAGTTGCTATCGAAGATGCTTTGAAGGTTG
17 Rps12 T23A rev CAACCTTCAAAGCATCTTCGATAGCAACTTCGGCAGTTTGTTC
18 S12 T23D for GAACAAACTGCCGAAGTTGATATCGAAGATGCTTTGAAGGTTG
19 S12 T23D rev CAACCTTCAAAGCATCTTCGATATCAACTTCGGCAGTTTGTTC
20 5’Pst1 Rps12 3HA GGGCTGCAGTCTGACGTTGAAGAAGTCGTTGAAG
21 5’18S rRNA CGGTTTCAAGCCGATGGA





27 528S rRNA CCGCCCGTCTTGAAACAC
28 328S rRNA TTACACCCAAACACTCGCATAGA
4.1.9 Plasmids and Strains
Table 4.7: Plasmids used in this study.
Plasmid Description / Reference
BSEF-RPL38 Britta Coordes (AG Stra¨ßer)
pSP6P (Verge´ et al., 2004)
pWG299 (Gilbert et al., 2017)
pRS315 (Sikorski and Hieter, 1989)
pRS316 (Sikorski and Hieter, 1989)
pBSIIKS(+) (Alting-Mees and Short, 1989)
pNOP-3HA1L U. Hardeland
pDB688 (Salas-Marco and Bedwell, 2005)
Continued on next page
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Table 4.7 (continued)
Plasmid Description / Reference
pDB690 (Salas-Marco and Bedwell, 2005)
pDB691 (Salas-Marco and Bedwell, 2005)
pDB720 (Salas-Marco and Bedwell, 2005)
pDB721 (Salas-Marco and Bedwell, 2005)
pDB722 (Salas-Marco and Bedwell, 2005)
pDB723 (Salas-Marco and Bedwell, 2005)
pDB866 (Salas-Marco and Bedwell, 2005)
pDB868 (Salas-Marco and Bedwell, 2005)
pDB869 (Salas-Marco and Bedwell, 2005)
pDB870 (Salas-Marco and Bedwell, 2005)
pYDL-control (Hager and Dinman, 2003)
pYDL-LA (Hager and Dinman, 2003)
pYDL-TY1 (Hager and Dinman, 2003)
pYDL-HIV (Hager and Dinman, 2003)
pYDL-TY3 (Hager and Dinman, 2003)
pPMB24 (Martin-Marcos et al., 2011)
pPMB25 (Martin-Marcos et al., 2011)
pPMB28 (Martin-Marcos et al., 2011)
pRaugFFuug (Cheung et al., 2007)
pJM48 (Berthelot et al., 2004)
pJM250 (Berthelot et al., 2004)
pJM251 (Berthelot et al., 2004)
RPS5-pRS316 The NotI/XhoI fragment of RPS5 was inserted into pRS316
using primers 1+2
RPS5-pRS315 The NotI/XhoI fragment of RPS5 was inserted into pRS315
rps5-T38A-pRS315 Quickchange mutagenesis of RPS5-pRS315 using primers 3+4
rps5-T21A-pRS315 Quickchange mutagenesis of RPS5-pRS315 using primers 5+6
Continued on next page
68
4. Materials and Methods
Table 4.7 (continued)
Plasmid Description / Reference




The PstI/XhoI fragment of RPS5 was inserted into
pNOP-3HA1L using primers 9+2
rps5-T38A-pNOP-
3HA1L
The PstI/XhoI fragment of rps5-T38A was inserted into
pNOP-3HA1L using primers 9+2
rps5-T38D-pNOP-
3HA1L
The PstI/XhoI fragment of rps5-T38D was inserted into
pNOP-3HA1L using primers 9+2
RPS12-pRS316 The NotI/XhoI fragment of RPS12 was inserted into pRS316
using primers 10+11
RPS12-pRS315 The NotI/XhoI fragment of RPS12 was inserted into pRS315
rps12-S2A-pRS315 Quickchange mutagenesis of RPS12-pRS315 using primers 12+13
rps12-T19A-pRS315 Quickchange mutagenesis of RPS12-pRS315 using primers 14+15
rps12-T23A-pRS315 Quickchange mutagenesis of RPS12-pRS315 using primers 16+17




The PstI/XhoI fragment of RPS12 was inserted into
pNOP-3HA1L using primers 20+11
rps12-T23A-pNOP-
3HA1L
The PstI/XhoI fragment of rps12-T23A was inserted into
pNOP-3HA1L using primers 20+11
rps12-T23D-pNOP-
3HA1L
The PstI/XhoI fragment of rps12-T23D was inserted into
pNOP-3HA1L using primers 20+11
Table 4.8: Saccharomyces cerevisiae and Escherichia coli strains used in this study.
Strain Genotype Origin




Continued on next page
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Table 4.8 (continued)
Strain Genotype Origin
∆lys Mata/α as W303; ∆lys::KANMX6
RPS5 shuﬄe Mata/α as W303; RPS5::KANMX6 (RPS5-pRS316)
RPS12 shuﬄe Mata/α as W303; RPS12::KANMX6 (RPS12-pRS316)
DH5α F- φ80dlacZ∆M15; ∆(lacZYA-argF)U169; it deoR; it





Cloning procedures were done according to Sambrook, J. and Russell, D. W. (2001)
and cover restriction digests, ligations, transformation of vectors in Escherichia coli, and
separation of DNA in agarose gels. Commercially available kits were used according to
manufacturer’s instructions. Point mutations were generated by site directed mutagenesis
using the Invitrogen protocol (Invitrogen, Karlsruhe). The PCR sample was digested with
10 U DpnI for at least 2 h at 37℃ and transformed into E. coli DH5α. All plasmids were
sequenced by MWG, Eurofins (Munich).
Polymerase Chain Reaction (PCR)
All PCR reactions were done in a 30 µl Phusion Flash®High fidelity PCR reaction, if not
indicated differently (see Tab. 4.9) except for amplification of disruption cassettes from
genomic DNA, a 100 µl KNOP PCR was used (see Tab. 4.10).
Phenol-Chloroform Extraction of DNA
To purify DNA fragments from plasmids or PCR products one volume of phenol:chloroform:
isoamylalcohol (25:24:1) was added and after 10 min centrifugation at 16000 g, the aqueous
phase was extracted with an equal volume of chloroform. DNA was precipitated with 1/10
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Table 4.9: Phusion Flash®High fidelity PCR reaction and amplification cycle
0.5 µl template DNA (100-300 ng)
0.25 µl primer1 (10 pmol/ µl)
0.25 µl primer2 (10 pmol/ µl)
10 µl 2xPhusion PCR Master Mix
ad 20 µl dd H2O
98℃ 1 min
98℃ 30 s ∣∣∣∣∣ 3555-45℃ 30 s
72℃ 1 kb/15 s
72℃ 10 min
Table 4.10: KNOP mix PCR reaction and amplification cycle
1 µl template DNA (100-300 ng)
0.5 µl primer 1 (100 pmol/ µl)
0.5 µl primer 2 (100 pmol/ µl)
10 µl 10XKNOP Buffer
8 µl dNTPs (25mM each)
2 µl KNOP Polymerase
ad 100 µl dd H2O
94℃ 2 min
94℃ 1 min ∣∣∣∣∣ 3555-45℃ 0.5 min
68℃ 750 bp/ min
68℃ 10 min
volume of 3 M NaOAc, pH 5.2 and 2 volumes of 100 % ethanol at -20℃. After washing with
70 % ethanol, the DNA was dried and resuspended in 10 µl TE buffer.
4.2.2 Yeast Specific Methods
Culture of Saccharomyces cerevisiae
Yeast strains were cultured in either full media or synthetic complete (SC) medium. The
cell density of a yeast culture was determined in a spectrophotometer at a wavelength of
600 nm. One density at 600 nm (1 OD600) corresponds to 2.5× 107 cells.
Transformation of Yeast Cells
50 ml of a yeast culture were grown to an OD600 of 0.5 to 0.8 and harvested by centrifugation
(3600 rpm, 3 min). After washing with 10 ml of H2O and with 500 µl of solution I cells
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were resuspended in 250 µl solution I. 1-3 µg DNA and 5 µl of single stranded carrier DNA
(DNA of salmon or herring testis, 2 mg/ml) were mixed with 50 µl of cells in solution I
and incubated with 300µl solution II on a turning wheel at rt for 30 min. The samples
were heat shocked at 42℃ for 10 min, followed by 3 min incubation on ice. 1 ml of H2O
was added, the sample centrifuged, the pellet resuspended in 50µl H2O and plated on a
selective plate. For genomic integrations, the pellets were resuspended in 1-5 ml YPD and
incubated on a turning wheel for 1 h up to over night prior to plating.
Preparation of Genomic DNA
10 ml of an overnight yeast culture with an OD600 > 1 were harvested by centrifugation
(3600 rpm, 3 min) and washed with 10 ml H2O. The cells were resuspended in
500µl H2O and 200 µl TSNTE buffer. For lysis, 300µl glass beads and 300µl
phenol:chloroform:isoamylalcohol (25:24:1) were added and the sample vortexed for 3 min.
After centrifugation (16000 g, 10 min), the aqueous phase was extracted with an equal
volume of chloroform. Genomic DNA was precipitated with 1.2 ml of 100 % ethanol at
-20℃ for at least 10 min. After centrifugation (16000 g, 4℃, 30 min), the pellet was dried
and resuspended in 400 µl TE buffer. To remove RNA, the DNA was incubated with 20 µl
RNaseA (10 mg/ml) at 37℃ for 40 min. The genomic DNA was precipitated by addition
of 40µl 3 M NaOAc, pH 5.2 and 800µl 100 % ethanol at -20℃ for at least 10 min. After
centrifugation (16000 g, 4℃, 30 min), the pellet was washed with 80 % ethanol, dried and
resuspended in 30µl TE buffer.
Deletion of Genes
In order to disrupt a gene, the coding sequence of the respective gene has to be replaced by
homologous recombination using a construct carrying overlapping regions in the promoter
and terminator region of the respective gene, separated by an auxotrophy marker. The
XYZ::KANMX4 disruption cassette was amplified by KNOP PCR from genomic DNA of
the corresponding BY deletion strain (euroscarf). The shuﬄe strain was generated by
transformation of the XYZ::KANMX4 fragment in a diploid W303 strain and selection
for KANMX4+ transformants. Deletion of XYZ was assessed by colony PCR (see 4.2.1)
using primers that anneal in the promoter of XYZ and in the KANMX4 gene. Positive
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heterozygous transformants were transformed with XYZ-pRS316. Cells were sporulated
and tetrades dissected.
Mating of Yeast Strains
In order to combine two or more gene deletions, the single deletion strains were mated.
For mating, haploid parental strains carrying opposite mating types were mixed onto YPD
plates. After several hours, the characteristic diploid cells were selected using a dissection
microscope onto YPD plates.
Sporulation and Tetrad Dissection
For sporulating a diploid strain, freshly grown diploid cells were restreaked onto sporulation
plates. On these plates, the diploid cells undergo meiosis and the genetic information is
divided in four haploid spores, enclosed in a tetrad. Sporulation was monitored on a light
microscope. The outer cell wall of the tetrad was destroyed by incubating 1 loop of cells in
10 µl Zymolase 20T. The destruction was stopped by addition of 50µl of TE buffer, and the
spores were dissected using the tetrad microscope. Tetrads with four growing spores were
then restreaked onto YPD and the respective selection plates to check for segregation of
markers. Double knock out strains were selected by checking for the correct 2:2 auxotrophy
marker distribution or by a 1:3 distribution by PCR.
Yeast Whole Cell Extracts (WCE)
Denaturing protein extraction from yeast cells was carried out essentially as described
(Knop et al., 1996). Briefly, 5 OD600 of cells were resuspended in 500 µl of H2O, 150 µl of
pre-treatment solution (1.85 M NaOH, 7.5 % β-mercaptoethanol) were added and incubated
for 20 min on ice. After TCA precipitation the protein pellets were resuspended in 100 µl
of 1xSB and 20 µl of 1 M Tris base.
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4.2.3 Preparation of Ribosomes
Purification of Ribosomes for Phosphoproteomic Analysis
Yeast cells were grown to an OD600 of 0.5-0.7. Cells were harvested (4000 rpm, 4℃,
4 min), resuspended in 5 ml of lysis buffer (20 mM HEPES-KOH, pH 7.5; 75 mM KCl;
2.5 mM MgCl2; 1 mM EGTA; 1 mM DTT; 0.5 mM PMSF) containing a mix of phosphatase
inhibitors (PhI) to preserve protein phosphorylation. Cells were lysed by vortexing the
cell suspension with two volumes glass beads for 5 min in the cold. After washing the
beads once with lysis buffer, cell debris were removed by centrifugation (27000 rpm, SW40
rotor, 4℃, 15 min) and the fatty phase was aspirated. The ribosomes were washed
with high salt by adding equal volume of 1 M KCl containing lysis buffer and crude
ribosomes were sedimented through a high salt (500 mM KCl) 15 % sucrose cushion
(42000 rpm, 45Ti, 4℃, 4 h). The high salt washed ribosomes were resuspended in lysis
buffer (phosphatase inhibitor mix containing 200 µM NaVO4) and different ribosomal
populations such ribosomal subunits or polysomes were separated on 5-15 % or 10-40 %
linear sucrose gradients in lysis buffer by centrifugation (32000 rpm, SW32, 4℃, 2 h). If
polysomes should be isolated, 100 mg/l cycloheximide was added 10 min prior to harvesting
and in all purification steps present in a final concentration of 100 mg/l. The pooled
ribosomal gradient fractions were pelleted by ultracentrifugation (100000 rpm, TLA110,
4℃, 45 min) and washed once with lysis buffer to remove remaining sucrose. Purified
ribosomes were resuspended (6 M urea; 2 M thiourea; 10 mM Tris-HCl, pH 8) and protein
concentrations were determined using Bradford Assay (BioRad).
Protein samples were digested in-solution with trypsine and Lys-C, and phosphopeptides
were enriched by TiO2 chromatography (Olsen et al., 2006). The resulting phosphopeptide
fractions were analyzed by online nanoLC-MS/MS on a high-resolution LTQ-Orbitrap
Velos instrument using Higher-energy collisional dissociation (HCD) for high-mass accuracy
tandem mass spectrometry (Olsen et al., 2006). Peptides and phosphopeptides were
identified by Mascot (www.matrixscience.com).
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SILAC - Stable Isotope Labeling with Amino Acids in Cell Culture
The labeling of yeast cells with stable isotopes was adapted from (Gruhler et al., 2005). Two
cultures of 500 ml of liquid YNB medium containing 30 mg/ml lysine or [13C6] lysine were
inoculated with ∆lys::KANMX6 cells from a stationary YPD culture (1:10000). Yeasts
were grown at 30℃ for 18-20 h until they reached an OD600 of 0.5-0.7. To treat the cells
with heat shock, 300 ml 80℃ hot YNB complemented with the corresponding lysine were
added to one of the cultures and incubated for 10 min at 42℃ while 30℃ warm media was
added to the untreated culture and incubated for additional 10 min at 30℃. For glucose
deprivation the yeasts were sedimented by centrifugation (4000 rpm, rt, 4 min) and one
of the two cultures was resuspended in YNB medium lacking glucose and the other in
glucose containing YNB and incubated for further 5 min at 30℃. Cells were harvested
(4000 rpm, 4℃, 4 min), resuspended in 5 ml lysis buffer and vortexed with glass beads at
4℃ for 5 min. The lysates were centrifuged (27000 rpm, SW40 rotor, 4℃, 15 min), equal
amounts of A280 of treated and untreated extracts were combined, diluted 1:1 with lysis
buffer containing 1 M KCl and the differently labeled ribosomes were purified as described
above (Section 4.2.3). Protein samples were digested in-solution with Lys-C, and processed
like above. SILAC pairs were quantified and normalized using the MaxQuant software suite
(Cox and Mann, 2008).
4.2.4 Polysome Gradients
Polysome gradients were performed as described in (Rother and Strasser, 2007). Briefly,
yeast cells were grown to an OD600 of 0.5. Then, 0.1 mg/ml cycloheximide was added
and the cells incubated at 30℃ for 10 min before harvesting by centrifugation (3600 rpm,
4℃, 3 min). The cells were resuspended in polysome buffer (20 mM HEPES-KOH, pH 7.5;
75 mM KCl; 2.5 mM MgCl2; 1 mM EGTA; 1 mM DTT; 0.1 mg/ml cycloheximide). Lysis
was done by adding 500 µl glass beads and vortexing at 4℃ for 5 min. After removal
of the cell debris by centrifugation (16000 g, 5 min), 5 A260 were loaded onto a 12 ml
10-40 % linear sucrose gradient for polysome profiles and 5-25 % for separation of initiation
complexes, respectively, and centrifuged at 38000 rpm for 2 h using an SW40 Ti rotor. The
absorption profile at 254 nm was recorded with a Teledyne ISCO gradient fractionator and,
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when needed, 500 µl fractions were taken for subsequent Western blot analysis or RT-PCR
analysis (see Section 4.2.5). For Western blot analysis, 300µl 30 % TCA was added to
300µl of gradient fractions, the samples were incubated overnight on ice and centrifuged
(16000 g, 4℃, 30 min). After washing with cold acetone, the pellets were resuspended in
50 µl 1xSB containing 1 M Tris-Base, denatured and subjected to SDS-PAGE and Western
blotting (see Section 4.2.11).
4.2.5 Quantitative Reverse Transcription PCR of Gradient Fractions
Isolation of RNA from Gradient Fractions
To isolate RNA from gradient fractions, RNA of 220µl fraction were precipitated by
addition of 500 µl 100 % EtOH and 1 µl glycogen at -20℃ over night. After centrifugation
(16000 g, 4℃, 30 min) the pellet was resuspended in RNA-Buffer (20 mM Tris, 100 mM
NaCl, 2.5 mM EDTA, 1 % SDS, pH 7.5) and extracted twice with phenol/chloroform. RNA
was precipitated with 500 µl 100 % EtOH and 1µl glycogen from the aqueous phase. Pellets
were washed once with 70 % ethanol, dried for 5 min in the speedvac and redissolved in
50 µl DEPC H2O.
Quantitative Reverse Transcription PCR
For 1st strand cDNA synthesis the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) was used according to the manufacturer’s instructions except that the reverse
transcription (RT) was performed in a total volume of 10µl. Quantitative PCR (qPCR)
was performed using the StepOnePlus™Real Time PCR System (Applied Biosystems).
Reaction mixtures (10 µl final volume) contained 2.5µl of 1:200 dilutions of the individual
cDNA samples, 5 pmol forward and reverse primers and Power SYBR®Green PCR Master
Mix (Applied Biosystems) as prescribed by the manufacturer. Primers were designed using
Primer express 3.0 software and tested for mispriming or formation of primer dimers by
melting curve analysis of the individual amplification products. The thermocycling profile
included an initial denaturation for 10 min at 95℃, followed by 45 cycles of amplification,
comprising denaturation at 95℃ for 15 s and annealing/elongation at 60℃ for 1 min. For
melting curve analysis of the amplification products, the temperature was increased in
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0.3℃ increments to a final temperature of 95℃ (continuous fluorescence measurement). All
reactions were run in triplicates and included negative controls ( H2O and no-RT samples
in 1:400 dilution). Relative quantifications were performed by the comparative CT method
(Livak and Schmittgen, 2001).
4.2.6 In Vitro Transcription
The capped luciferase mRNA was in vitro transcribed from pSP6P (Verge´ et al., 2004) after
its linearization with BsrBI (Fermentas). The in vitro transcription was carried out with the
AmpliCap SP6 High Yield Message Maker Kit (Biozym) according to the manufacturer’s
directions. The CrPV IRES plasmid (Gilbert et al., 2017) was linearized with EcI136II
before being transcribed with T7 polymerase (NEB). The GpppA cap (KEDAR, Poland)
for the IRES construct was added to the reaction together with ATP, CTP and UTP. After
5 min incubation at 37℃, GTP was added and the DNA transcribed for 1 h at 37℃. The
template DNA was digested with DNAseI (Fermentas) for 15 min at 37℃. The scanning
processivity plasmids (Berthelot et al., 2004) were linearized with AgeI (Fermentas) and
in vitro transcribed using the AmpliCap-Max T7 High Yield Message Maker Kit (Biozym)
according to the manufacturer’s instructions. For generating radiolabeled mRNA the
BSEF-RPL3 plasmid was linearized with HindIII before being in vitro transcribed with
T3 polymerase (Roche). m7GpppG (KEDAR, Poland) together with ATP, CTP and
32P-αUTP were added to the reaction. After 5 min incubation at 37℃, GTP was added
and the DNA transcribed at 37℃ for 1 h. The template DNA was digested with DNAseI
(Fermentas) for 15 min at 37℃. All mRNAs were purified by using the RNA MinElute Kit
according to the manufacturer’s directions (Qiagen).
4.2.7 In Vitro Translation Assays
Preparation of yeast translation active extracts
In vitro translation active extracts were prepared as described in (Tuite and Plesset, 1986).
Briefly, cells were harvested at OD600 of 1.0 -1.2 by centrifugation (3000 g, 4℃, 5 min,
Sorvall Evolution). After washing with 50 ml H2O, the cells were weighed and incubated
with 40 ml buffer1 (20 mM Tirs-H2SO4, pH 9.4; 7.5 mM DTT) on a shaking device at
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RT for 10 min. After centrifugation, the pellet was resuspended in 40 ml 1 M sorbitol
containing 1 mg zymolyase 20T per g cells for spheroblasting. The reaction was monitored
by taking 5µl of the cell suspension and measuring the OD600 when put into 1 ml of H2O.
If after 1 min the OD600 of this cell suspension dropped to 50 % of the original value,
the cells were pelleted by centrifugation (3000 g, 4℃, 4 min). The pellet was carefully
resuspended in YPD additionally containing 1 M sorbitol and incubated with gentle shaking
for regeneration for 30 min. After another centrifugation, the cells were resuspended in
2.5 ml translation buffer A (30 mM Hepes-KOH, pH 7.4; 100 mM KOAc; 2 mM DTT) and
5 ml of glass beads added. The cells were lysed by 8x18 s shaking by hand at 4 ℃. The
cell lysates were centrifuged (3000 g, 4℃, 2 min) to be separated from the glass beads
and transferred to a new tube. After two centrifugation steps (25000 rpm, 10 min and
45000 rpm, 21 min, 4℃, TLA 110 rotor), the lipid layer was removed by aspiration and
2 ml of the supernatant applied onto a PD10 column. The first 1 ml was discarded and the
next 2 ml collected, aliquoted and stored in liquid nitrogen.
Determination of Translation Activity of In Vitro Transcribed Luciferase mRNA
In vitro translation assays were performed as described in (Altmann and Trachsel, 1997).
1.25 A260 of the respective extract were incubated with 1.6 µg of creatin kinase (5 mg/ml
(Roche) in 30 mM Hepes-KOH, pH 7.4; 50 % glycerol) in a total volume of 20µl for 5 min
on ice, followed by an incubation with 2mM MgOAc, 76 mM KCl, 0.4 mM GTP, 1 mM
ATP, 50 µM of each AA, 12.5 mM creatin phosphate and 4 U RNase inhibitor (RNasin,
Promega) in a total volume of 30 µl for 7.5 min, leading to ribosome run-off. 400 ng of in
vitro transcribed luciferase mRNA (m7G cap or IRES) were added and in vitro translated
at 20℃ for 30 min. For measurement of luciferase activity, 25µl of the in vitro translation
reaction were mixed with 100 µl of 25 mM glycyl-glycine, pH 7.8; 10 mM K3PO4, pH 7.8;
12 mM Mg2SO4; 3.2 mM EGTA; 2 mM ATP; 1mM DTT and 200M luciferin using a Lumat
LB9507 Luminometer (Berthold). The emitted luminescence was detected for 10 s. WT
activity was set to 100 % and the activity of the mutant strain calculated accordingly.
The results are the mean of two independent experiments for at least three independently
prepared extracts.
To determine the scanning processivity, 60 ng of in vitro transcribed luciferase mRNA were
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added and after 5 min incubation at 20℃ a 20µl sample was measured every minute for
12 min in total to determine a time course. The results are the mean of at least four
independently prepared extracts.
Determination of Translation Activity Using Endogenous mRNA
The translation activity was measured by incorporation of [35S]-Met into the nascent
polypeptide using endogenous mRNA as template (Altmann and Trachsel, 1997).
Translation reactions were assembled as described above except that instead of luciferase
mRNA 4 µCi [35S]-Met were added and the reaction was incubated for 30 min at 22℃.
5 µl of the reaction were take at the indicated timepoints and charged met-tRNA were
hydrolyzed in the presence of 0.5 M KOH for 30 min at 37℃. After neutralization with
glacial acidic, proteins were precipitated in 10 % TCA-50 % EtOH for at least 20 min on ice.
Proteins were filtrated on nitrocellulose, washed with 5 % TCA and counted with 3 ml of
scintillation cocktail (Roth) using a scintillation counter (Tri-Carb 2810TR, PerkinElmer,
Waltham, USA). Results are the mean of three to four independent experiments of
independent extracts.
Determination of Elongation Activity and Miscoding Events
Translation elongation can be determined by polyphenylalanine synthesis using poly(U)
as mRNA template in the presence of [14C]-F. In parallel, misincorporation of [3H]-L can
be measured due to pairing of the UUU codon with the near-cognate UAA or CAA of
L-tRNAs. 1.25 A260 of extract were incubated with 80 mM spermidine, 2 mM spermine,
and 1 µg/ml poly(U) mRNA. The in vitro translation reaction was supplemented with
10 U RNase inhibitor, 200 pmol bulk tRNA, 40 pmol F-tRNA, , 150µg/ml creatin kinase,
360 mM creatin phosphate, 30 mM ATP, and 12 mM GTP. For elongation measurements
2 µl [14C] phenylalanine (specific activity 9,5 dpm/pmol) and for determination of
miscoding activity 2 µl [3H]-leucine (specific activity 9,5 dpm/pmol) were added. After
30 min incubation, incorporated radioactivity was measured as described in Section 4.2.7.
The result of the negative control (without poly(U) mRNA) was subtracted from the
result of the reaction containing poly(U) mRNA. Elongation activity of wt was set to
100 % and the activity of the mutant strain calculated accordingly. Misincorporation was
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determined by calculating the ratio of incorporated leucine over phenylalanine, followed by
the determination of the percentual increase in misincorporation of the mutant extract in
comparison to wt. Results are the mean of at least three independent experiments.
4.2.8 In Vivo Translation Activity by Labelling with [35S]
Methionine
Cells were grown to mid-log phase. 4 OD600 were pelleted and resuspended in 0.2 ml of
YPD. Cells were labeled with 10µCi [35S] methionine for up to 30 min at 30℃. Samples
of 30µl were taken at indicated time points and NaOH and β-mercaptoethanol added to
final concentration of 0.5M and 1 %, respectively. Precipitation and Filtration was done as
described in Section 4.2.7. Results are the mean of four independent experiments of two
independent spores.
4.2.9 In Vitro Translation Initiation Assay
Three A260 of translation active extract were incubated with 6.25µg creatin kinase for
5 min on ice, followed by 30 min incubation with 1.25 mM EGTA, 2 mM MgOAc, 76 mM
KCl, 0.4 mM GTP, 1 mM ATP, 50µM of each AA, 12.5 mM creatin phosphate, 1 mM
cycloheximide, 8 U RNAse inhibitor, 35 ng of in vitro transcribed radioactive mRNA and,
where indicated, 1.25 mM GMP-PNP in a total volume of 120 µl at RT. The entire reaction
was loaded on a 5-25 % sucrose gradient and centrifuged at 38000 rpm (SW40 Ti rotor) for
2.45 h. 450µl fractions were taken off and 300 µl of each fraction were counted with 3 ml
of scintillation cocktail.
4.2.10 Dual Luciferase Assay
Yeast cells transformed with the corresponding dual luciferase reporters were grown
until an OD600 of 0.5. Yeast cells of 20 µl, 15 µl, 10 µl and 5 µl aliquots were
transferred to black 96-well plates. For measurement of the dual luciferase activity,
the Dual-Luciferase®Reporter Assay System (Promega) was used according to the
manufacturer’s instructions in a Centro LB 960 plate reader (Berthold) with the following
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settings: inject 50 µl of passive lysis buffer, shake 2 s, wait 10 s, inject 30µl solution I, shake
2 s, measure for 8 s, inject 30µl stop&glow, shake 2 s and measure for 4 s. The results are
the mean of at least six independently prepared measurements.
4.2.11 SDS-PAGE and Western Blotting
SDS-PAGE
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was done according
to Laemmli (Laemmli, 1970) using the Mini-Protean II system (Biorad). After
electrophoresis, separated proteins were either transferred to a membrane (Western blot)
or directly stained with Coomassie.
Western Blotting
For blotting, the proteins were transferred onto a PVDF membrane using a wet blotting
device. For this, 3 layers of Whatman paper followed by the methanol activated PVDF
membrane, the SDS-PAGE gel and another 3 layers of Whatman paper, all presoaked in
wet blotting buffer, were assembled in the blotting machine (Biorad). The transfer occurred
at 100V for 60-70 min. After transfer, the membrane was blocked with blocking buffer (2 %
milk powder and optional 2 % BSA in TBS-T) and incubated with the primary antibody at
4℃ overnight. The antibody was removed by washing the membrane with blocking buffer
at RT for 45 min. Then, the membrane was incubated with the corresponding secondary
antibody at RT for at least 2 h. The immunostained proteins were detected with ECL
kit (Applichem). After exposure of the membrane the light sensitive films were developed
with a Kodak X omat M35 developing machine.
4.2.12 β-Galactosidase Assay
Yeast cells transformed with the corresponding lacZ-fusion reporters were grown until
log phase. Cells were lysed in Z-buffer (60 mM Na2HPO4, 40 mM Na2HPO4, 10 mM
KCl, 1 mM MgSO4, pH 7) by three freeze and thaw cycles. The hydrolysis of
Onitrophenylgalactopyranoside (ONPG) was assayed as described (Miller, 1972). Briefly,
10 µl lysate were added to 125 µl Z-Buffer containing 40 mM β-mercaptoethanol and 25 µl
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4 mg/ml ONPG in Z-Buffer. Reactions were carried out in triplicates in honeycombe2
plates using a Bioscreen C Analyzer. β-galactosidase activity was calculated from at least
four independent experiments.
4.2.13 Yeast Growth Curves
Growth curves under different conditions were monitored using a Bioscreen C Analyzer.
10 µl of stationary phase yeast culture were used to inoculate 300 µl of SDC containing the
indicated drugs and conditions in Honeycomb2 plates. Growth curves were measured at
30℃ under continuous shaking for two days. The optical density was measured using an
wideband filter of 420-580 nm. All experiments were carried out using two independent
spores in triplicates and at least twice at different positions on the Honeycomb2 plates.
The observed OD values (ODobs), from which the blank (OD recorded with corresponding
medium) value has been subtracted, were corrected for the non-linearity at higher cell
densities using the formula ODcor = ODobs + 0.449(ODobs)
2 + 0.191(ODobs)
3. Doubling
times were estimated according to Warringer and Blomberg (2003): ODcor values were
log10 transformed. A slope was calculated between every third consecutive measurement.
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CDK cyclin dependent kinase
CH cyclohximide




4E-BP eIF4E binding protein
ECL enhanced chemiluminescence
E. coli Escherichia coli
eEF eukaryotic elongation factor
EGF(R) epidermal growth factor (receptor)
eIF eukaryotic initiation factor
ER endoplasmic reticulum
E-site exit site of the ribosome
et al. et alia (and others)
FDR false discovery rate
FOA 5-fluoorotic acid
G guanine
Gcn2 general control non derepressable 2
GAP GTPase activating protein
GTP / GDP guanosine triphosphate / diphosphate
H histidine
HRI Heme-regulated eIF2α kinase
IC initiation complex




LC-MS/MS liquid chromatography-tandem mass spectrometry
MAPK mitogen-activated protein kinase
Met methionine
Met-tRNAi methionyl initiator tRNA
MFC multi factor complex
mRNA messenger ribonucleic acid
mRNP messenger ribonucleoprotein
(m)TOR (mammalian) target of rapamycin
nt nucleotide
OD optical density
ORF open reading frame
PAGE polyacrylamide gel electrophoresis
PCR polymerase chain reaction
PERK PKR-like ER-localized eIF2α kinase
pH potential of hydrogen
PKR protein kinase R
PI3K phosphatidylinositol 3-kinase
PIC pre-initiation complex





Rpl ribosomal protein of the large subunit
Rps ribosomal protein of the small subunit
RT room temperature
S svedberg, serine
SDC synthetic complete medium
SDS sodium dodecyl-sulfate
SH2 Src-homology-2






UPR unfolded protein response
UTR untranslated region
WCE whole cell extracts
wt wild-type
Y tyrosine
YPD yeast extract, peptone, glucose containing medium
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Table A.1: Phosphorylation sites in ribosomal protins identified by phosphoproteomics
Protein Position pSite Class Sequence Window Matching Kinase and binding Motifs Intensity
YGR214W 219 2 QVAEEATTEEAGE CK2 4,2E+05
YGR214W 220 2 VAEEATTEEAGEE FHA KAPP 4,2E+05
YGR214W 103 1 PIAGRFTPGSFTN Proline-directed, FHA KAPP, PKA 8,8E+05
YGR214W 112 1 SFTNYITRSFKEP 1,1E+06
YGR214W 114 1 TNYITRSFKEPRL CK2 9,4E+05
YMR230W 98 1 IQERNPSQRPQRR ATM/ATR, CAMK2, PKC 7,2E+07
YMR230W 48 1 VIKALQSLTSKGY 2,5E+06
YBR048W 2 1 MSTELTVQ 3,5E+06
YBR048W 3 3 MSTELTVQS 3,5E+06
YBR048W 6 1 MSTELTVQSERA FHA KAPP, PLK1 3,5E+06
YBR048W 9 1 TELTVQSERAFQK 3,5E+06
YBR048W 44 1 AGLGFKTPKTAIE Proline-directed, CDK1 1,1E+07
YBR048W 52 1 KTAIEGSYIDKKC PLK1 6,3E+06
YOR369C 2 1 MSDVEEVV CK2 7,4E+07
YOR369C 19 3 ETVVEQTAEVTIE 7,4E+07
YOR369C 23 1 EQTAEVTIEDALK FHA1 Rad53p, PLK, PLK1 7,4E+07
YDR064W 12 1 SAGKGISSSAIPY 7,0E+06
YDR064W 13 1 AGKGISSSAIPYS 7,0E+06
YDR064W 14 1 GKGISSSAIPYSR 7,0E+06
YDR064W 19 1 SSAIPYSRNAPAW 7,0E+06
YDR064W 30 1 AWFKLSSESVIEQ 8,5E+06
YDR064W 147 1 YESATASALVN CK1 5,8E+05
YCR031C 2 1 MSNVVQAR 2,8E+07
YCR031C 11 1 VQARDNSQVFGVA ATM/ATR, CAMK2 1,8E+07
YCR031C 125 1 TPVPSDSTRKKGG 8,5E+05
YCR031C 126 1 PVPSDSTRKKGGR CK1 8,5E+05
YJL191W 12 1 VQARDNSQVFGVA ATM/ATR, CAMK2 2,0E+08
YJL191W 126 1 TPVPSDSTRKKGG 1,3E+07
YJL191W 127 1 PVPSDSTRKKGGR CK1 1,3E+07
YOL040C 2 1 MSQAVNAK ATM/ATR 3,0E+05
YOL040C 29 1 EKLLEMSTEDFVK NEK6 1,2E+07
YOL040C 30 1 KLLEMSTEDFVKL 1,8E+06
YDL083C 2 1 MSAVPSVQ GSK3 6,5E+06
YDL083C 6 1 MSAVPSVQTFGK CK1 3,7E+07
YDL083C 15 1 TFGKKKSATAVAH 7,6E+05
YDL083C 17 2 GKKKSATAVAHVK FHA KAPP 2,0E+06
YDL083C 34 1 LIKVNGSPITLVE Proline-directed 2,3E+06
YDR447C 70 1 GPVRGISFKLQEE CAMK2 7,4E+06
YDR447C 89 1 QYVPEVSALDLSR 3,4E+07
YDR447C 94 1 VSALDLSRSNGVL NEK6 3,4E+07
YDR447C 96 1 ALDLSRSNGVLNV NEK6 1,2E+07
YDR447C 106 1 LNVDNQTSDLVKS FHA2 Rad53p 1,6E+07
YDR447C 107 1 NVDNQTSDLVKSL 1,2E+07
YDR447C 120 1 GLKLPLSVINVSA NEK6 1,8E+06
YDR447C 125 1 LSVINVSAQRDRR 9,3E+06
YDR450W 107 1 LANNVESKLRDDL 7,6E+05
YNL302C 5 1 MAGVSVRDVAA 4,3E+05
YNL302C 117 1 IGIVEISPKGGRR Proline-directed, CDK1 1,4E+07
YNL302C 139 1 DRIAAQTLEEDE CK2 1,1E+06




Protein Position Class pSite Sequence Window Matching Kinase and binding Motifs Intensity
YML063W 236 1 ALHGEGSGEEKGK CK2 2,1E+06
YML063W 245 1 EKGKKVSGFKDEV 5,0E+07
YML063W 254 1 KDEVLETV 5,0E+07
YGL123W 2 1 MSAPEAQQ CK2 2,3E+06
YGL123W 181 1 GSGIVASPAVKKL Proline-directed, ERK/MAPK 5,7E+05
YHL015W 38 3 KQLENVSSNIVKN 1,2E+05
YHL015W 39 3 QLENVSSNIVKNA 1,2E+05
YJL136C 84 1 LLKNVWSYSR 1,3E+08
YJL136C 85 3 LKNVWSYSR 1,6E+07
YJL136C 86 1 KNVWSYSR 1,3E+08
YGR118W 40 2 LGTAFKSSPFGGS CK1 1,4E+06
YER074W 2 1 MSDAVTIR 1,5E+07
YER074W 14 1 RTRKVISNPLLAR 2,9E+07
YER074W 56 1 AEKDAVSVFGFRT 6,0E+06
YLR333C 74 1 RLKIGGSLARIAL 5,9E+06
YLR333C 93 1 GIIKPISKHSKQA CHK1, PKD 2,8E+05
YGL189C 110 1 NRENKVSPADAAK Proline-directed 1,3E+06
YER131W 54 1 AAVRDLSEASVYP CAMK2 3,4E+06
YGL189C 54 1 AAVRDLSEASVYP CAMK2 1,5E+06
YGL189C 57 2 RDLSEASVYPEYA CK1, PLK1 1,5E+06
YGL189C 59 2 LSEASVYPEYALP EGFR 1,5E+06
YHR021C 11 1 QDLLHPTAASEAR FHA KAPP, NEK6 6,9E+06
YHR021C 14 1 LHPTAASEARKHK 6,9E+06
YOR167C 5 1 MDNKTPVTLAK Proline-directed 2,3E+07
YLR264W 3 3 MDSKTPVTL 5,2E+06
YLR264W 5 1 MDSKTPVTLAK Proline-directed 1,5E+07
YLR264W 8 3 DSKTPVTLAKVIK 1,5E+07
YOR167C 19 1 IKVLGRTGSRGGV NEK6 4,7E+06
YOR167C 37 1 EFLEDTSRTIVRN 3,3E+06
YDL061C 25 1 RQCRVCSSHTGLV CAMK2 1,5E+05
YNL178W 104 1 AVAQAESMKFKLL 7,1E+04
YNL178W 207 1 ALPDAVTIIEPKE CK2 5,1E+08
YNL178W 221 1 EPILAPSVKDYRP NEK6 1,1E+09
YNL178W 231 1 YRPAEETEAQAEP 5,5E+05
YHR203C 120 1 ITDEEASYKLGKV PLK1 2,0E+05
YHR203C 247 1 GKGIKLSIAEERD AURORA, CK2 1,8E+06
YJR123W 2 2 MSDTEAPV CK2 5,6E+08
YJR123W 21 2 EVVEEFTPVVLAT Proline-directed 5,6E+08
YJR123W 38 3 EVQQAQTEIKLFN 1,6E+10
YJR123W 47 1 KLFNKWSFEEVEV CK2 2,3E+05
YJR123W 206 3 NAAKGSSTSYAIK 2,3E+05
YJR123W 207 2 AAKGSSTSYAIKK FHA KAPP 2,3E+05
YJR123W 208 2 AKGSSTSYAIKKK CK1 2,3E+05
YBR181C 15 1 VNGSQKTFEIDDE CK1, FHA2 Rad53p 2,1E+06
YBR181C 163 1 VIRREVTKGEKTY CAMK2, CHK1, CK2, PKD 1,3E+07
YBR181C 180 1 KIQRLVTPQRLQR Proline-directed, CAMK2, CDK1, CDK2, CHK1, PKD 1,0E+06
YBR181C 232 1 IRKRRASSLKA CAMK2, PKA, PKA/AKT 2,9E+08
YBR181C 233 1 RKRRASSLKA CAMK2 2,9E+08
YOR096W 187 1 IVFEIPSETH 9,8E+06
YOR096W 189 3 FEIPSETH 9,8E+06
YNL096C 30 2 FIDLESSSPELKA CK2, NEK6 3,3E+04
YNL096C 31 1 IDLESSSPELKAD Proline-directed, Polo box 3,3E+06
YNL096C 187 1 IVFEIPSQTN ATM/ATR 1,3E+07
YNL096C 115 1 VQKRPRSRTLTAV CAMK2, PKA 1,7E+07
YNL096C 117 1 KRPRSRTLTAVHD CAMK2, FHA KAPP, PKA/AKT 2,4E+07
YNL096C 119 1 PRSRTLTAVHDKI;
PRSRTLTAVHDKV
CAMK2, PKA/AKT 2,4E+07
YOR096W 103 3 RILPKPSRTSRQV 3,6E+05
YOR096W 105 3 LPKPSRTSRQVQK 3,6E+05
YOR096W 106 2 PKPSRTSRQVQKR CK1, PKA 3,6E+05
YOR096W 115 1 VQKRPRSRTLTAV CAMK2, PKA 7,5E+06
YOR096W 117 1 KRPRSRTLTAVHD CAMK2, FHA KAPP, PKA/AKT 1,1E+07
YOR096W 119 1 PRSRTLTAVHDKI;
PRSRTLTAVHDKV
CAMK2, PKA/AKT 1,1E+07
YBL072C 45 1 GAKRIHSVRTRGG CAMK2, PKA, PKC 1,8E+05
YBL072C 132 1 NVKEEETVAKSKN PLK1 4,9E+04




Protein Position Class pSite Sequence Window Matching Kinase and binding Motifs Intensity
YBL072C 155 2 SAKIESSVESQFS PLK1 2,6E+06
YBL072C 158 1 IESSVESQFSAGR ATM/ATR, CK1 2,6E+06
YBL072C 161 1 SVESQFSAGRLYA CK1 3,9E+06
YPL081W 184 1 ARKAEASGEAADE 4,2E+05
YBR189W 184 1 ARKAEASGEAAEE 4,9E+06
YBR189W 13 2 TYSKTYSTPKRPY CK1 2,1E+05
YBR189W 14 1 YSKTYSTPKRPYE Proline-directed, CDK1, CDK2, Polo box 2,1E+05
YBR189W 161 1 HIDFAPTSPFGGA 3,1E+08
YBR189W 162 1 IDFAPTSPFGGAR Proline-directed, ERK/MAPK, WW GroupIV 4,9E+07
YLR340W 273 3 IENPEKYAAAAPA 4,3E+09
YLR340W 281 2 AAAPAATSAASGD FHA KAPP 4,3E+09
YLR340W 302 1 AEEEEESDDDMGF 4,3E+09
YDL081C 96 1 EEAKEESDDDMGF 3,5E+08
YDL081C 62 3 DLLVNFSAGAAAP 9,1E+07
YDL130W 58 1 DLKEILSGFHNAG 1,1E+09
YDL130W 73 3 AGAGAASGAAAAG 2,6E+08
YDL130W 96 1 EEAAEESDDDMGF 2,0E+09
YOL039W 43 1 KVSSVLSALEGKS CK1, CK2 1,2E+07
YOL039W 49 1 SALEGKSVDELIT CK2 1,1E+08
YOL039W 71 1 PAAGPASAGGAAA 5,2E+08
YOL039W 79 1 GGAAAASGDAAAE 5,2E+08
YOL039W 96 1 EEAAEESDDDMGF 2,3E+09
YDR382W 65 3 GQKKFATVPTGGA 4,3E+09
YDR382W 68 2 KFATVPTGGASSA FHA KAPP 5,2E+08
YDR382W 72 2 VPTGGASSAAAGA CK1 5,2E+08
YDR382W 73 3 PTGGASSAAAGAA 5,2E+08
YDR382W 100 1 EEAKEESDDDMGF 3,1E+09
YGL135W 5 2 MSKITSSQVRE CK1 3,4E+06
YGL135W 6 1 MSKITSSQVREH CHK1, CK1 1,4E+07
YGL135W 7 1 MSKITSSQVREHV ATM/ATR 1,4E+07
YGL135W 79 1 DVDRAKSCGVDAM CAMK2, CHK1, PKD 2,1E+07
YGL135W 86 1 CGVDAMSVDDLKK 2,1E+07
YLR075W 205 1 FLSKKGSLENNIR AURORA, CHK1, CK1, PKD 4,6E+07
YGR085C 44 1 EQLSGQTPVQSKA Proline-directed, CK1 2,6E+07
YGR085C 161 1 TKEDTVSWFKQKY 2,9E+07
YDR418W 38 1 IGPLGLSPKKVGE Proline-directed, CDK1, CDK2, NEK6 2,4E+07
YMR142C 144 2 VLSAAATFPIAQP FHA2 Rad53p 4,9E+07
YMR142C 152 1 PIAQPATDVEARA CK2 4,9E+07
YMR142C 165 1 VQDNGESAFRTLR 1,7E+07
YHL001W 3 1 MSTDSIVKA FHA2 Rad53p 8,8E+05
YHL001W 5 1 MSTDSIVKASN CK1 8,8E+05
YLR029C 165 1 REARGLTATGKKS CAMK2 5,2E+05
YLR029C 167 1 ARGLTATGKKSRG NEK6 5,2E+05
YLR029C 196 1 TWKRQNTLSLWRY CAMK2, FHA2 Rad53p, PKA 9,1E+05
YIL133C 163 1 EAKRKVSSAEYYA CAMK2, CK2, PKA 2,5E+05
YIL133C 180 1 FTKKVASANATAA 7,8E+05
YIL133C 184 1 VASANATAAESDV CK2 7,8E+05
YIL133C 188 1 NATAAESDVAKQL CK1 5,8E+05
YNL069C 2 1 MSQPVVVI ATM/ATR 6,7E+06
YNL069C 178 2 AFTKKVSSASAAA CK1 1,2E+07
YNL069C 179 3 FTKKVSSASAAAS 1,2E+07
YNL069C 181 1 KKVSSASAAASES CK1, GSK3 1,2E+07
YNL069C 185 1 SASAAASESDVAK CK1 1,2E+07
YNL069C 187 1 SAAASESDVAKQL 1,2E+07
YJL177W 65 1 PFRRFNSSIGRTA CAMK2 2,4E+07
YJL177W 66 3 FRRFNSSIGRTAQ 1,1E+07
YJL177W 141 1 RINKYESSPSHIE CHK1, PKD 5,7E+05
YKL180W 65 1 PFRRFNSSIGRTA CAMK2 3,5E+07
YKL180W 66 1 FRRFNSSIGRTAQ 3,5E+07
YKL180W 141 1 RINKYESSPSHIE CHK1, PKD 5,6E+06
YKL180W 142 1 INKYESSPSHIEL Proline-directed, Polo box 5,6E+06
YKL180W 144 2 KYESSPSHIELVV CK1, CK2 5,6E+06
YNL301C 63 1 INRPPVSVSRIAR 6,2E+05
YNL301C 65 1 RPPVSVSRIARAL 6,2E+05
YNL301C 167 1 KAPRILSTGRKFE CAMK2 2,5E+06
YNL301C 168 3 APRILSTGRKFER 2,5E+06
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YBL027W 29 1 WLDPNETSEIAQA FHA2 Rad53p 8,4E+07
YBL027W 30 1 LDPNETSEIAQAN 8,4E+07
YBL027W 37 1 EIAQANSRNAIRK 8,4E+07
YBL027W 56 2 IVKKAVTVHSKSR CHK1, FHA KAPP, PKD 1,4E+06
YBL027W 59 1 KAVTVHSKSRTRA 1,3E+05
YBL027W 91 1 REARLPSQVVWIR ATM/ATR, CAMK2 2,7E+06
YFR031C-A 95 1 YAGKKASLNVGNV AURORA 9,5E+05
YFR031C-A 195 1 YRLKRNSWPKTRG PKA 6,1E+06
YFR031C-A 249 1 TGLLRGSQKTQD ATM/ATR, NEK6, PKA 1,5E+07
YMR242C 16 1 IGRRLPTESVPEP CAMK2 1,4E+07
YMR242C 18 1 RRLPTESVPEPKL CK2 1,4E+07
YMR242C 60 1 ASGEIVSINQINE 1,2E+06
YMR242C 169 2 FSYKRPSTFY PKA 1,1E+06
YMR242C 170 2 SYKRPSTFY CAMK2, PKA 1,1E+06
YBR191W 70 1 VYNVTKSSVGVII 1,0E+06
YBR191W 142 1 RESRIVSTEGNVP CAMK2, CK1 2,9E+07
YBR191W 143 3 ESRIVSTEGNVPQ 2,9E+07
YLR061W 20 2 TFTVDVSSPTENG CK1 4,8E+06
YLR061W 21 1 FTVDVSSPTENGV Proline-directed, CK2, ERK/MAPK, Polo box 2,2E+06
YLR061W 23 1 VDVSSPTENGVFD CK1 4,8E+06
YLR061W 111 1 LAFYQVTPEEDEE Proline-directed, CK2 9,2E+05
YFL034C-A 21 2 LTVDVSSPTENGV Proline-directed, CK2, ERK/MAPK, Polo box 1,6E+05
YGL031C 7 1 MKVEIDSFSGAKI 2,2E+07
YGL031C 9 1 VEIDSFSGAKIYP 2,2E+07
YGL031C 83 1 KAQRPITGASLDL CAMK2, FHA KAPP 1,3E+07
YGL031C 86 1 RPITGASLDLIKE 1,3E+07
YGL031C 95 1 LIKERRSLKPEVR AURORA, PKA 7,0E+05
YGL031C 153 1 FQKVAATSR 0,0E+00
YGL031C 154 3 QKVAATSR 0,0E+00
YGR148C 26 1 LFVRGDSKIFRFQ CAMK2 3,4E+06
YGR148C 83 1 KAQRPITGASLDL CAMK2, FHA KAPP 6,2E+07
YGR148C 86 1 RPITGASLDLIKE 6,2E+07
YGR148C 95 1 LIKERRSLKPEVR AURORA, PKA 3,6E+07
YGR148C 153 1 FQKVAATSR 2,2E+06
YGR148C 154 1 QKVAATSR 2,2E+06
YGR148C 7 1 MKVEVDSFSGAKI 4,1E+07
YGR148C 9 1 VEVDSFSGAKIYP 4,1E+07
YOL127W 28 3 KALKVRTSATFRL 3,3E+06
YOL127W 29 1 ALKVRTSATFRLP PKA 2,3E+05
YOL127W 31 2 KVRTSATFRLPKT FHA2 Rad53p 4,3E+06
YOL127W 69 3 IEQPITSETAMKK 2,3E+06
YOL127W 71 1 QPITSETAMKKVE 2,3E+06
YLR344W 21 1 ARKAYFTAPSSQR FHA KAPP 4,9E+05
YLR344W 24 3 AYFTAPSSQRRVL 1,7E+06
YLR344W 25 2 YFTAPSSQRRVLL ATM/ATR, CK1 1,7E+06
YGR034W 24 3 AYFTAPSSERRVL 7,0E+05
YGR034W 25 1 YFTAPSSERRVLL CK1 1,2E+06
YGR034W 62 1 VLVVRGSKKGQEG PKA 9,6E+05
YGR034W 72 1 QEGKISSVYRLKF 4,4E+06
YGR034W 94 1 EKVNGASVPINLH 2,1E+05
YHR010W 33 1 KPHDEGSKSHPFG 1,3E+05
YHR010W 94 1 DVEAFKSVVSTET 1,5E+07
YHR010W 97 2 AFKSVVSTETFEQ CK1 1,5E+07
YHR010W 98 1 FKSVVSTETFEQP 1,5E+07
YHR010W 105 1 ETFEQPSQREEAK ATM/ATR, CK2 1,5E+07
YDR471W 94 1 DVEAFKSVVSTET 6,3E+06
YDR471W 97 2 AFKSVVSTETFEQ CK1 6,3E+06
YDR471W 98 3 FKSVVSTETFEQP 6,3E+06
YDR471W 105 1 ETFEQPSQREEAK ATM/ATR, CK2 6,3E+06
YOR063W 24 1 PRKRAASIRARVK CAMK2, PKA, PKA/AKT, PKC 5,9E+08
YOR063W 65 1 DLDRPGSKFHKRE CAMK2, CHK1, CHK1/2, PKD 1,7E+05
YOR063W 101 1 TPRGLRSLTTVWA 1,3E+07
YOR063W 103 1 RGLRSLTTVWAEH CAMK2 1,3E+07
YOR063W 296 1 DEANGATSFDRTK FHA1 Rad53p 9,8E+05
YOR063W 297 1 EANGATSFDRTKK 9,8E+05
YOR063W 301 3 ATSFDRTKKTITP 2,2E+07
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YGL030W 6 1 MAPVKSQESINQ ATM/ATR 2,8E+05
YBL092W 40 1 KQKGIDSVVRRRF 6,6E+05
YBL092W 51 1 RFRGNISQPKIGY ATM/ATR 1,6E+06
YBL092W 67 1 KKTKFLSPSGHKT Proline-directed, CK1 2,0E+07
YBL092W 69 1 TKFLSPSGHKTFL NEK6 9,6E+07
YPL143W 15 1 VKGKHLSYQRSKR GSK3 5,4E+06
YPL143W 97 1 AKTFGASVRIFLY CK1 2,2E+05
YER056C-A 64 1 RPRQYATVSKTHK 3,9E+05
YER056C-A 66 1 RQYATVSKTHKTV 3,8E+06
YDL136W 19 1 SKEQLASQLVDLK ATM/ATR 5,6E+06
YDL136W 40 1 QKLSRPSLPKIKT AURORA, CK1, PKA 3,2E+07
YDL136W 98 1 LTKFEASQVTEKQ ATM/ATR 0,0E+00
YMR194W 18 3 NKGKKVTSMTPAP 1,7E+05
YMR194W 19 3 KGKKVTSMTPAPK 1,7E+05
YPL249C-A 79 1 AKKRLGSFTRAKA CAMK2, PKA 4,3E+07
YPL249C-A 81 1 KRLGSFTRAKAKV 3,6E+06
YPL249C-A 21 1 KKVTQMTPAPKIS Proline-directed 2,3E+05
YPL249C-A 64 1 IDLIRNSGEKRAR PKA 5,4E+05
YPL249C-A 97 1 NNIIAASRRH 1,9E+06
YLR185W 80 2 FKNGFQTGSASKA FHA KAPP 7,1E+05
YLR185W 82 1 NGFQTGSASKASA 7,1E+05
YLR185W 84 1 FQTGSASKASA CK1 4,9E+06
YDR500C 80 2 FKNGFQTGSAKAT FHA KAPP 6,1E+05
YDR500C 82 3 NGFQTGSAKATSA 6,1E+05
YLR185W 5 1 MGKGTPSFGKR Proline-directed 5,8E+05
YLR185W 7 1 MGKGTPSFGKRHN 5,8E+05
YBR031W 60 1 EKAGHQTSAESWG CK2 2,1E+06
YBR031W 61 3 KAGHQTSAESWGT 2,1E+06
YBR031W 282 1 LPSHIISTSDVTR CK1 2,7E+07
YBR031W 284 1 SHIISTSDVTRII 2,7E+07
YBR031W 287 1 ISTSDVTRIINSS CK1, FHA2 Rad53p 2,7E+07
YBR031W 293 1 TRIINSSEIQSAI GSK3 9,4E+06
YBR031W 297 1 NSSEIQSAIRPAG CK1 9,4E+06
YDR012W 53 1 RQAYAVSEKAGHQ 3,9E+05
YDR012W 60 1 EKAGHQTSAESWG CK2 1,6E+07
YDR012W 61 1 KAGHQTSAESWGT 1,6E+07
YDR012W 64 1 HQTSAESWGTGRA CK1 1,6E+07
YDR012W 85 1 GGGTGRSGQGAFG 1,6E+06
YDR012W 270 1 SETVASSKVGYTL CK1 2,8E+05
YDR012W 278 2 VGYTLPSHIISTS GSK3 2,8E+07
YDR012W 282 1 LPSHIISTSDVTR CK1 2,8E+07
YDR012W 283 1 PSHIISTSDVTRI 2,8E+07
YDR012W 284 1 SHIISTSDVTRII 2,8E+07
YDR012W 287 1 ISTSDVTRIINSS CK1, FHA2 Rad53p 2,8E+07
YDR012W 292 1 VTRIINSSEIQSA 5,6E+06
YDR012W 293 1 TRIINSSEIQSAI GSK3 5,6E+06
YDR012W 297 1 NSSEIQSAIRPAG CK1 5,6E+06
YDR012W 306 1 RPAGQATQKRTHV ATM/ATR 5,6E+06
YPL131W 9 1 FQKDAKSSAYSSR GSK3 3,4E+06
YPL131W 235 1 DDIDADSLEDIYT 4,0E+07
YML073C 12 1 APKWYPSEDVAAL 8,5E+07
YLR448W 12 1 APKWYPSEDVAAP 2,0E+05
YML073C 88 1 RYVIATSTKVSVE GSK3 1,0E+05
YML073C 164 1 YLSASFSLKNGDK CK1 1,5E+05
YGL076C 8 1 AAEKILTPESQLK;
STEKILTPESQLK
Proline-directed, FHA KAPP 2,8E+08
YGL076C 11 1 KILTPESQLKKSK;
KILTPESQLKKTK
ATM/ATR 2,8E+08
YGL076C 113 1 RLTRINSGTFVKV CAMK2, CHK1, CHK1/2, CK1, PKD 6,4E+06
YGL076C 228 1 HFIQGGSFGNREE 5,4E+05
YPL198W 8 1 AAEKILTPESQLK;
STEKILTPESQLK
Proline-directed, FHA KAPP 1,6E+08
YPL198W 11 1 KILTPESQLKKSK;
KILTPESQLKKTK
ATM/ATR 1,6E+08
YPL198W 113 1 RLTRINSGTFVKV CAMK2, CHK1, CHK1/2, CK1, PKD 2,1E+06
YPL198W 228 1 HFIQGGSFGNREE 5,4E+06
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YPL198W 115 1 TRINSGTFVKVTK 1,5E+06
YHL033C 29 1 RNPLTHSTPKNFG NEK6 5,0E+06
YHL033C 30 1 NPLTHSTPKNFGI Proline-directed, CDK1, Polo box 5,0E+06
YHL033C 216 1 ALAKLVSTIDANF CHK1, PKD 5,0E+06
YLL045C 126 1 KSKQDASPKPYAV Proline-directed, CDK1 1,1E+06
YLL045C 130 1 DASPKPYAVKYGL 1,1E+06
YLL045C 216 1 ALAKLVSTIDANF CHK1, PKD 1,6E+06
YPL237W 112 1 DNVDAESKEGTPS 5,4E+06
YMR309C 93 3 SNKFLKSSNYDSS 3,1E+04
YMR309C 96 2 FLKSSNYDSSDEE EGFR 3,1E+04
YMR309C 98 1 KSSNYDSSDEESD CK1, CK2 6,3E+05
YMR309C 99 1 SSNYDSSDEESDE CK2, GSK3 6,3E+05
YMR309C 103 1 DSSDEESDEEDGK CK1, CK2 3,1E+04
YEL034W 2 1 MSDEEHTF CK2 9,2E+08
YEL034W 7 1 MSDEEHTFETADA PLK1 9,2E+08
YEL034W 10 2 EEHTFETADAGSS FHA KAPP 9,2E+06
YEL034W 15 3 ETADAGSSATYPM 1,0E+09
YEL034W 19 2 AGSSATYPMQCSA EGFR 9,2E+08
YEL034W 24 3 TYPMQCSALRKNG 1,0E+09
YPR016C 91 1 RNSLPDSVKIQRV CK1, NEK6 1,0E+05
YPR016C 231 1 QDAQPESISGNLR 2,8E+07
YOR260W 294 1 LKLGPQSMSRQAS 8,3E+06
YOR260W 296 1 LGPQSMSRQASFK GSK3 1,2E+07
YOL137W 33 2 ELKNLLSSSDSRR GSK3 1,6E+08
YOL137W 34 2 LKNLLSSSDSRRN NEK6 1,6E+08
YOL137W 35 2 KNLLSSSDSRRNS NEK6 1,6E+08
YOL137W 37 2 LLSSSDSRRNSQD CK1, GSK3 1,6E+08
YOL137W 41 1 SDSRRNSQDEDSL ATM/ATR, CAMK2, CK1, CK2, PKA 2,8E+07
YCL037C 86 2 WVPIKASITVSGT AURORA, GSK3 8,5E+08
YCL037C 88 3 PIKASITVSGTKR 8,5E+08
YCL037C 90 2 KASITVSGTKRSG CK1 8,5E+08
YCL037C 92 2 SITVSGTKRSGSK FHA KAPP 8,5E+08
YCL037C 95 3 VSGTKRSGSKNGA 8,5E+08
YCL037C 97 2 GTKRSGSKNGASN CAMK2, PKA 8,5E+08
YHR170W 189 1 AHVDTISISEAKD CK2 6,7E+04
YHR170W 427 1 HKDIDASLDYNSR PLK1 1,8E+05
YMR049C 20 2 SKKRAASEESDVE CAMK2, PKA 3,8E+06
YMR049C 23 1 RAASEESDVEEDE CK1, CK2 8,1E+07
YMR049C 72 1 KEAQDDSDDDSDA GSK3 1,2E+06
YMR049C 76 1 DDSDDDSDAELNK CK1, CK2 1,2E+06
YMR049C 95 2 GDGEEDYDSSEFS EGFR, SRC 1,0E+07
YMR049C 97 1 GEEDYDSSEFSDD GSK3 1,0E+07
YMR049C 98 1 EEDYDSSEFSDDT 1,0E+07
YMR049C 101 1 YDSSEFSDDTTSL CK1 1,0E+07
YMR049C 146 3 INPVYDSDDSDAE 8,3E+07
YMR049C 149 2 VYDSDDSDAETQN CK1, CK2 8,3E+07
YMR049C 212 1 LDKNSGSSLNLTK 1,3E+06
YMR049C 347 1 PEEYLLSPEEKEA Proline-directed, CK2 8,0E+06
YNL227C 393 1 DLEKFDSADESVK CHK1, CK2, GSK3, PKD 6,5E+05
YBR267W 106 1 LENMQKSQEGNTP ATM/ATR 2,1E+06
YBR267W 111 1 KSQEGNTPDLSKL Proline-directed, FHA2 Rad53p 2,1E+06
YBR267W 118 1 PDLSKLSLQENEE AURORA, CK1, CK2 5,3E+05
YBR267W 140 1 EEPEQLTEEEMAE CK2 1,5E+07
YDR365C 86 1 AENDEDSEVNAKT 4,3E+04
YDR365C 223 1 KKKTDDSDSDMDI 3,5E+06
YDR365C 225 1 KTDDSDSDMDIGI 3,5E+06
YNR054C 47 1 KVEDIESENESDI CK2, GSK3 5,9E+05
YNR054C 51 1 IESENESDIEEEQ CK1, CK2 5,9E+05
YPR104C 44 1 KESITNSPTSEVP Proline-directed, CK1 1,0E+06
YPR104C 47 2 ITNSPTSEVPIET CK1 1,0E+06
YKL143W 7 1 MSKKFSSKNSQRY 1,2E+05
YDR496C 34 1 PRISIDSSDEESE CK1, CK2 2,1E+06
YDR496C 35 1 RISIDSSDEESEL CK1, CK2, GSK3 1,2E+07
YGR245C 278 1 ENFEENSEDEDGF CK2 1,5E+07
YGR245C 591 1 DVDMEDSDDEKDN CK2 1,4E+07
YGR245C 603 1 NAKGKESDSDLEL 6,9E+06
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YGR245C 610 1 DSDLELSDDDDEK NEK6 6,9E+06
YOR294W 41 3 DKNDLDSSNARRE 1,6E+05
YOR294W 42 2 KNDLDSSNARREE NEK6 1,6E+05
YOR294W 169 1 DDKVKGTDNELID CK2 1,2E+05
YPL012W 1034 3 RKDEEVTTGVSDV 1,5E+06
YPL012W 1035 2 KDEEVTTGVSDVA FHA KAPP 1,5E+06
YPR143W 69 1 IIDNEQSDAEEDD CK2 3,5E+06
YPR137W 29 1 TVDEEITDPSSNE FHA KAPP 5,1E+05
YLR221C 83 1 DIAIEVSDVELTD CK2 3,3E+06
YLR221C 88 1 VSDVELTDEESKD CK2 3,3E+06
YLR221C 92 2 ELTDEESKDLKLN CK1 3,3E+06
YPL217C 478 1 DIDNLPSDEEPYT CK2 2,1E+07
YPL217C 483 2 PSDEEPYTNDDDV SRC 2,1E+07
YPL217C 484 2 SDEEPYTNDDDVQ FHA1 Rad53p 1,3E+04
YPL217C 578 1 DDSKDESDIEEDV CK1, CK2 1,5E+07
YGR145W 524 2 KRIRALTAAEESD CAMK2, CK2, PKA/AKT 9,4E+06
YGR145W 529 1 LTAAEESDEERIA CK2 1,7E+08
YGR145W 555 2 ESDEEESDDETNQ CK2 3,0E+07
YDR060W 73 1 KLIQGLSDDDDAK 1,3E+07
YDR060W 80 1 DDDDAKSEQEFDA CK2 2,8E+06
YDR060W 710 1 VDYEYESDAEEEQ CK2 5,1E+07
YGL111W 257 1 LRFLEPSPGKTEK Proline-directed, CDK1, CDK2, NEK6 4,6E+04
YLR009W 156 1 ERAESVSEQEESE CK2 1,2E+07
YLR009W 161 1 VSEQEESEEEEED CK2 1,2E+07
YLR009W 172 1 EDMEIDSDEEEEE CK2 1,2E+07
YNL002C 14 1 KAQTLNSNPEILL CK2 3,1E+05
YNL002C 114 1 NGAEENSVDLEET PLK1 2,8E+07
YNL002C 120 1 SVDLEETEEEEDD CK2, NEK6 2,8E+07
YNL002C 278 1 KLNREVSGFGSLN CAMK2, CHK1, CHK1/2, GSK3, PKD 1,4E+05
YHR064C 477 1 AEEDDESEWSDDE 6,4E+07
YHR064C 480 1 DDESEWSDDEPEV CK1, CK2 6,4E+07
YMR229C 187 1 EDAEYESSDDEDE 1,7E+05
YMR229C 188 1 DAEYESSDDEDEK CK2 3,0E+05
YKL172W 104 1 EAQKHMSGDEDES CK2 9,6E+07
YKL172W 110 1 SGDEDESGDDREE 9,6E+07
YKL172W 177 1 EQDVPLSDVEFDS CK2 3,6E+07
YKL172W 183 1 SDVEFDSDADVVP 3,6E+07
YGR285C 50 1 LRNHTWSEFERIE CK2 1,6E+08
YOL041C 181 1 TNPIAETEESGNE FHA KAPP 3,3E+08
YOL041C 184 1 IAETEESGNEKEE CK2 3,3E+08
YNL175C 105 1 EESTINTPTGDES Proline-directed 2,1E+06
YNL175C 107 1 STINTPTGDESGE CK2 2,1E+06
YER002W 152 1 EIKARDTTEETEV CK2, PKA 2,3E+05
YER002W 153 2 IKARDTTEETEVV CAMK2 2,3E+05
YER002W 176 1 VIRKERSQSEREE ATM/ATR, CHK1, CK2, PKD 4,2E+05
YJL076W 231 1 KIVSNNSDDEDED CK1, CK2 7,3E+06
YHR052W 11 1 SNSKKSTPVSTPS Proline-directed, FHA KAPP, Polo box 3,3E+07
YHR052W 14 1 KKSTPVSTPSKEK CK1 2,1E+07
YHR052W 15 1 KSTPVSTPSKEKK Proline-directed, CDK1, CDK2, ERK/MAPK, Polo box 4,0E+06
YHR052W 17 1 TPVSTPSKEKKKV CK1 4,0E+06
YHR052W 357 2 NNAKKRSSSELEK CK2 0,0E+00
YLR387C 287 1 FTYDDHSISKNLQ PLK1 4,8E+06
YLR387C 304 1 ITSKLSSVYGAKN CK1 2,1E+04
YNL124W 255 1 EEEQEFSDDEKEA CK2 1,2E+07
YLR175W 378 1 GRVNENTPEQWKK Proline-directed 7,0E+06
YLR175W 398 2 AEQSTSSSQETKE CK1, CK2 3,3E+07
YLR175W 399 1 EQSTSSSQETKET ATM/ATR, CK1 3,3E+07
YLR175W 402 2 TSSSQETKETEEE CK1 3,3E+07
YLR175W 416 1 KKAKEDSLIKEVE PLK1 2,5E+07
YKL009W 181 2 IKAGKITIDSPYL AURORA, FHA KAPP 2,8E+07
YKL009W 184 1 GKITIDSPYLVCT Proline-directed 8,0E+06
YNL308C 174 3 LLNEIKSAFSDEE 4,3E+04
YNL308C 177 2 EIKSAFSDEENEE CK1, CK2 4,3E+04
YNL308C 184 1 DEENEESSGDEDD 4,3E+04
YNL308C 185 1 EENEESSGDEDDG CK2 4,3E+04
YNL308C 482 2 QDLKFRYREVSPE ALK 5,5E+05
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YLR196W 52 1 EEAEGESGVEDDA CK2 7,5E+07
YLR196W 105 3 SMFPGLSNDSDVK 3,5E+04
YLR196W 108 2 PGLSNDSDVKFHE CK1 3,5E+04
YLR196W 131 1 LPNQEDSQEEKQE ATM/ATR, CK2 2,6E+06
YER036C 43 1 EAAAEESEVDAAA 1,0E+05
YLR106C 3816 3 LDYAAQTLSVISK 5,6E+04
YLR106C 3821 2 QTLSVISKYSATS CK1 5,6E+04
YLR106C 3823 3 LSVISKYSATSEQ 5,6E+04
YLR106C 3824 2 SVISKYSATSEQQ CK1 5,6E+04
YLR106C 3826 3 ISKYSATSEQQKI 5,6E+04
YLR106C 3827 2 SKYSATSEQQKIL CK1 5,6E+04
YLR106C 4353 1 PEEQAMSDEEELK CK2 4,5E+05
YLR106C 4555 1 DEEEMLSDIDAHD 3,5E+07
YMR290C 12 1 NKRSRDSESTEEP CK1, PKA 6,2E+05
YMR290C 15 1 SRDSESTEEPVVD CK1 6,3E+05
YLL008W 208 1 IDEEDDSEEAKAD 3,0E+05
YCR057C 225 1 EFTKRPSDDDDNE CK1, PKA 1,9E+07
YCR057C 232 1 DDDDNESEDDDKQ 1,9E+07
YCR057C 244 3 QEEVDISKYSWRI 1,8E+07
YCR057C 651 1 DDAGENSDLEDRI CK2 1,4E+07
YCR057C 888 1 NDVVMESDDEEGW CK2 5,6E+05
YCR057C 912 1 LSNENDSSDEEEN CK2 9,9E+07
YCR057C 913 1 SNENDSSDEEENE CK2 9,9E+07
YAL025C 241 1 EKWLADSDREASS CK2, NEK6 3,0E+05
YMR014W 257 1 SNIDYDTDDGNEK 6,5E+06
YMR014W 283 2 TQSNKETTSDNED FHA1 Rad53p 3,9E+07
YMR014W 284 3 QSNKETTSDNEDL 3,9E+07
YMR014W 285 1 SNKETTSDNEDLL CK2 3,9E+07
YPL093W 469 1 LENEGFYNSDDEE SRC 4,0E+07
YPL093W 471 1 NEGFYNSDDEEEI CK2 4,0E+07
YNL224C 217 1 DEEAQQSPDLTKI Proline-directed 4,6E+06
YDL167C 675 2 PPLSMATKSMKEG CK1 2,1E+04
YDL167C 677 2 LSMATKSMKEGDG CK2 2,1E+04
YHR065C 45 1 KEGGSESDSEEDA CK2 7,5E+04
YNR053C 60 1 NLIRAASFQDSTI CAMK2, CHK1, CHK1/2, GSK3, PKD 2,9E+07
YNR053C 64 1 AASFQDSTIPDAR CK1 2,9E+06
YNR053C 85 1 GNTRVISQDALQH ATM/ATR, CAMK2, CK1 7,1E+06
YIL019W 47 1 EVDTRDSSGDEID PKA 4,8E+05
YIL019W 48 1 VDTRDSSGDEIDN CAMK2, CK1, CK2 4,8E+05
YIL019W 55 1 GDEIDNSDHGSDF GSK3 4,8E+05
YER127W 288 1 KERRVTSFEEDNF CAMK2, CK2 2,1E+06
YJL109C 385 2 EVRLIITDLIYLS FHA2 Rad53p, NEK6 7,3E+06
YJL109C 398 2 EILEDKSQLVELF ATM/ATR 7,3E+06
YJL109C 409 1 LFEYFISINEDLV CK2 7,3E+06
YLR222C 430 1 FDIYAKYIGHSAA EGFR 1,8E+06
YLR222C 434 1 AKYIGHSAAVTAV 1,8E+06
YML093W 34 3 NGEFDNSSDNDKR 3,8E+07
YML093W 35 3 GEFDNSSDNDKRH 3,8E+07
YML093W 423 1 RELAAVSSDEDNE CK2 2,2E+07
YML093W 424 1 ELAAVSSDEDNED 2,2E+07
YML093W 488 1 KMLDRNSDDEEDG CK2, PKA 3,2E+05
YML093W 498 1 EDGRVQTLSDVEN CAMK2, FHA1 Rad53p 5,6E+07
YML093W 500 1 GRVQTLSDVENEE CK2 4,0E+06
YML093W 562 1 DIKLFESDEEETN CK2, NEK6 7,8E+07
YML093W 640 1 IIVEEESDGEPLQ CK2 1,4E+06
YML093W 668 1 PWLANESDEEHTV CK2 1,2E+08
YML093W 673 1 ESDEEHTVKKQSS PLK1 1,2E+08
YML093W 738 1 VDPYGGSDDEQGD CK2 7,7E+07
YGR090W 12 3 KRKASETSDQNIV 3,1E+07
YGR090W 13 2 RKASETSDQNIVK CK1 3,1E+07
YGR090W 60 1 ENDESDTSPESNE CK2 9,1E+06
YGR090W 10 1 SVKRKASETSDQN CAMK2, CHK1, PKA, PKD 1,1E+06
YGR090W 58 1 EQENDESDTSPES 5,8E+06
YDR398W 626 2 QDGRLETEQSDGE CAMK2, FHA KAPP 7,0E+07
YDR398W 629 1 RLETEQSDGEEEA CK2 3,7E+06
YDR398W 638 1 EEEAGYSDVEME CK2 3,7E+06
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YGR128C 150 2 NDHLSESDIDNKA NEK6 5,6E+06
YGR128C 142 2 LEDTTDTSNDHLS FHA1 Rad53p 4,1E+06
YJR002W 177 1 QDERHSSPDPYGI Proline-directed, CAMK2, Polo box 5,3E+06
YOL144W 268 1 PMTLNDSDEELLT CK1, CK2, NEK6 4,7E+05
YOL144W 370 1 FKLIEDSDNDIDH 3,1E+07
YPL226W 120 1 SGTPTPSASTTSL CK1 1,6E+07
YPL226W 124 3 TPSASTTSLTSLN 1,6E+07
YPL226W 125 2 PSASTTSLTSLNE CK1 1,6E+07
YPL226W 127 1 ASTTSLTSLNEKL 1,6E+07
YPL226W 1191 1 TPKPVDTDDEED CK2 3,4E+07
YOR104W 194 1 ENFEGSSPQPQYD Proline-directed, Polo box 3,7E+05
YLR342W 269 1 EANPEDTEETLNK 3,6E+06
YOR117W 52 1 SELQRLSHENNVM PKA 3,4E+06
YHR027C 184 1 SSDGSKSDGSAAT 2,0E+05
YHR027C 187 1 GSKSDGSAATSGF CK1, GSK3 2,0E+05
YLR421C 132 2 IGVLNNSSESDEE NEK6 2,0E+08
YLR421C 133 3 GVLNNSSESDEEE 1,9E+07
YLR421C 135 1 LNNSSESDEEESN CK1, CK2 2,9E+06
YLR421C 153 1 AQDVDVSMQD PLK, PLK1 6,4E+05
YDL147W 95 1 LKLSIQYMIQKVM 3,0E+06
YGL009C 494 1 SPKVEVTSEDEKE FHA1 Rad53p 7,1E+07
YGL009C 495 1 PKVEVTSEDEKEL CK2 7,1E+07
YGL173C 1500 3 KGEIKPSSGTNST 1,9E+07
YGL173C 1506 1 SSGTNSTECQSPK 6,6E+07
YGL173C 1510 1 NSTECQSPKSQSN Proline-directed, CDK1, CK1 6,6E+07
YGR240C 179 1 AFLEATSEDEIIS CK2 1,0E+04
YMR205C 163 1 PEASAESGLSSKV CK1, GSK3 1,3E+08
YMR205C 166 2 SAESGLSSKVHSY CK1 1,3E+08
YMR205C 167 1 AESGLSSKVHSYT CK1, GSK3 1,3E+08
YMR205C 171 1 LSSKVHSYTDLAY CK1 6,2E+06
YMR205C 173 1 SKVHSYTDLAYRM FHA KAPP 1,6E+08
YNR016C 1162 1 VSVSDLSYVANSQ CK1, PLK1 8,8E+06
YNR016C 9 2 EESLFESSPQKME CK1, NEK6 2,8E+06
YNR016C 10 1 ESLFESSPQKMEY Proline-directed, CDK1, CDK2, Polo box 2,8E+06
YNR016C 1157 1 GMNRAVSVSDLSY CAMK2, CHK1 6,5E+07
YIL095W 507 1 PDNINGSKIVRSL 1,5E+06
YCL054W 432 1 KKRMIFTDDELAK CK2 4,6E+04
YCL054W 505 1 TGFNEGSLEKKEE PLK1 4,9E+05
YCL054W 529 1 EGVEGDSDDDEAI 1,5E+07
YCL054W 765 1 GLINDDSDKTEKD 4,3E+05
YER122C 281 3 DEFTNSSSSTKIR 2,1E+06
YER122C 282 2 EFTNSSSSTKIRQ CK1 2,1E+06
YOL086C 2 1 MSIPETQK CK2 1,2E+07
YNL323W 36 1 EEDVDASEFEEDE CK2 2,6E+07
YLR398C 209 1 GIKPMDSPAENED Proline-directed, CK2 4,1E+05
YPL195W 918 1 KTKAKNSPEPNEF Proline-directed 1,0E+07
YPR095C 144 2 PDGERVTLTSSGS AURORA, FHA KAPP, PKA 1,5E+05
YPR095C 157 2 DNVKRNSKHAPFI PKA 1,5E+05
YEL022W 284 1 NNEEAISEDDGIE 4,0E+06
YDR465C 181 1 DGQKEESVGSDDD PLK1 8,4E+07
YDR465C 184 1 KEESVGSDDDATA CK1 8,4E+07
YLL048C 944 1 ILSRANSSANLAA CAMK2, CHK1, CHK1/2, CK1, PKD 7,0E+06
YLL048C 954 1 LAAKSSTSLSNLP FHA KAPP 2,3E+06
YLL048C 955 1 AAKSSTSLSNLPA CK1 2,3E+06
YPL058C 52 1 QLSRHLSNILSNE CAMK2, CHK1, CHK1/2, CK1, GSK3, PKD 2,9E+06
YJL033W 692 1 AMEEEISGDEEEG CK2 4,7E+06
YDL160C 14 1 FNTNNNSNTDLDR CK1 3,4E+07
YDL160C 16 2 TNNNSNTDLDRDW FHA1 Rad53p 3,4E+07
YJL050W 34 1 DTNVGDTPDHTQD Proline-directed 1,5E+07
YJL050W 38 2 GDTPDHTQDKKHG ATM/ATR 1,5E+07
YBR142W 138 1 SKLTDPSEDVDED 9,6E+03
YBR142W 678 1 LGIDVDSDEDDIS 1,1E+08
YDL084W 13 1 EDLLEYSDNEQEI CK2, NEK6 6,7E+07
YKL004W 392 1 SRSSATSITSLGV CK1 1,4E+06
YKL004W 395 1 SATSITSLGVKRA CK1 1,4E+06
YGR166W 398 1 FSLGAASTTSLVN 5,3E+04
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YGR166W 401 1 GAASTTSLVNSKL CK1, GSK3 5,3E+04
YPR159W 116 1 NNSRAVSTANDNS CAMK2, CK1 3,5E+05
YPR159W 134 1 HRAIASSPSLNSN Proline-directed, Polo box 3,5E+06
YPR159W 136 2 AIASSPSLNSNLS CK1 2,5E+06
YPR159W 139 2 SSPSLNSNLSKND CK1 2,5E+06
YPR159W 142 1 SLNSNLSKNDILS CK1 1,0E+06
YGR143W 92 1 YNNDPNSDTSLLA 3,5E+03
YGR143W 95 1 DPNSDTSLLANEK CK1, PLK1 3,5E+03
YLR399C 270 1 AKGRRSSAQEDAP CAMK2, CK2, PKA 1,2E+06
YLR399C 615 1 RDASSLSPTSAGS Proline-directed, CK1 1,6E+05
YOR078W 39 3 KDKEVHSSSDEES 6,1E+04
YOR078W 40 2 DKEVHSSSDEESD CK2 6,1E+04
YOR078W 45 1 SSSDEESDDDDAP CK1 4,3E+05
YOR078W 144 1 FDKLDESDENEEA NEK6 1,2E+07
YFL023W 458 1 KQETTRSVENEVV 3,2E+05
YFL023W 580 1 KILENISDDDYDD 1,8E+07
YCL014W 1075 1 ADVENLSDDDEHR 8,7E+05
YCL014W 1085 1 EHRQNESRVFNDD 8,7E+05
YLR319C 347 1 ASPRRLSSVVTTS CAMK2, PKA 1,2E+06
YGL203C 660 1 NNRQHDSPNKTVS Proline-directed, CDK1, CDK2 1,7E+06
YFL034C-B 38 2 IYSSPHSSNSRLS CK1 1,5E+06
YFL034C-B 39 2 YSSPHSSNSRLSL CK1 1,5E+06
YFL034C-B 41 2 SPHSSNSRLSLRN CK1 1,0E+05
YLR413W 652 1 EKAVQESDSTTSR 2,9E+07
YLR413W 654 1 AVQESDSTTSRII 3,2E+06
YLR413W 655 2 VQESDSTTSRIIE CK1 3,3E+06
YLR413W 656 1 QESDSTTSRIIEE FHA2 Rad53p 3,2E+06
YLR413W 657 1 ESDSTTSRIIEEH CK1 3,2E+06
YLR413W 665 1 IIEEHESPIDAEK Proline-directed 3,0E+07
YLR332W 5 1 MLSFTTKNSFR NEK6 0,0E+00
YLR332W 6 1 MLSFTTKNSFRL CK1, FHA KAPP 0,0E+00
YNL192W 299 1 GKEELDSVKSGYS 4,3E+04
YNL192W 318 1 YDKDDFSRDDEYD 3,2E+05
YNL192W 328 1 EYDDLNTIDKLQF 3,2E+05
YBR023C 146 3 VDNFEESSTQPIN 8,8E+06
YBR023C 147 1 DNFEESSTQPINK 2,4E+07
YBR023C 148 1 NFEESSTQPINKS ATM/ATR, FHA2 Rad53p 2,4E+07
YBR023C 538 1 GHKRASTFDLLKK CAMK2, FHA2 Rad53p, PKA 5,1E+05
YGR202C 59 1 NKDTQLTPRKRRR Proline-directed, CDK1, CDK2 1,2E+06
YHR090C 188 1 KSVTPVSPSIEKK Proline-directed, ERK/MAPK, WW GroupIV 2,6E+06
YHR090C 190 3 VTPVSPSIEKKIA 2,6E+06
YMR091C 4 1 MSDSEGGLAS 1,5E+07
YER164W 36 1 QNYFNDSDDEDDE CK2 9,3E+05
YHL002W 162 1 STQADNSDDEELQ CK2 4,4E+06
YPL085W 483 1 KLPWEVSDGEVSS CK2 6,1E+06
YPL085W 806 1 NKYAPVSPTVQQK Proline-directed, ERK/MAPK, WW GroupIV 4,0E+06
YPR124W 8 3 EGMNMGSSMNMDA 2,1E+06
YPR124W 9 3 GMNMGSSMNMDAM 2,1E+06
YPR124W 16 3 MNMDAMSSASKTV 2,1E+06
YPR124W 17 3 NMDAMSSASKTVA 2,1E+06
YPR124W 19 2 DAMSSASKTVASS CK1 2,1E+06
YPR124W 349 1 ESKVAISENNQKK 4,3E+06
YLR429W 460 2 SPSPLKSASSSST CK1, GSK3 3,5E+08
YLR429W 476 1 VLKEDNSINKLLK PLK1 3,5E+08
YHR007C 207 3 PEMTIFTASRSLL 7,0E+06
YHR007C 209 3 MTIFTASRSLLGK 7,0E+06
YHR007C 211 2 IFTASRSLLGKEM CK1 7,0E+06
YIL106W 36 1 NNAGSVSPTKATP Proline-directed, CDK1, CDK2 3,2E+06
YIL106W 38 1 AGSVSPTKATPHN 1,9E+07
YDR284C 285 1 EELHPLSDEGM 4,2E+06
YPL265W 12 1 KKMFTSTSPRNSS 9,4E+06
YPL265W 18 2 TSPRNSSSLDSDH CAMK2, GSK3 2,0E+05
YPL265W 19 3 SPRNSSSLDSDHD 8,5E+03
YPL265W 22 1 NSSSLDSDHDAYY CK1 2,0E+05
YCR092C 392 2 LVSKLYSHMVEYN CHK1, CK1, PKD 2,2E+06
YCR092C 798 3 PNMGGKSSYIRQV 1,3E+05
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YCR092C 800 2 MGGKSSYIRQVAL EGFR 1,3E+05
YCR092C 815 3 IMAQIGSFVPAEE 1,3E+05
YDR097C 166 1 KGKVVDSESDEDE 3,6E+03
YDR097C 168 1 KVVDSESDEDEYL 3,6E+03
YDR097C 201 1 GELAEDSGDDDDL 4,9E+06
YNL102W 31 1 DYEGDESDGDRIY 3,2E+06
YEL055C 789 1 DQLEGLSDDGGDD 1,9E+05
YBR202W 685 2 FSFGQATPRTLLG Proline-directed, CDK1 8,2E+04
YOL006C 14 1 KVNHELSSDDDDD 2,5E+07
YOL006C 15 1 VNHELSSDDDDDV 2,5E+07
YOL006C 47 1 QDEAEPYDSDEAI EGFR 2,0E+07
YOL006C 49 1 EAEPYDSDEAISK 2,0E+07
YOL006C 54 3 DSDEAISKISKKK 2,0E+07
YPR190C 392 1 SDNKKRSGSNAAA 3,7E+06
YPR190C 394 1 NKKRSGSNAAASL CAMK2, PKA 3,7E+06
YPR190C 399 3 GSNAAASLPSKKL 3,7E+06
YDL150W 181 2 DGESEKSSDVDMD CK1 8,2E+05
YDL150W 182 2 GESEKSSDVDMDD CK1 8,2E+05
YNL151C 189 1 EDVDDASTGDGAA 7,8E+05
YNL113W 33 1 EQDVDMTGDEEQE CK2 7,0E+06
YAL023C 34 2 SSSISVSEELSSA CK1, GSK3 2,0E+04
YAL023C 38 2 SVSEELSSADERD CK1 2,0E+04
YAL023C 39 1 VSEELSSADERDA CK2 2,0E+04
YAR028W 176 2 SDSSSNSAEDTQS CK1 3,0E+05
YAR028W 182 1 SAEDTQSPVSAGK Proline-directed 3,0E+05
YCR034W 334 1 DLKNVPTPSPSPK Proline-directed, ERK/MAPK 5,1E+05
YCR034W 336 1 KNVPTPSPSPKPQ Proline-directed 5,1E+05
YPL046C 21 1 EYEISRSAAMISP 2,3E+08
YPL046C 26 2 RSAAMISPTLKAM Proline-directed 2,3E+08
YPL046C 28 2 AAMISPTLKAMIE FHA KAPP 2,3E+08
YLR144C 187 1 KAREFVSSNDIKL 0,0E+00
YDR153C 322 1 KNNNINSNSDDDD 3,1E+07
YDR153C 324 1 NNINSNSDDDDDE 3,1E+07
YGL233W 593 1 NNILVKTMDDIFN FHA1 Rad53p, NEK6 8,2E+06
YPL231W 50 1 VVEIGPSPTLAGM Proline-directed 9,1E+06
YPL231W 52 3 EIGPSPTLAGMAQ 1,2E+07
YPL231W 91 1 AKEIYYTPDPSEL Proline-directed 2,0E+06
YPL231W 95 1 YYTPDPSELAAKE CK1 2,0E+06
YPL231W 112 1 EEAPAPTPAASAP Proline-directed, FHA KAPP 7,1E+05
YPL231W 162 1 AHKLKKSLDSIPM AURORA, NEK6, NIMA 6,8E+04
YPL231W 180 1 DLVGGKSTVQNEI 3,6E+06
YPL231W 576 1 EFEKLYSDLMKFL 5,4E+04
YPL231W 615 1 STKEVASLPNKST 1,9E+05
YPL231W 827 1 QVILPMSPNHGTF Proline-directed, ERK/MAPK, NEK6, WW GroupIV 4,8E+05
YPL231W 958 1 EVRKAVSIETALE CHK1, PKD 9,0E+05
YPL231W 977 1 NSADAAYAQVEIQ ALK 3,4E+04
YPL231W 1073 2 LKGRPYTGWVDSK CAMK2 4,8E+06
YPL231W 1080 3 GWVDSKTKEPVDD 4,8E+06
YPL231W 1440 1 SSVKYASPNLNMK Proline-directed 8,6E+05
YPL231W 1479 1 EAEEIPSEDQNEF 1,0E+06
YPL231W 1730 1 KDKKSGSLTFNSK 6,0E+04
YPL231W 1827 1 KSLGVKSLGGGAA 1,1E+05
YKL182W 56 1 ADDEPTTPAELVG Proline-directed, CK2, ERK/MAPK, WW GroupIV 1,7E+05
YKL182W 449 1 LVKNNVSFNAKDI 5,2E+04
YKL182W 733 1 PIALQWTGGRGGG NEK6 7,5E+06
YKL182W 1119 2 SQVDSSSVSEDSA CK2 3,8E+08
YKL182W 1121 1 VDSSSVSEDSAVF CK1 5,2E+08
YKL182W 1525 1 FLKRNGSTLEQKV CAMK2, CHK1, CHK1/2, CK2, PKA, PKD 2,9E+05
YLR449W 66 3 ELTRGEYYNQDNN 1,8E+07
YLR449W 80 1 GLEEDESESEQEA CK2 1,8E+07
YLR449W 82 1 EEDESESEQEADV CK2 1,8E+07
YPL221W 640 1 KSQEGKSEDNLFG 6,7E+04
YAL053W 688 1 LFDDETSSSSFKQ 3,4E+04
YAL053W 689 1 FDDETSSSSFKQN 3,4E+04
YAL053W 691 1 DETSSSSFKQNSS CK1 3,4E+04
YDL035C 480 2 NDNSDITSNIKEK CK1, FHA2 Rad53p 1,7E+06
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YBR018C 273 1 VKEDLASILKQLT 2,9E+04
YCL025C 87 2 DLTSAISPSSRQA Proline-directed, CK1 4,2E+07
YCL025C 89 1 TSAISPSSRQAQE 4,2E+07
YCL025C 101 1 ELEKNESSDNIGA CHK1, PKD 3,9E+06
YBR112C 741 1 KKQKLNSPNSNIN Proline-directed 2,1E+06
YJL031C 44 2 MRDEKIYSIEALK SRC 3,3E+07
YJL031C 45 3 RDEKIYSIEALKK 3,3E+07
YEL017W 116 1 DDEKPQSGDETSA CK2 2,1E+05
YGR192C 199 1 DWRGGRTASGNII 9,0E+07
YGR192C 201 1 RGGRTASGNIIPS CAMK2 9,0E+07
YGR192C 208 1 GNIIPSSTGAAKA 9,0E+07
YGR192C 209 2 NIIPSSTGAAKAV FHA KAPP 9,0E+07
YHL032C 4 3 MFPSLFRLVV 1,9E+05
YHL032C 12 3 FRLVVFSKRYIFR 1,9E+05
YDL022W 22 2 NAGRKRSSSSVSL CAMK2, PKA 3,1E+07
YDL022W 23 2 AGRKRSSSSVSLK GSK3, PKA 1,7E+06
YDL022W 24 2 GRKRSSSSVSLKA CAMK2, PKA, PKA/AKT 1,7E+06
YDL022W 27 1 RSSSSVSLKAAEK CK1 1,1E+07
YOL059W 70 1 DHPIRRSDSAVSI PKA 2,6E+06
YOL059W 72 1 PIRRSDSAVSIVH CAMK2, CHK1, PKD 2,6E+06
YER155C 1932 3 YLIQTASSSDLTE 1,1E+06
YER155C 1933 3 LIQTASSSDLTEW 1,1E+06
YER155C 1934 2 IQTASSSDLTEWI CK1 1,1E+06
YER155C 1937 2 ASSSDLTEWIKMI CK1, FHA2 Rad53p 1,1E+06
YER155C 1946 2 IKMIKASKRFSFH GSK3 1,1E+06
YOR070C 25 2 SSSLVTSLMKSWR CK1, GSK3, NEK6 1,6E+05
YDR389W 16 1 SKIENVSPSKGHV Proline-directed, CDK1, CDK2 7,9E+05
YDR389W 18 1 IENVSPSKGHVPS 7,9E+05
YDR389W 465 1 LSPISTSIPENSS CK2 2,5E+06
YFL038C 172 1 ARQIKESMSQQNL 2,3E+06
YFL038C 174 1 QIKESMSQQNLNE ATM/ATR 2,3E+06
YML001W 17 1 VIILGDSGVGKTS NEK6 2,6E+06
YML001W 22 1 DSGVGKTSLMHRY 2,6E+06
YML001W 23 1 SGVGKTSLMHRYV AURORA 2,6E+06
YMR116C 3 1 MASNEVLVL 2,0E+07
YMR116C 120 1 DIDKKASMIISGS CHK1, GSK3, PKD 6,6E+05
YMR116C 166 1 EKADDDSVTIISA PLK1 1,7E+07
YMR116C 168 1 ADDDSVTIISAGN FHA KAPP 1,7E+07
YLR259C 141 1 MDLRRGSQVAVEK ATM/ATR, CAMK2, PKA 2,1E+06
YBR169C 363 3 VFGKPLSSTLNQD 2,9E+04
YBR169C 365 2 GKPLSSTLNQDEA NEK6 2,9E+04
YDL229W 516 1 AVGRLSSEEIEKM CAMK2, CHK1, PKD 3,5E+05
YJR045C 21 2 SSFRIATRLQSTK CAMK2 1,5E+07
YJR045C 25 2 IATRLQSTKVQGS CAMK2, CK1 1,5E+07
YJR045C 26 2 ATRLQSTKVQGSV NEK6 1,5E+07
YJR045C 40 2 GIDLGTTNSAVAI FHA KAPP, NEK6 1,5E+07
YJR045C 42 3 DLGTTNSAVAIME 1,5E+07
YGL253W 15 1 PQARKGSMADVPK CAMK2, PKA 1,5E+07
YMR011W 29 1 IVQKLETDESPIQ CHK1, FHA KAPP, PKD 4,8E+07
YMR011W 32 1 KLETDESPIQTKS Proline-directed 4,8E+07
YDR508C 111 2 PISTKDSSSQLDN CK1 2,0E+07
YDR508C 112 2 ISTKDSSSQLDNE CK1 2,0E+07
YDR508C 113 1 STKDSSSQLDNEL ATM/ATR 2,0E+07
YDR508C 123 2 NELNRKSSYITVD PKA 2,2E+04
YDR508C 124 1 ELNRKSSYITVDG CAMK2, CHK1, CHK1/2, PKA, PKD 2,2E+04
YDR508C 127 1 RKSSYITVDGIKQ CK1 2,2E+04
YGR055W 42 1 DADNGASDFEAGQ CK2 5,5E+05
YGR260W 66 1 EREIMATTTDDDG FHA1 Rad53p 1,0E+06
YGR260W 67 1 REIMATTTDDDGI FHA1 Rad53p 1,0E+06
YGR260W 68 1 EIMATTTDDDGIP FHA1 Rad53p 1,0E+06
YDR225W 129 1 AKATKASQEL ATM/ATR 9,6E+05
YBR215W 330 1 SEKAKKSSSASAI GSK3 2,0E+07
YBR215W 331 1 EKAKKSSSASAIL 2,0E+07
YBR215W 332 1 KAKKSSSASAILP 2,0E+07
YBR215W 334 2 KKSSSASAILPKP CK1 2,0E+07
YBR215W 342 2 ILPKPTTTKTSKK CHK1, PKD 2,0E+07




Protein Position Class pSite Sequence Window Matching Kinase and binding Motifs Intensity
YBR215W 346 2 PTTTKTSKKAASN CK1 2,0E+07
YDR168W 14 1 WDKIELSDDSDVE 1,9E+07
YGL133W 332 1 NDSENNSSEEDKK CK1, CK2 6,8E+05
YGL133W 333 1 DSENNSSEEDKKK 6,8E+05
YBR086C 704 1 DNDTAGSAGKKPL 3,0E+05
YBR086C 726 2 SLVKVPTVGSYGV CHK1, FHA KAPP, PKD 7,4E+06
YBR086C 729 1 KVPTVGSYGVAGA 2,1E+07
YBR086C 736 2 YGVAGATLPETIP CK2 2,1E+07
YBR086C 763 2 SIRDAKSSAESSN CK2, GSK3 5,3E+06
YBR086C 767 1 AKSSAESSNATNN CK1 5,3E+06
YBR086C 847 1 DNQSKVSVATEQT AURORA, CK1 1,2E+05
YKL092C 768 1 SKILNLSSTISRP GSK3, NEK6 2,0E+05
YKL092C 769 1 KILNLSSTISRPK 2,0E+05
YOL081W 927 2 NVNSLNSSPKNLS CK1 6,0E+05
YOL081W 928 2 VNSLNSSPKNLSS Proline-directed, CDK1, CK1, NEK6, Polo box 6,0E+05
YOL081W 1018 1 IRTRRYSDESLGK CAMK2, CK1, PKA, PKA/AKT 2,3E+04
YML123C 321 1 ASTAVESLDNHPP CK1 2,8E+05
YML123C 578 3 NNDIESSSPSQLQ 5,3E+06
YML123C 579 1 NDIESSSPSQLQH Proline-directed, Polo box 4,6E+07
YML123C 581 1 IESSSPSQLQHEA ATM/ATR, CK1 5,3E+06
YLR410W 31 1 SAPSEMSPLFLNK Proline-directed, CK1 1,3E+05
YLR410W 139 3 DADNINSISKTGS 6,2E+06
YLR410W 141 1 DNINSISKTGSPH GSK3 6,2E+06
YLR410W 1106 3 FTPVNITSPNLSF 1,9E+07
YLR410W 1107 1 TPVNITSPNLSFQ Proline-directed, GSK3 1,9E+07
YBR245C 175 1 LLKEEDSDDDESI 1,2E+07
YMR044W 73 1 ARDREQSEEEEDI CAMK2, CK2, PKA/AKT 1,7E+07
YMR044W 242 1 QQAIDASEEEEEE CK2 1,4E+05
YDL051W 15 1 EQEKPQSRRNSFA GSK3 1,9E+06
YDL051W 19 1 PQSRRNSFAVIEF CAMK2, CK1, PKA 1,6E+07
YFR024C-A 290 1 NSRLAPTNSGGSG NEK6 5,8E+05
YFR024C-A 292 3 RLAPTNSGGSGGK 5,8E+05
YBR068C 4 1 MLSSEDFGSS 3,6E+05
YBR068C 9 1 SSEDFGSSGKKET 1,9E+06
YBR068C 16 2 SGKKETSPDSISI Proline-directed 6,1E+06
YBR068C 21 1 TSPDSISIRSFSA 6,1E+06
YBR068C 75 1 KQINENTSDLEDG FHA2 Rad53p 4,4E+07
YBR068C 76 1 QINENTSDLEDGV CK2 6,8E+06
YBR068C 84 1 LEDGVESITSDSK 3,4E+06
YBR068C 86 2 DGVESITSDSKLK FHA KAPP 6,8E+06
YBR068C 87 1 GVESITSDSKLKK CK1 3,4E+06
YBR068C 89 1 ESITSDSKLKKSM 4,4E+07
YHR094C 13 2 LISPQKSNSSNSY CK1 1,7E+06
YHR094C 15 1 SPQKSNSSNSYEL 2,0E+06
YHR094C 16 2 PQKSNSSNSYELE CK1 1,7E+06
YHR094C 18 2 KSNSSNSYELESG CK1 1,7E+06
YHR094C 19 2 SNSSNSYELESGR EGFR 2,0E+06
YHR094C 38 1 PEGKNESFHDNLS 1,0E+07
YHR094C 44 1 SFHDNLSESQVQP 1,0E+07
YHR094C 46 1 HDNLSESQVQPAV ATM/ATR, NEK6 1,0E+07
YDR345C 23 1 SNADLPSNSSQVM 7,4E+06
YDR345C 25 3 ADLPSNSSQVMNM 7,4E+06
YHR094C 3 1 MNSTPDLIS 3,7E+07
YHR094C 4 1 MNSTPDLISP Proline-directed, FHA2 Rad53p, Polo box 3,7E+07
YNL268W 87 1 TRLQVVSHETDIN 2,5E+05
YNL268W 90 1 QVVSHETDINEDE CK1 2,5E+05
YKL064W 177 1 VDENSPTDRRQSN 1,7E+05
YKL064W 461 2 IKTHPNSPTPGIK Proline-directed, CK1, ERK/MAPK, WW GroupIV 8,9E+05
YKL064W 463 1 THPNSPTPGIKAE Proline-directed, FHA2 Rad53p 8,9E+05
YKL064W 571 3 EKQESATLDHESI 4,8E+05
YKL064W 576 1 ATLDHESISRRKS 4,8E+05
YML115C 21 1 AMDNGLSLPISRN GSK3 6,4E+06
YML115C 25 1 GLSLPISRNGSSN CK1, GSK3, NEK6 4,3E+06
YML115C 29 1 PISRNGSSNNIKD CAMK2, CHK1, CK1, PKD 2,4E+06
YML115C 30 1 ISRNGSSNNIKDK 1,3E+06
YPR079W 279 1 DELHDISPSLNEQ Proline-directed 8,4E+05
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YPR079W 335 2 GIRLRSSPSASSS Proline-directed, GSK3, NEK6, PKA, Polo box 3,6E+05
YPL057C 349 1 KRLRKDSNTNIVL CAMK2, PKA, PKA/AKT 1,5E+06
YJL128C 66 2 QRALKRSASVGSN NEK6, NIMA 8,5E+06
YJL128C 68 1 ALKRSASVGSNQS CAMK2, CHK1, CHK1/2, PKA, PKD 8,5E+06
YJL128C 71 2 RSASVGSNQSEQD CK1 8,5E+06
YJL128C 74 2 SVGSNQSEQDKGS CK1 8,5E+06
YCL061C 19 2 AKKRTTTYKKVAV CAMK2, PKA 6,7E+06
YCL061C 20 2 KKRTTTYKKVAVP ALK 6,7E+06
YDR443C 425 1 SNDLENSPLKTEL Proline-directed, CDK1, CDK2, NEK6 0,0E+00
YOL051W 810 1 TPNTNPSPLKTQT Proline-directed, CDK1, CDK2 1,0E+06
YBR290W 47 1 GETEIGSDEEDSI CK1, CK2 5,2E+05
YBR290W 52 2 GSDEEDSIEDEGS PLK, PLK1 5,2E+05
YDR135C 903 1 GNSDAISLRRASD CK1 4,8E+06
YDR135C 908 1 ISLRRASDATLGS CAMK2, PKA 1,5E+06
YDR135C 911 1 RRASDATLGSIDF CK1, FHA KAPP, PLK1 1,5E+06
YDR135C 914 1 SDATLGSIDFGDD 1,5E+06
YBL091C 35 1 QAKADESDPVESK 1,1E+06
YGL125W 260 1 LVRDIGTNLIVEM FHA2 Rad53p 3,5E+05
YGL125W 275 1 KLLDSGYVSHLHI EGFR 3,5E+05
YGL125W 277 1 LDSGYVSHLHIYT CK1, F box bTrCP 3,5E+05
YGL125W 282 1 VSHLHIYTMNLEK 3,5E+05
YGL125W 283 1 SHLHIYTMNLEKA FHA2 Rad53p 3,5E+05
YGR076C 67 1 RRMSDVYKLALRY 1,3E+07
YMR302C 477 3 FRNMLTTSLMSIR 1,6E+07
YMR302C 478 2 RNMLTTSLMSIRR NEK6 1,6E+07
YKR018C 380 1 SSNSEDSEDEEMD CK1, CK2 6,3E+07
YDR456W 494 2 IKTGCISEEDTSD CK1 1,4E+07
YDR456W 499 1 ISEEDTSDDEFDI CK2 1,3E+06
YDR456W 569 1 NETENTSPNPARS Proline-directed, CK1 1,2E+07
YDR456W 575 3 SPNPARSSMDKRN 1,2E+07
YDR456W 576 2 PNPARSSMDKRNL PKA 1,2E+07
YBR014C 98 2 NKIMEQSPMIVFS Proline-directed 1,1E+08
YBR014C 106 3 MIVFSKTGCPYSK 1,1E+08
YPR112C 220 1 LVIENESDDEYSA CK2 1,3E+06
YJL020C 158 1 RKVPMDSPKLKAR Proline-directed, CDK1 8,6E+06
YJL020C 620 2 GNVLPVSSPQTRV NEK6 5,0E+06
YJL020C 621 2 NVLPVSSPQTRVA Proline-directed, ERK/MAPK, Polo box 5,0E+06
YJL020C 624 2 PVSSPQTRVARNG CK1, FHA KAPP 5,0E+06
YJL020C 631 1 RVARNGSINSLTK CAMK2, CHK1, PKD 1,3E+05
YJL020C 634 1 RNGSINSLTKSIS CK1, GSK3 1,3E+05
YKL129C 776 1 KERRSMSLLGYRA CAMK2 3,0E+05
YLR138W 447 1 RHLNTITLTKTFT 1,5E+04
YLR138W 449 1 LNTITLTKTFTTH 1,5E+04
YOR025W 380 1 QKDSIGTPPTTPL Proline-directed, CK1 2,1E+05
YGR197C 42 1 QRFAEGSGHSSDL GSK3 5,7E+04
YGR197C 45 1 AEGSGHSSDLAKS CK1 4,1E+04
YGR197C 46 1 EGSGHSSDLAKSL CK1 4,1E+04
YDR150W 2217 1 KDNDDTSVASSID GSK3, PLK1 4,9E+06
YDR150W 2220 1 DDTSVASSIDLDH CK1 4,9E+06
YDR150W 2221 1 DTSVASSIDLDHL CK1 4,9E+06
YOL123W 2 1 MSSDEEDF CK2 5,1E+07
YOL123W 3 1 MSSDEEDFN CK2 5,1E+07
YOL123W 12 1 EDFNDIYGDDKPT 5,1E+07
YOR206W 149 1 PLDGIDSQDEGED ATM/ATR, CK2 7,7E+07
YOR206W 166 1 SNIEEKSEQMELE 5,1E+05
YOR206W 698 1 LLNSLESDDDNED CK1 7,0E+06
YOR206W 708 1 NEDVEMSDA 9,5E+06
YBL079W 397 1 MSIEPAYISRIIG EGFR 0,0E+00
YLR335W 17 3 QRETYDSNESDDD 1,5E+06
YLR335W 20 1 TYDSNESDDDVTP CK1 1,5E+06
YLR335W 317 3 PSLEKSSFTFGST 4,2E+05
YLR335W 322 3 SSFTFGSTTIEKK 4,2E+05
YLR335W 323 2 SFTFGSTTIEKKN CK2 4,2E+05
YLR335W 324 3 FTFGSTTIEKKND 4,2E+05
YMR153W 43 1 EQQKQPTGLLKGL FHA2 Rad53p 5,7E+05
YGR281W 10 1 TVGDAVSETELEN CK2 1,5E+07
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YJL212C 48 1 EDVNNLTATTDEE 1,4E+06
YJL212C 50 1 VNNLTATTDEEDR CK2, NEK6 1,4E+06
YJL212C 51 1 NNLTATTDEEDRD CK2 4,9E+06
YML065W 237 1 TQTAQISDAETRA CK1, CK2 1,1E+06
YBR060C 213 2 PGKLTLSRNFTPT NEK6 3,5E+06
YBR060C 217 2 TLSRNFTPTPVPK Proline-directed, CAMK2, CHK1, CHK1/2, PKD 3,5E+06
YIL147C 833 1 FNKAPGSDDEEGG CK2 1,4E+07
YHR073W 323 1 QFEDKDTSTLEEN FHA2 Rad53p 3,1E+04
YHR073W 324 1 FEDKDTSTLEENP CK2 3,1E+04
YBR233W 51 1 ALKDADSHSDNDH 2,8E+06
YDR264C 51 1 SLKAIRSGNEEES CK2 4,6E+07
YDR264C 57 1 SGNEEESGNEQVN CK2 4,6E+07
YKR093W 6 1 MLNHPSQGSDDA ATM/ATR 3,9E+07
YKR093W 9 1 NHPSQGSDDAQDE CK1 3,9E+07
YKR093W 39 1 LKDSYVSDDVANS CK1 1,0E+07
YKR093W 45 1 SDDVANSTERYNL 1,0E+07
YKR093W 594 3 ILEPMESLRSTTK 7,4E+06
YKR093W 597 2 PMESLRSTTKY CK1 8,8E+07
YKR093W 598 2 MESLRSTTKY NEK6, PKA 3,1E+07
YKR093W 599 2 ESLRSTTKY CAMK2 3,1E+07
YKR093W 601 3 LRSTTKY 1,2E+06
YLR216C 56 2 KPDVPLSYKGSIF GSK3 7,3E+06
YPL112C 15 2 IVSGSETPPYSGA Proline-directed 3,0E+05
YPL112C 190 1 LGKFNKTRKCNFQ 4,7E+05
YPL112C 302 2 AHKDDGSQSPIRK ATM/ATR 9,8E+05
YPL112C 304 1 KDDGSQSPIRKQL Proline-directed, CDK1, CDK2 9,8E+05
YGR103W 271 1 ESRQEDSLLKLDP PLK1 5,7E+05
YGR103W 288 1 EDVKVESLDASTL GSK3 1,8E+06
YGR103W 292 2 VESLDASTLKSAL CK1, GSK3, NEK6 1,8E+06
YGR103W 293 2 ESLDASTLKSALN FHA KAPP 1,8E+06
YGR103W 305 1 NADEANTDETEKE 5,9E+06
YGR103W 308 1 EANTDETEKEEEQ CK2 5,9E+06
YGR103W 330 1 KEQNEETELDTFE FHA1 Rad53p 1,4E+06
YGR103W 334 1 EETELDTFEDNNK FHA1 Rad53p 3,1E+06
YFL026W 354 2 YPRRKETTSDKHS CAMK2, FHA1 Rad53p, PKA 2,9E+05
YFL026W 355 3 PRRKETTSDKHSE 2,9E+05
YFL026W 356 2 RRKETTSDKHSER GSK3 2,9E+05
YFL026W 360 1 TTSDKHSERTFVS CK1 2,1E+04
YFL026W 363 2 DKHSERTFVSETA CK1, FHA KAPP, PLK1 1,5E+06
YFL026W 366 1 SERTFVSETADDI 2,4E+07
YFL026W 368 2 RTFVSETADDIEK FHA1 Rad53p 1,5E+06
YFL026W 382 1 QFYQLPTPTSSKN Proline-directed, FHA KAPP 1,1E+07
YFL026W 385 1 QLPTPTSSKNTRI 1,1E+07
YFL026W 386 1 LPTPTSSKNTRIG CK1 1,1E+07
YFL026W 398 1 GPFADASYKEGEV CK2, PLK1 4,8E+06
YFL026W 399 1 PFADASYKEGEVE SRC 4,8E+06
YFL026W 410 3 VEPVDMYTPDTAA 2,2E+05
YFL026W 411 1 EPVDMYTPDTAAD Proline-directed 9,9E+06
YMR043W 2 1 MSDIEEGT CK2 8,4E+06
YMR043W 8 1 SDIEEGTPTNNGQ Proline-directed 1,1E+07
YDL127W 275 1 IKPFNFSKARPVI 0,0E+00
YER059W 312 1 NNENDDSDDENTG CK2 1,7E+05
YOR281C 35 1 IPERAPSPTAKLE Proline-directed, CAMK2 3,3E+07
YOR281C 37 2 ERAPSPTAKLEEA FHA2 Rad53p 3,3E+07
YBR029C 248 1 TKLIEISPKKTLE Proline-directed, CDK1, CDK2 2,4E+06
YMR105C 111 2 TYEEKCTGGIILT FHA2 Rad53p 1,7E+06
YMR105C 117 1 TGGIILTASHNPG 1,7E+06
YGL008C 911 1 AAMQRVSTQHEKE PKA 1,2E+08
YGL008C 912 1 AMQRVSTQHEKET ATM/ATR, CAMK2, CHK1, CK2 1,2E+08
YOR153W 49 2 IQKLARTLTAQSM FHA KAPP, NEK6 2,6E+06
YOR153W 51 1 KLARTLTAQSMQN CAMK2, CHK1, CHK1/2, FHA KAPP, PKD 3,4E+06
YOR153W 54 1 RTLTAQSMQNSTQ GSK3 3,4E+06
YOR153W 58 1 AQSMQNSTQSAPN CK1 1,1E+07
YOR153W 59 2 QSMQNSTQSAPNK ATM/ATR, FHA KAPP 2,6E+06
YOR153W 61 1 MQNSTQSAPNKSD CK1 1,1E+07
YOR153W 837 2 ENVGERSDLSSDR GSK3 2,8E+07
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YOR153W 841 2 ERSDLSSDRKMLQ CK1 2,8E+07
YOR153W 849 1 RKMLQESSEEESD CK2, NEK6 9,1E+06
YOR153W 850 1 KMLQESSEEESDT CK2, GSK3 9,1E+06
YOR153W 854 1 ESSEEESDTYGEI CK1 9,1E+06
YLL028W 72 1 RTTTMNSAAESEV CK1, CK2, GSK3 7,2E+05
YLL028W 76 1 MNSAAESEVNITR CK1 7,2E+05
YLL028W 89 1 RLTKILTGSVNEP CHK1, PKD 9,3E+03
YLL028W 91 1 TKILTGSVNEPDR CK2, NEK6 9,3E+03
YPR156C 132 1 NEDALESDNNEKG 1,8E+07
YOR273C 646 1 DNEDGYSYTEMAT CK2 2,7E+06
YDL166C 188 1 EYQGPRSDDEDDE CK2 2,4E+07
YDL166C 196 1 DEDDEDSE 2,5E+06
YJR093C 15 1 DKFLYGSDSELAL CK2, NEK6 4,9E+07
YMR213W 385 1 DFEIVLSEDEKEE CK2 1,1E+04
YEL040W 360 2 SSTQKSSSSTATS CK1 5,7E+04
YEL040W 361 3 STQKSSSSTATSS 5,7E+04
YEL040W 362 2 TQKSSSSTATSSS CK1, GSK3 5,7E+04
YEL040W 363 2 QKSSSSTATSSSK CK1, FHA KAPP 5,7E+04
YEL040W 366 2 SSSTATSSSKTSS CK1 5,7E+04
YEL040W 367 2 SSTATSSSKTSSD CK1, GSK3 5,7E+04
YEL040W 368 2 STATSSSKTSSDH GSK3 5,7E+04
YEL040W 370 2 ATSSSKTSSDHSS CK1, FHA1 Rad53p 5,7E+04
YEL040W 375 2 KTSSDHSSSTKKS CK1 5,7E+04
YER166W 19 2 MSPFEDTFQFEDN PLK1 2,7E+06
YER166W 26 2 FQFEDNSSNEDTH CK2 2,7E+06
YER166W 27 3 QFEDNSSNEDTHI 2,7E+06
YER166W 94 1 LNNGSGTFDDVEL FHA1 Rad53p 1,2E+07
YER166W 104 1 VELDNDSGEPHTN 1,2E+07
YER166W 1483 1 MHGEDGSPSGYQK Proline-directed 8,7E+06
YER166W 1495 3 KQETWMTSPKETQ 5,2E+06
YER166W 1496 2 QETWMTSPKETQD Proline-directed, CDK1, CK1, CK2 5,2E+06
YER166W 1506 2 TQDLLQSPQFQQA Proline-directed, NEK6 4,0E+06
YER166W 1551 2 SVERARTSLDLPG CAMK2, CHK1, FHA1 Rad53p, PKD 8,0E+05
YER166W 1552 2 VERARTSLDLPGV AURORA, PKA 8,0E+05
YDR093W 69 1 KPMKDISTPDLSK 4,7E+06
YDR093W 70 1 PMKDISTPDLSKV Proline-directed, FHA2 Rad53p, Polo box 4,7E+06
YDR093W 85 1 DGIDDYSNDNDIN 2,0E+06
YDR093W 1542 1 ERRDQLSPVTTTN Proline-directed 3,3E+06
YAL026C 1352 1 SSRDDISFDI PLK1 3,7E+03
YIL048W 102 1 MYDNRLSQDDNFK ATM/ATR, PKA 2,1E+07
YCL024W 296 1 TIKDSKSIKDLPR 8,6E+04
YAL017W 607 2 SLPKMASSPTGSK CHK1, PKD 1,6E+05
YAL017W 608 2 LPKMASSPTGSKL Proline-directed, GSK3, Polo box 1,6E+05
YAL017W 612 2 ASSPTGSKLEYSL CK1, CK2 1,6E+05
YNR047W 300 1 TNTKNLSNLSLNE CK1 2,0E+06
YNR047W 303 1 KNLSNLSLNEIKE CK1, CK2 2,0E+06
YNR047W 438 1 ARKTSGSSNINDK 2,8E+05
YDR299W 44 1 NGESDLSDYGNSN CK1 4,1E+06
YDR299W 91 1 GSRQALYEEVSEN ALK, EGFR 2,7E+06
YDR299W 95 1 ALYEEVSENEDEE CK2 2,7E+06
YDR299W 379 1 VDDNENSDDGLDI 6,0E+07
YBL085W 655 1 PLKTSLSPINSKS Proline-directed, GSK3 8,4E+05
YBL085W 659 1 SLSPINSKSNIAL CK1 8,4E+05
YER114C 24 1 SRDKDVSDTLSPD GSK3 9,8E+06
YER114C 28 1 DVSDTLSPDFDSK Proline-directed, CK1 9,8E+06
YPR171W 462 1 DEIEALSLRNNLK 1,1E+07
YKL179C 364 1 GVNEDDSDNDIRS 6,3E+06
YKL179C 448 3 SPHFNETASMMSG 2,7E+04
YKL179C 450 3 HFNETASMMSGVT 2,7E+04
YKL179C 453 1 ETASMMSGVTRQM CK1 2,7E+04
YKR071C 206 1 DDLIEDSDDDDFS 3,2E+07
YOR092W 389 1 NLTRIITSDATVS CAMK2, CHK1, CHK1/2, FHA KAPP, PKD 1,5E+05
YOR092W 395 1 TSDATVSKKDIET 1,5E+05
YMR212C 564 1 SRDNQISTSDLLS 3,1E+05
YMR212C 773 1 EDLHSLSSRGKIF 3,0E+05
YMR221C 269 1 RPQRRKSVLETYV AURORA, AURORA-A, CAMK2, CK2, PKA 5,9E+06
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YNL307C 198 2 HNQPSISYICSRF GSK3 1,7E+06
YNL307C 199 3 NQPSISYICSRFY 1,7E+06
YNL307C 202 2 SISYICSRFYRAP CK1 2,6E+07
YKL021C 430 1 ADIGDQSEVESDT CK2, GSK3 1,9E+07
YKL021C 434 1 DQSEVESDTEELK CK1, CK2 1,9E+07
YKL021C 436 1 SEVESDTEELKKI FHA2 Rad53p 1,9E+07
YOL060C 439 2 ESSPLLSPSNSNH Proline-directed, CK1, GSK3 1,1E+07
YOL060C 441 2 SPLLSPSNSNHPS NEK6 1,1E+07
YOL060C 443 2 LLSPSNSNHPSEH CK1, GSK3 1,1E+07
YOL060C 637 1 DWDESKSEYGNEN 4,8E+05
YNL085W 358 1 NKDGKKSNLSSPS GSK3 1,8E+04
YNL085W 362 2 KKSNLSSPSSASS Proline-directed, CK1, Polo box 1,8E+04
YNL085W 364 2 SNLSSPSSASSSA CK1, GSK3 1,8E+04
YDR033W 289 1 PKAPVASPRPAAT Proline-directed, CDK1, ERK/MAPK 3,5E+07
YDR033W 295 1 SPRPAATPNLSKD Proline-directed, FHA2 Rad53p 3,5E+07
YDR033W 299 1 AATPNLSKDKKKK CK1 3,5E+07
YNL156C 81 1 LPRNTVSSNNLER 8,6E+05
YPR075C 285 1 QIAEEESDKEIQD CK2 1,3E+07
YKL193C 121 1 LTSLDLSFNKIKH CK1, NEK6, PLK1 5,5E+05
YGL056C 430 1 SSRMANSPVLKSS Proline-directed 1,1E+06
YLR187W 470 1 MKSPAISSAELFE CK1, CK2 1,2E+06
YLR187W 471 1 KSPAISSAELFEG 1,2E+06
YLR187W 478 1 AELFEGYDSLPER ALK, EGFR 1,2E+06
YBL061C 330 1 TRDSRKSVNFLKF AURORA, CK1, PKA 5,2E+05
YNL243W 294 2 ARTPARTPTPTPP Proline-directed 1,5E+05
YNL243W 308 1 VAEPAISPRPVSQ Proline-directed, CDK1 1,5E+05
YDR525W-A 70 2 RYSHLSSSDDNYG CK1 3,5E+06
YDR525W-A 71 2 YSHLSSSDDNYGS NEK6 3,5E+06
YDL123W 134 1 KQSLVESPPPYVP Proline-directed, CK1, ERK/MAPK, NEK6 9,3E+06
YDR011W 10 2 IKSTQDSSHNAVA CK1 1,0E+06
YDR011W 11 2 KSTQDSSHNAVAR CK1 1,0E+06
YDR011W 26 1 SASFAASEESFTG CK1 1,4E+04
YDR011W 29 2 FAASEESFTGITH CK1, PLK1 1,4E+04
YDR011W 31 3 ASEESFTGITHDK 1,4E+04
YDR011W 80 1 VVSKVESFADALS CHK1, CK1, PKD 9,1E+06
YDR011W 834 3 AKEQFSSESSGAN 1,7E+05
YDR011W 836 1 EQFSSESSGANDE CK1 1,7E+05
YER118C 183 2 RRGNRNTTPYQNN PKA 1,8E+06
YER118C 184 2 RGNRNTTPYQNNV Proline-directed, CAMK2 1,8E+06
YHR084W 400 1 NKEKLVSPSDPTS Proline-directed 1,8E+07
YML052W 293 1 FFTIRKSHERPDD CK1, PKA 4,3E+07
YML052W 301 1 ERPDDVSV PLK1 4,3E+07
YIL047C 859 1 GTFRRRSSVFENI CAMK2, PKA 2,2E+04
YIL047C 860 1 TFRRRSSVFENIS AURORA, AURORA-A, CAMK2, CK2, PKA 2,2E+04
YOL109W 40 1 KEQAEASIDNLKN PLK1 1,9E+08
YER056C 18 1 QDLEKRSPVIGSS Proline-directed 7,3E+06
YER176W 389 1 KGTSRWTIGSDTE AURORA, CK1, FHA KAPP, PKA 1,7E+07
YER176W 392 1 SRWTIGSDTESSR CK2, GSK3 8,0E+05
YLR419W 11 3 TKNNSKSSTPVND 1,9E+06
YNL321W 121 1 NTATPSSPKRMHS Proline-directed, CDK1, CDK2, ERK/MAPK, Polo box,
WW GroupIV
3,3E+06
YGL139W 635 1 KDHDDNSDYESND CK2, GSK3 3,6E+05
YER178W 309 3 EYETYRYGGHSMS 5,1E+06
YER178W 313 1 YRYGGHSMSDPGT 5,1E+06
YER178W 315 1 YGGHSMSDPGTTY 8,0E+07
YER178W 351 1 IDLGIATEAEVKA CK2 2,2E+05
YAL038W 130 1 KIMYVDYKNITKV ALK 4,9E+06
YAL038W 21 2 GSDLRRTSIIGTI FHA2 Rad53p, NEK6, NIMA, PKA 7,7E+05
YAL038W 22 1 SDLRRTSIIGTIG AURORA, AURORA-A, CAMK2, PKA 8,0E+06
YNL272C 492 2 RCILHWTHIGIWA NEK6 1,9E+06
YNL272C 515 1 PLVEDDSDEDQND 2,2E+06
YMR235C 360 1 DFEEVDSEDEEGE CK2 1,4E+06
YIL063C 179 1 DKDKVHSGSEQLA CK2 3,7E+06
YIL063C 181 3 DKVHSGSEQLANA 3,7E+06
YOR101W 229 1 TGSSSKSAVNHNG CK1 2,5E+05
YNL098C 207 1 NSVPRNSGGHRKM PKA 1,8E+04
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YJL204C 679 2 PPPSRNSPIRDIK Proline-directed, CDK1, CDK2, CK1, PKA 3,3E+06
YGL097W 135 1 DMDADDSSDDEDG 7,0E+06
YGL097W 136 1 MDADDSSDDEDGD CK2 7,0E+06
YDR379W 686 1 QKENIATSITVKS 1,1E+04
YDR379W 687 3 KENIATSITVKSP 1,1E+04
YDR379W 689 1 NIATSITVKSPSS FHA KAPP 1,1E+04
YNL221C 524 1 YKLLTATPNSINK Proline-directed, FHA KAPP, NEK6 9,2E+05
YNL221C 527 1 LTATPNSINKTTV 9,2E+05
YKR017C 188 3 CCDKKDTETFALE 1,1E+07
YKR017C 190 2 DKKDTETFALECG FHA2 Rad53p 1,1E+07
YOL145C 1017 1 KKTLSDSDEDDDD CK1, NEK6 2,9E+04
YOL145C 1046 1 NEFIEDSDEEEAQ CK2 2,3E+05
YOL145C 1056 1 EAQMSGSEQNKND 2,3E+05
YOR123C 132 1 EDANNFSDQDETT 1,1E+08
YDL189W 148 1 IDGNTRTPNSNLT Proline-directed, FHA KAPP 5,6E+06
YPL274W 20 3 TKIETESTTIPND 6,1E+05
YPL274W 21 3 KIETESTTIPNDS 6,1E+05
YJL095W 1058 1 ITEGIASPTSPKS Proline-directed 2,2E+05
YJL095W 1061 1 GIASPTSPKSLDS Proline-directed, CDK1, CK1, ERK/MAPK, WW GroupIV 2,2E+05
YDR507C 459 3 STIVNQSSPTPAS 3,1E+05
YDR507C 460 2 TIVNQSSPTPASR Proline-directed, Polo box 3,1E+05
YDR507C 462 1 VNQSSPTPASRNK Proline-directed, CK1, FHA KAPP 1,5E+07
YDR507C 1004 2 REKNAGSQAKDHS ATM/ATR 1,0E+10
YDR507C 1010 1 SQAKDHSKDHLKE 1,8E+08
YHL007C 169 1 KLSLTDSTETIEN CK1, NEK6 9,7E+06
YNL173C 160 1 VVELPDSEDETQQ CK2, NEK6 6,1E+06
YNL173C 164 1 PDSEDETQQVNKT ATM/ATR 6,1E+06
YNL173C 306 3 PTGKVATETQTYE 2,4E+06
YNL173C 308 2 GKVATETQTYETK ATM/ATR 2,4E+06
YFR040W 253 2 KRRKRGSSSFGND PKA 3,2E+06
YFR040W 254 2 RRKRGSSSFGNDD CAMK2, PKA, PKA/AKT 3,2E+06
YFR040W 255 3 RKRGSSSFGNDDI 3,2E+06
YDL153C 124 3 NENAWGSTKGEYY 4,3E+05
YDL153C 125 2 ENAWGSTKGEYYG CK2 4,3E+05
YDL153C 314 2 VNEGDGSESEETA CK2 2,8E+05
YDL153C 319 1 GSESEETANIEAF CK1, FHA2 Rad53p 4,6E+06
YDL153C 477 1 DDKDYGSEDEAVS CK2 1,5E+07
YDL153C 483 3 SEDEAVSRSINTQ 1,5E+07
YOR171C 110 2 TENLSSSSENDDV NEK6 1,5E+07
YOR171C 111 2 ENLSSSSENDDVE CK1 1,5E+07
YOR171C 120 1 DDVENHSLSNDKA 1,5E+07
YGL086W 324 1 WEIYNDSDDDDDN 4,3E+06
YML008C 378 1 ETPSQTSQEATQ ATM/ATR, CK1 5,9E+04
YLR020C 75 2 SRPLSISSTTPLD NEK6 2,9E+06
YLR020C 76 2 RPLSISSTTPLDL CK1 2,9E+06
YCR048W 21 1 KIRRLNSAEANKR CAMK2, CHK1, PKD 1,7E+06
YNR019W 175 1 NLHHRKSSPDAVD PKA 4,2E+06
YKR100C 216 1 HNTRQSSNENLIR CAMK2, CK1 8,1E+06
YKR100C 257 1 FHTRNSSITSVNK CAMK2, CK1 9,0E+05
YKR100C 273 1 LEDVFATPKSAAQ Proline-directed, CDK1, FHA KAPP 3,3E+06
YDR310C 623 2 PKPRSASISGISD CAMK2, PKA/AKT 3,5E+06
YKR092C 301 1 AEETPASSNESTP CK2, GSK3 1,3E+07
YKR092C 302 1 EETPASSNESTPS CK1 1,3E+07
YKR092C 305 2 PASSNESTPSASS CK1 1,3E+07
YKR092C 306 2 ASSNESTPSASSS Proline-directed, FHA KAPP, Polo box 1,3E+07
YKR092C 312 2 TPSASSSSSANKL CK1 1,3E+07
YKR092C 313 2 PSASSSSSANKLN CK1 1,3E+07
YJL176C 210 2 DDQPMISPDNSIF Proline-directed, GSK3 6,6E+06
YJL176C 214 2 MISPDNSIFGDTK CK1, PLK1 6,6E+06
YJL176C 229 1 SKQLGNTSSVANT NEK6 5,7E+06
YJL176C 230 1 KQLGNTSSVANTP 5,7E+06
YJL176C 231 1 QLGNTSSVANTPS 5,7E+06
YJL176C 235 1 TSSVANTPSEIPD Proline-directed, CK2 5,7E+06
YJL176C 237 1 SVANTPSEIPDAH 5,7E+06
YAL030W 2 3 MSSSTPFD 4,1E+07
YAL030W 10 3 STPFDPYALSEHD 8,5E+06
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YAL030W 39 2 QAEIDDTVGIMRD FHA2 Rad53p, PLK1 3,2E+06
YOR327C 57 2 ERGERLTSIEDKA CK2, PKA 3,8E+06
YOR327C 58 1 RGERLTSIEDKAD CAMK2 2,5E+06
YER093C 10 2 PHSAKQSSPLSSR CK1, GSK3 5,3E+04
YER093C 14 2 KQSSPLSSRRRSV CK1 5,3E+04
YGR270W 11 1 LRNRRGSDVEDAS CAMK2, CK2, PKA, PKA/AKT 1,1E+05
YGR270W 984 1 VLKIKLSGLMDLF 3,9E+07
YGR270W 1142 1 LEAKEQSQENILQ ATM/ATR 1,2E+07
YDR212W 298 1 GAQVVLTTKGIDD 2,0E+05
YDR212W 299 1 AQVVLTTKGIDDL FHA2 Rad53p 2,0E+05
YJL008C 218 3 IMGGSLSNSTVIK 6,0E+06
YML062C 264 1 DNIDEDYESDEDE EGFR, SRC 1,8E+07
YML062C 266 1 IDEDYESDEDEER 1,8E+07
YML010W 36 3 TKDENTSDKDTVD 1,4E+06
YGR116W 155 1 KLEDFFSEDEEEE CK2 2,0E+07
YPR133C 89 1 HISTDFSDDDLEK CK1 2,4E+06
YOL148C 438 1 SSSTSNSASNTRN CK1 9,9E+05
YOL148C 440 2 STSNSASNTRNNS CK1 9,9E+05
YLR055C 83 1 AARMDKTATPTNE 1,5E+06
YLR055C 85 1 RMDKTATPTNEHQ Proline-directed, CHK1 1,5E+06
YLR055C 87 3 DKTATPTNEHQHD 1,5E+06
YLR055C 385 1 ADDDMDSLFGDED 1,2E+06
YDR145W 286 2 QNQRKISSSNSTE CAMK2, GSK3, PKA 1,2E+06
YDR145W 288 3 QRKISSSNSTEIP 1,2E+06
YDR145W 290 2 KISSSNSTEIPSV CK1 1,2E+06
YDR145W 291 2 ISSSNSTEIPSVT CK1 1,2E+06
YCR042C 261 1 GQNGEESEKEKED CK2 7,2E+05
YPL254W 6 1 MSAIQSPAPKPL Proline-directed, CK1 5,6E+05
YPL254W 387 1 GDISMSSITKAGE CK1 1,0E+06
YKL185W 115 2 PEFNKASLSQISF AURORA 1,2E+07
YKL185W 117 2 FNKASLSQISFTN ATM/ATR 1,2E+07
YKL185W 120 2 ASLSQISFTNPLN CK1 1,2E+07
YKL185W 122 2 LSQISFTNPLNYG FHA2 Rad53p 1,2E+07
YKL185W 129 3 NPLNYGSGLGFSS 1,2E+07
YKL185W 134 2 GSGLGFSSNSQPR NEK6 1,2E+07
YKL185W 135 3 SGLGFSSNSQPRL 1,2E+07
YKL185W 137 2 LGFSSNSQPRLPL ATM/ATR, CK1 1,2E+07
YHR099W 172 1 EQGDLDSPKEPQA Proline-directed, CDK1, CK2 4,5E+07
YHR099W 542 1 KEDINDSPDVEMT Proline-directed 5,4E+04
YDR098C-B 404 3 ARAHNVSTSNNSP 6,7E+06
YDR098C-B 405 3 RAHNVSTSNNSPS 6,7E+06
YDR098C-B 406 3 AHNVSTSNNSPST 6,7E+06
YDR098C-B 411 3 TSNNSPSTDNDSI 6,7E+06
YDR098C-B 412 2 SNNSPSTDNDSIS CK1, FHA1 Rad53p 6,7E+06
YDR098C-B 960 1 VLSKAVSPTDSTP Proline-directed, CHK1, CK1, GSK3, PKD 8,5E+07
YDR098C-B 962 1 SKAVSPTDSTPPS 8,5E+07
YDR098C-B 993 1 EVDPNISESNILP 1,2E+07
YDR098C-B 1055 2 RHSDSYSENETNH CK1, CK2 4,9E+07
YDR098C-B 1059 3 SYSENETNHTNVP 4,9E+07
YDR098C-B 1062 3 ENETNHTNVPISS 4,9E+07
YDR098C-B 1072 3 ISSTGGTNNKTVP 4,9E+07
YDR098C-B 1081 1 KTVPQISDQETEK CK2 3,3E+07
YDR098C-B 1093 2 KRIIHRSPSIDAS Proline-directed 3,6E+07
YDR098C-B 1095 2 IIHRSPSIDASPP CAMK2, CHK1, GSK3, PKD 3,6E+07
YDR098C-B 1181 1 INSKKRSLEDNET AURORA, CK1 1,7E+06
YHR214C-B 1089 2 SKDFRHSDSYSDN GSK3, PKA 1,0E+06
YHR214C-B 1091 3 DFRHSDSYSDNET 1,0E+06
YHR214C-B 1093 2 RHSDSYSDNETNH CK1, CK2 1,0E+06
YPR158W-B 961 1 VLSKAVSPTDSTP Proline-directed, CHK1, CK1, GSK3, PKD 1,2E+06
YPR158W-B 965 2 AVSPTDSTPPSTH CK1, GSK3 1,2E+06
YPR158W-B 994 1 EVDPNISESNILP 1,1E+06
YPR158W-B 996 3 DPNISESNILPSK 1,1E+06
YPR158W-B 1082 1 KTVPQISDQETEK CK2 1,4E+06
YPR158W-B 1094 2 KRIIHRSPSIDAS Proline-directed 1,8E+06
YPR158C-D 960 1 VLSKAVSPTDSTP Proline-directed, CHK1, CK1, GSK3, PKD 5,6E+07
YPR158C-D 962 1 SKAVSPTDSTPPS 5,6E+07
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YPR158C-D 993 1 EVDPNISESNILP 4,7E+05
YPR158C-D 1081 1 KTVPQISDQETEK CK2 1,3E+06
YPR158C-D 1093 2 KRIIHRSPSIDAS Proline-directed 1,7E+06
YPR158C-D 1095 2 IIHRSPSIDASPP CAMK2, CHK1, GSK3, PKD 1,7E+06
YPR158C-D 1181 1 INSKKRSLEDNET AURORA, CK1 1,1E+05
YPR158C-D 1488 2 KLGMENSLTEKIP CK2, PLK, PLK1 1,9E+05
YPR158C-D 1490 2 GMENSLTEKIPKL FHA2 Rad53p 1,9E+05
YPR158C-D 404 3 ARAHNVSTSNNSP 4,5E+05
YPR158C-D 405 3 RAHNVSTSNNSPS 4,5E+05
YPR158C-D 406 3 AHNVSTSNNSPST 4,5E+05
YPR158C-D 411 3 TSNNSPSTDNDSI 4,5E+05
YPR158C-D 412 2 SNNSPSTDNDSIS CK1, FHA1 Rad53p 4,5E+05
YML072C 1350 1 LNSTSVTPRASLD Proline-directed, CDK1, FHA KAPP 1,9E+06
YML072C 1371 3 SYAPVQSASPVVK 6,2E+05
YML072C 1373 2 APVQSASPVVKPT Proline-directed 6,2E+05
YML072C 1383 2 KPTDNTSSSSNKK CK1 6,2E+05
YML072C 1384 3 PTDNTSSSSNKKD 6,2E+05
YML072C 1385 3 TDNTSSSSNKKDT 6,2E+05
YML072C 1386 2 DNTSSSSNKKDTP CK1 6,2E+05
YML072C 1404 1 GHSRASSFARTLA CAMK2, CK1 8,9E+05
YBR291C 268 1 KEEGLKTFWKGAT 2,8E+04
YIR026C 202 1 SGSELVSNSGMFK CK1 2,3E+06
YIR026C 204 3 SELVSNSGMFKDS 1,6E+05
YDR204W 135 2 LENLKQTMLSDSS FHA KAPP, NEK6 9,5E+04
YDR204W 138 3 LKQTMLSDSSGRR 9,5E+04
YLR167W 86 1 RKKKVYTTPKKIK 4,3E+06
YLR167W 87 1 KKKVYTTPKKIKH Proline-directed, CDK1, CDK2 4,3E+06
YLR167W 122 2 KLRRECSNPTCGA CAMK2, CHK1, CHK1/2, PKD 1,9E+05
YLR167W 125 2 RECSNPTCGAGVF CK1, FHA KAPP 1,9E+05
YDL122W 555 1 EQEFEDSEEEKEY CK2 3,3E+05
YDL122W 755 1 DLEAIQSNNEEDD CK2 2,5E+06
YOR124C 907 1 SNDAEVSENEDTT CK2 1,2E+06
YOR042W 220 1 EQHHEDSEEEDSW CK2 6,0E+05
YOR042W 407 1 DEFLINSDDEM CK2, NEK6 6,1E+07
YBR165W 83 1 CFPINRTVSMTHL 7,4E+07
YBR165W 91 2 SMTHLNYLLLKDL ALK 7,4E+07
YDR510W 2 1 MSDSEVNQ CK2 8,1E+06
YDR510W 4 1 MSDSEVNQEA 8,1E+06
YMR067C 388 1 VNTINKSNPQGPS CK1 3,7E+06
YMR067C 399 3 PSDNATSIKKTLN 3,7E+06
YMR067C 403 1 ATSIKKTLNRVPK AURORA 3,7E+06
YJL163C 306 2 EKLRSQSGSDDAR CAMK2, PKA/AKT 1,3E+05
YJL163C 308 2 LRSQSGSDDARNY CK1 1,3E+05
YMR010W 181 1 IKSLSFTNLLKFS FHA2 Rad53p, NEK6 1,3E+05
YMR266W 931 1 ANGEFDTASKENN 2,5E+06
YMR266W 933 1 GEFDTASKENNPF 2,5E+06
YAL037W 228 1 LWEFGQTQEILKR ATM/ATR, FHA2 Rad53p 2,8E+05
YDR089W 668 1 TTDNEESLLLRNS PLK1 1,4E+06
YDR333C 119 1 AAKDKGSDDDDDD 7,8E+05
YDR384C 7 1 MTSSASSPQDLEK Proline-directed, CK1, Polo box 2,0E+06
YER134C 151 1 NKEVEKYGVKFVY 0,0E+00
YHR146W 343 1 LVEKRESTEGVLD CHK1, PKA, PKD 4,4E+07
YHR146W 344 2 VEKRESTEGVLDG CAMK2, PKA 4,4E+07
YHR149C 135 2 INHLYSSDSQQDF NEK6 5,5E+06
YHR149C 137 1 HLYSSDSQQDFME ATM/ATR, CK1 5,5E+06
YHR149C 157 1 SDPFVGSMHSSKY GSK3 5,1E+03
YHR149C 160 1 FVGSMHSSKYNVR CK1 1,5E+04
YHR149C 161 1 VGSMHSSKYNVRS CK1 5,1E+03
YIL091C 155 1 DEKDIDSEDEQDP CK2 2,7E+07
YKL082C 230 1 DQDEIASDSDMED 7,3E+06
YKL082C 232 1 DEIASDSDMEDID CK2 7,3E+06
YKL082C 239 1 DMEDIDSDLENNS CK2 7,3E+06
YKR023W 398 2 NGRREKYVVSMNI EGFR 7,4E+04
YKR060W 270 1 QKNEDLSDIKL 4,2E+06
YKR078W 41 1 SVSVSISDDEDSK CK1, CK2 4,6E+05
YMR192W 17 1 RIEVPRTPHQTQP Proline-directed, ERK/MAPK, WW GroupIV 4,4E+05
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YMR295C 11 2 RKKSSISNTSDHD CK1 4,1E+06
YMR295C 13 3 KSSISNTSDHDGA 4,1E+06
YMR295C 14 1 SSISNTSDHDGAN CK1 4,1E+06
YMR295C 23 1 DGANRASDVKISE PKA 1,3E+07
YNL050C 25 1 LGEDYDSNSSSKN GSK3 2,4E+06
YNL050C 28 1 DYDSNSSSKNNSE CK1 2,4E+06
YNL058C 143 3 RGHHKHSSSLQSN 2,4E+05
YNL058C 144 2 GHHKHSSSLQSNP GSK3 2,4E+05
YNL058C 148 2 HSSSLQSNPFDIN CK1 2,4E+05
YNL149C 119 1 QGLDPDSDADIEE 5,2E+07
YNL224C 105 1 PGNRYDSSTDLQA CAMK2 2,4E+05
YPL146C 31 1 RKNIDLSDVEQYM CK2 2,9E+07
YPL146C 363 1 EETEILSAIESDS CK1, CK2, GSK3 5,3E+06
YNL110C 37 3 ALETSSSSSDEED 1,4E+04
YNL110C 38 1 LETSSSSSDEEDE CK1, CK2 1,1E+05
YNL110C 39 1 ETSSSSSDEEDEK CK1, CK2 1,1E+05
YNL110C 56 1 IEGLAASDDEQSG CK2, NEK6 2,1E+08
YNL110C 63 2 DDEQSGTHKIKRL FHA2 Rad53p 2,1E+08
YDR119W 99 1 GPKIDDSPQDEVN Proline-directed 2,7E+07
YDR119W 106 1 PQDEVNSIKGKPA 2,3E+07
YBR074W 606 2 VPLLKGSNSMEEG NEK6 4,9E+05
YBR074W 608 1 LLKGSNSMEEGLS CK2 7,7E+06
YPR091C 622 1 DNVGNSSDTEDMD CK2 9,1E+05
YPR091C 640 1 DKKNDDSADERES CK2 3,0E+06
YCL012C 71 1 RNFDIISENSNDV 9,8E+05
YCL012C 74 2 DIISENSNDVRGG CK1 9,8E+05
YBL042C 4 1 MPVSDSGFDN 6,8E+06
YBL042C 38 1 SEMGDATKITSKI 3,5E+06
YBL042C 54 2 VIEKKDTDSENNI CHK1, CK2, PKD 5,1E+06
YBL042C 56 1 EKKDTDSENNITI 1,6E+07
YKL035W 347 3 IIPNQKTITRDGH 3,1E+05
YJR001W 8 1 PEQEPLSPNGRKR Proline-directed, ERK/MAPK, WW GroupIV 1,1E+07
YJR001W 77 1 SLRRANSFRNIEL CAMK2, CHK1, CHK1/2, PKC, PKD 5,3E+06
YJR001W 187 1 TNNDMDSIVVKRV 4,6E+06
YMR054W 223 1 DLTRNQSVEDLSF CAMK2, CHK1, CHK1/2, CK1, PKD 3,1E+06
YBR127C 501 2 DEEDPDTRSSGKK FHA KAPP 3,9E+06
YBR127C 503 3 EDPDTRSSGKKKD 3,9E+06
YBR127C 504 2 DPDTRSSGKKKDA PKA 3,9E+06
YLR148W 907 1 KIDQPISIDETEL CK2 2,6E+06
YJL154C 853 2 ISDLHITGENNVK NEK6 4,5E+06
YDR372C 14 1 RVNRADSGDTSSI CAMK2, CHK1, F box bTrCP, GSK3, PKD 2,0E+06
YDR372C 19 2 DSGDTSSIHSSAN GSK3 2,8E+05
YNL054W 599 1 SPDKRSSLVSLSK AURORA, AURORA-A, PKA 4,0E+05
YFL004W 182 3 SNFNTASEPLASA 3,6E+06
YFL004W 187 1 ASEPLASASKFSS 3,6E+06
YFL004W 189 2 EPLASASKFSSIV GSK3 3,6E+06
YFL004W 193 2 SASKFSSIVSNDI CK1 2,0E+04
YFL004W 196 1 KFSSIVSNDIDMN CK1 2,0E+04
YFL004W 615 1 DLEADGSSDEETE CK2 4,6E+07
YFL004W 616 1 LEADGSSDEETEQ CK2 4,6E+07
YFL004W 657 1 KLMGVDSEEEEIE CK2 2,4E+07
YPL019C 592 1 RRLSKISVPDGKT AURORA, CK1 3,4E+07
YPL019C 621 1 DLEDHESSDEEGT CK2 2,4E+08
YPL019C 622 1 LEDHESSDEEGTA CK2 2,4E+08
YPL019C 627 1 SSDEEGTALPKKS 2,4E+08
YBR069C 6 1 MDDSVSFIAKEA 7,5E+06
YBR069C 13 1 FIAKEASPAQYSH Proline-directed, CHK1, PKD 2,0E+05
YBR069C 20 2 PAQYSHSLHERTH CK2 2,0E+05
YDR151C 165 2 ENLQKLSQVDSQS ATM/ATR, GSK3 8,0E+07
YDR151C 169 2 KLSQVDSQSTGLP ATM/ATR, CK1 8,0E+07
YDR151C 176 3 QSTGLPYTLPIQK 8,0E+07
YDR151C 177 2 STGLPYTLPIQKT FHA2 Rad53p, NEK6 8,0E+07
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AGP1 2 0,57 1,56 0,33 0,82 1,45 2,06 1,15 MSSSKSLY
AGP1 6 0,70 1,56 0,96 0,33 0,82 1,45 2,06 1,15 MSSSKSLYELKD
AGP1 87 0,45 1,00 0,45 0,87 1,12 DLTSAISPSSRQA
AGP1 89 0,45 1,00 0,45 0,87 1,12 TSAISPSSRQAQE
AGP1 90 0,45 1,00 0,45 0,87 1,12 SAISPSSRQAQEL
AGP1 101 3,14 0,91 3,31 2,97 0,71 1,12 ELEKNESSDNIGA
AKR1 75 1,04 1,04 EEDPLLTRYHTAC
AKR1 77 1,04 1,04 DPLLTRYHTACQR
ALD3 234 0,75 0,88 0,62 VGKALGTHMDIDK
ASC1 108 1,02 1,19 0,86 RFVGHKSDVMSVD
ASC1 135 KTIKVWTIKGQCL
ASC1 166 1,05 0,98 0,97 1,13 0,92 1,18 0,88 1,17 1,16 0,69 EKADDDSVTIISA
ASC1 168 1,06 1,07 0,98 1,12 1,15 0,98 0,94 1,32 0,95 1,07 ADDDSVTIISAGN
BAF1 720 DDEEDLSDENIQP
BAP2 3 2,87 3,32 2,43 MLSSEDFGS
BAP2 9 2,54 2,70 2,38 SSEDFGSSGKKET
BAP2 10 2,26 2,20 2,33 SEDFGSSGKKETS
BAP2 75 3,34 1,01 3,14 3,54 0,55 1,33 1,04 1,11 KQINENTSDLEDG
BAP2 76 3,34 1,05 3,14 3,54 0,55 1,43 1,04 1,19 QINENTSDLEDGV
BAP2 84 3,34 1,01 3,14 3,54 0,55 1,33 1,04 1,11 LEDGVESITSDSK
BAP2 86 3,34 1,01 3,14 3,54 0,55 1,33 1,04 1,11 DGVESITSDSKLK
BAP2 87 3,34 1,02 3,14 3,54 0,55 1,43 0,98 1,11 GVESITSDSKLKK
BAP2 89 3,34 1,01 3,14 3,54 0,55 1,33 1,04 1,11 ESITSDSKLKKSM
BBC1 103 1,01 1,09 0,92 DLPEPISPETKKE
BEM1 458 0,83 1,31 1,75 0,26 0,47 0,76 1,85 KLNKKLSDLSLSG
BEM1 461 0,83 1,31 1,75 0,26 0,47 0,76 1,85 KKLSDLSLSGSKQ
BEM1 465 0,83 1,31 1,75 0,26 0,47 0,76 1,85 DLSLSGSKQAPAQ
BFR2 41 0,53 1,19 0,03 0,44 1,12 1,07 1,44 1,20 1,04 NEKNGESDLSDYG
BFR2 44 0,54 1,19 0,03 0,44 1,15 1,07 1,44 1,20 1,04 NGESDLSDYGNSN
BFR2 46 0,54 1,19 0,03 0,44 1,13 1,07 1,44 1,20 1,04 ESDLSDYGNSNTE
BFR2 379 0,67 1,24 0,82 0,40 0,40 1,06 1,04 1,50 1,00 1,42 VDDNENSDDGLDI
BMS1 578 0,99 1,30 0,96 1,03 1,52 1,08 DDSKDESDIEEDV
BMS1 1160 3,79 3,79 KEKKKEYFAQNGK
BMS1 1168 3,79 3,79 AQNGKRTTMGGDD
BMS1 1176 3,79 3,79 MGGDDESRPRKMR
BUD21 144 0,96 1,13 0,95 0,47 1,45 1,30 0,97 FDKLDESDENEEA
CBF5 395 0,48 0,58 0,49 0,53 0,43 0,51 0,61 0,61 LDNAEQSTSSSQE
CBF5 396 0,48 0,58 0,49 0,53 0,43 0,51 0,61 0,61 DNAEQSTSSSQET
CBF5 397 0,55 0,58 0,49 0,53 0,62 0,51 0,61 0,61 NAEQSTSSSQETK
CBF5 398 0,54 0,58 0,49 0,53 0,62 0,51 0,61 0,61 AEQSTSSSQETKE
CBF5 399 0,54 0,58 0,49 0,53 0,62 0,51 0,62 0,61 EQSTSSSQETKET
CBF5 402 0,54 0,58 0,49 0,53 0,62 0,51 0,61 0,61 TSSSQETKETEEE
CBF5 405 0,93 1,11 0,93 1,11 SQETKETEEEPKK
CBF5 416 0,19 1,00 0,19 1,00 KKAKEDSLIKEVE
CCT8 537 2,69 2,69 ATEAATTVLSIDQ
CDC37 14 0,40 1,01 0,40 1,01 WDKIELSDDSDVE
CDC37 17 0,40 1,01 0,40 1,01 IELSDDSDVEVHP
CHS3 146 0,89 1,10 0,84 0,94 0,83 1,36 VDNFEESSTQPIN
CHS3 147 0,88 1,10 0,81 0,96 0,83 1,36 DNFEESSTQPINK
CHS3 148 0,89 1,12 0,84 0,94 0,88 1,36 NFEESSTQPINKS
CIC1 10 0,50 1,30 0,06 1,46 0,18 0,31 0,79 1,03 2,63 0,76 KSNSKKSTPVSTP
CIC1 11 0,50 1,30 0,06 1,46 0,18 0,31 0,79 1,03 2,63 0,76 SNSKKSTPVSTPS
CIC1 14 0,47 1,30 0,06 1,33 0,18 0,31 0,79 1,03 2,63 0,76 KKSTPVSTPSKEK
CIC1 15 0,47 1,30 0,06 1,33 0,18 0,31 0,79 1,03 2,63 0,76 KSTPVSTPSKEKK
CIC1 17 0,50 1,30 0,06 1,46 0,18 0,31 0,79 1,03 2,63 0,76 TPVSTPSKEKKKV
CIC1 359 0,20 0,20 AKKRSSSELEKES
CIC1 366 0,14 0,64 0,18 0,11 0,64 ELEKESSESEAVK
COX14 49 1,08 1,59 1,08 1,59 KYEQQVTQQKALE
CTR9 1015 0,86 0,55 0,68 0,92 1,30 AAKKTLSDSDEDD
CTR9 1017 0,86 0,55 0,68 0,92 1,30 KKTLSDSDEDDDD





























CYC8 741 1,16 0,88 1,45 KKQKLNSPNSNIN
DCP2 729 1,16 1,16 SSSNVSSSKDLLQ
DCP2 730 1,16 1,16 SSNVSSSKDLLQM
DHH1 10 1,82 1,82 INNNFNTNNNSNT
DHH1 14 1,82 1,82 FNTNNNSNTDLDR
DRS1 18 0,35 1,33 0,35 1,33 DFVPTISDSEDDV
DRS1 20 0,35 1,33 0,35 1,33 VPTISDSEDDVPI
DRS1 29 0,35 1,33 0,35 1,33 DVPILDSSDDEKV
DRS1 30 0,35 1,33 0,35 1,33 VPILDSSDDEKVE
DRS1 208 0,23 0,30 0,16 IDEEDDSEEAKAD
EBP2 104 0,30 1,05 0,23 0,37 1,05 1,05 1,28 0,80 EAQKHMSGDEDES
EBP2 110 0,30 1,05 0,23 0,37 1,05 1,05 1,28 0,80 SGDEDESGDDREE
EBP2 136 0,31 0,31 LEKLAKSDSESED
EBP2 138 0,31 0,31 KLAKSDSESEDDS
EBP2 140 0,31 0,31 AKSDSESEDDSES
EBP2 144 0,31 0,31 SESEDDSESENDS
EBP2 146 0,31 0,31 SEDDSESENDSEE
EBP2 150 0,31 0,31 SESENDSEEDEDV
EBP2 162 0,36 1,02 0,36 0,84 1,13 1,10 VVAKEESEEKEEQ
EBP2 177 0,31 0,97 0,31 0,33 0,23 0,36 0,84 1,13 0,96 0,94 EQDVPLSDVEFDS
EBP2 183 0,31 0,97 0,31 0,33 0,23 0,36 0,84 1,13 0,96 0,94 SDVEFDSDADVVP
ELF1 142 RGALVDSDDE
ERB1 20 0,29 0,84 0,31 0,25 0,22 0,38 0,75 1,13 0,68 0,82 SKKRAASEESDVE
ERB1 23 0,30 0,86 0,30 0,25 0,22 0,43 0,75 1,20 0,68 0,82 RAASEESDVEEDE
ERB1 62 1,35 1,35 AVEEKESSSDKEA
ERB1 63 1,35 1,35 VEEKESSSDKEAQ
ERB1 64 1,35 1,35 EEKESSSDKEAQD
ERB1 72 0,27 0,68 0,30 0,23 0,28 1,00 0,36 KEAQDDSDDDSDA
ERB1 76 0,27 0,68 0,30 0,23 0,28 1,00 0,36 DDSDDDSDAELNK
ERB1 97 0,33 0,99 0,33 1,14 0,85 GEEDYDSSEFSDD
ERB1 101 0,33 0,99 0,33 1,14 0,85 YDSSEFSDDTTSL
ERB1 212 0,83 1,17 0,48 LDKNSGSSLNLTK
ESF1 364 0,85 0,75 0,85 0,75 DMDFKAYLASDSD
ESF1 367 0,85 0,75 0,85 0,75 FKAYLASDSDESD
ESF1 369 0,85 0,75 0,85 0,75 AYLASDSDESDGQ
ESF1 372 0,85 0,75 0,85 0,75 ASDSDESDGQVDE
ESF2 7 1,19 0,79 1,19 0,79 MSEKVNSDFEDFS
ESF2 13 1,19 0,79 1,19 0,79 SDFEDFSSDEETD
ESF2 14 1,19 0,79 1,19 0,79 DFEDFSSDEETDQ
ESF2 47 1,02 1,02 KVEDIESENESDI
ESF2 51 1,02 1,02 IESENESDIEEEQ
FAS1 55 0,96 0,92 0,99 AADDEPTTPAELV
FAS1 56 0,96 0,92 0,99 ADDEPTTPAELVG
FAS1 1119 0,94 0,86 0,87 1,06 0,89 0,66 1,06 SQVDSSSVSEDSA
FAS1 1121 0,94 0,86 0,87 1,06 0,89 0,66 1,06 VDSSSVSEDSAVF






FAS2 615 0,58 1,13 0,52 0,64 0,71 1,56 STKEVASLPNKST
FAS2 958 0,92 0,99 0,92 0,99 EVRKAVSIETALE
FAS2 1440 0,87 0,69 1,04 SSVKYASPNLNMK
FAS2 1728 1,56 1,56 VSKDKKSGSLTFN
FAS2 1732 1,65 1,65 KKSGSLTFNSKNI
FAS2 1735 1,65 1,65 GSLTFNSKNIQSK
FAS2 1827 1,66 1,66 KSLGVKSLGGGAA
FAS2 1870 1,03 1,03 VTDVKVSISHDDL
FAS2 1872 1,03 1,03 DVKVSISHDDLQA
FAS3 2 0,72 0,93 0,60 0,84 1,05 0,81 0,95 MSEESLFE
FAS3 5 0,72 0,89 0,60 0,84 0,93 0,81 0,95 MSEESLFESSP
FAS3 9 0,72 0,89 0,60 0,84 0,93 0,81 0,95 EESLFESSPQKME
FAS3 10 0,78 0,86 0,72 0,84 0,83 0,81 0,95 ESLFESSPQKMEY
FBA1 313 0,97 0,97 KKDYIMSPVGNPE



























FKH2 3 8,78 2,89 8,78 1,79 3,99 MSSSNFNEM
FKH2 4 8,78 2,89 8,78 1,79 3,99 MSSSNFNEMN
FKH2 17 8,78 2,89 8,78 1,79 3,99 ELNMTQTNYGSTK
FKS1 269 1,86 1,86 EANPEDTEETLNK
FUI1 4 7,22 4,58 11,01 7,27 3,39 4,67 4,49 MPVSDSGFDN
FUI1 11 5,50 4,58 9,20 3,91 3,39 4,67 4,49 DSGFDNSSKTMKD
FUI1 12 5,50 4,58 9,20 3,91 3,39 4,67 4,49 SGFDNSSKTMKDD
FUI1 54 50,42 2,53 7,20 179,69 6,53 8,28 3,50 1,56 VIEKKDTDSENNI




GDS1 334 1,31 1,31 NYMDEDTNESMTE
GDS1 337 1,31 1,31 DEDTNESMTEPKK
GDS1 339 1,31 1,31 DTNESMTEPKKTK
GLN4 737 0,07 0,07 EVVYKESVMEHNF
GLN4 750 0,07 0,07 GDVVKNSPWVVDS
GLN4 756 0,07 0,07 SPWVVDSVKNSEF
GNP1 111 5,43 0,87 5,57 7,36 3,31 5,48 0,85 0,89 PISTKDSSSQLDN
GNP1 112 5,43 0,87 5,57 7,36 3,31 5,48 0,85 0,89 ISTKDSSSQLDNE
GNP1 113 5,43 0,87 5,57 7,36 3,31 5,48 0,85 0,89 STKDSSSQLDNEL
GNP1 123 2,36 0,98 3,27 1,54 1,75 2,88 1,00 0,96 NELNRKSSYITVD
GNP1 124 2,36 0,98 3,27 1,54 1,75 2,88 1,00 0,96 ELNRKSSYITVDG
GNP1 127 2,36 0,98 3,27 1,54 1,75 2,88 1,00 0,96 RKSSYITVDGIKQ
GPD1 23 2,17 0,73 0,37 4,19 1,94 0,36 0,97 1,00 0,59 AGRKRSSSSVSLK
GPD1 24 2,17 0,62 0,37 4,19 1,94 0,36 0,97 0,56 0,59 GRKRSSSSVSLKA
GPD1 25 2,17 0,73 0,37 4,19 1,94 0,36 0,97 1,00 0,59 RKRSSSSVSLKAA
GPD1 27 2,18 0,73 0,41 4,19 1,94 0,36 0,97 1,00 0,59 RSSSSVSLKAAEK
HFI1 6 0,76 0,76 MSAIQSPAPKPL
HFI1 384 0,85 0,90 0,64 0,42 1,49 1,64 0,12 0,67 1,18 DDIGDISMSSITK
HFI1 386 0,85 0,90 0,64 0,42 1,49 1,64 0,12 0,67 1,18 IGDISMSSITKAG
HFI1 387 0,85 0,90 0,64 0,42 1,49 1,64 0,12 0,67 1,18 GDISMSSITKAGE
HFI1 389 0,85 0,90 0,64 0,42 1,49 1,64 0,12 0,67 1,18 ISMSSITKAGEAV
HNM1 18 6,87 3,18 7,11 4,72 8,79 3,18 YMQPDQSSNASMH
HNM1 19 6,87 3,18 7,11 4,72 8,79 3,18 MQPDQSSNASMHK
HNM1 42 7,73 7,73 PLDDMDSKGAVAA
HOM3 332 1,26 0,86 1,66 VAKKGESTPPHPP
HOM3 333 1,26 0,86 1,66 AKKGESTPPHPPE
HPC2 45 0,98 0,94 1,02 NSIKKETGSDSED
HSP26 208 0,01 0,01 KKIEVSSQESWGN
HSP26 211 0,01 0,01 EVSSQESWGN
HXK2 15 1,00 1,00 PQARKGSMADVPK
HXT1 3 1,56 0,79 1,57 1,80 1,31 0,79 MNSTPDLIS
HXT1 4 1,54 0,79 1,52 1,80 1,31 0,79 MNSTPDLISP
HXT1 38 0,77 0,39 0,77 0,26 0,52 PEGKNESFHDNLS
HXT1 44 0,77 0,39 0,77 0,26 0,52 SFHDNLSESQVQP
HXT2 29 1,25 0,71 1,42 1,42 0,89 0,39 0,58 1,35 0,54 IVQKLETDESPIQ
HXT2 32 1,05 0,71 0,86 1,40 0,89 0,39 0,58 1,35 0,54 KLETDESPIQTKS
HYP2 2 0,87 0,85 0,93 0,80 0,77 0,94 0,83 MSDEEHTF
HYP2 10 0,87 0,81 0,93 0,80 0,77 0,83 0,83 EEHTFETADAGSS
IWS1 89 0,91 0,91 HISTDFSDDDLEK




KIC1 266 1,15 1,07 1,24 DPKERLSADDLLK
KRI1 174 0,38 0,42 0,38 0,42 LLNEIKSAFSDEE
KRI1 177 0,38 0,40 0,38 0,40 EIKSAFSDEENEE
KRI1 184 0,38 0,42 0,38 0,42 DEENEESSGDEDD
KRI1 185 0,38 0,42 0,38 0,42 EENEESSGDEDDG
LEU1 494 1,26 0,99 1,53 SPKVEVTSEDEKE
LEU1 495 1,26 0,99 1,53 PKVEVTSEDEKEL
LYS20 395 1,35 1,97 0,72 NFHAEVSTPQVLS
LYS20 396 1,35 1,97 0,72 FHAEVSTPQVLSA
LYS21 409 1,14 1,11 1,17 DFHAELSTPLLKP



























MAK11 423 3,09 0,59 7,82 0,44 1,02 0,55 0,43 0,77 KKRDAETADIGDQ
MAK11 430 3,07 0,62 7,82 0,42 0,99 0,55 0,54 0,77 ADIGDQSEVESDT
MAK11 434 3,10 0,66 7,82 0,46 1,02 0,48 0,73 0,77 DQSEVESDTEELK
MAK11 436 3,10 0,58 7,82 0,46 1,02 0,55 0,41 0,77 SEVESDTEELKKI
MAK21 73 0,44 1,05 0,34 0,43 0,32 0,66 0,54 0,88 1,73 KLIQGLSDDDDAK
MAK21 80 0,46 0,78 0,39 0,32 0,66 0,68 0,88 DDDDAKSEQEFDA
MAK21 708 0,67 0,52 0,82 TPVDYEYESDAEE
MAK21 710 0,67 0,52 0,82 VDYEYESDAEEEQ
MAK21 874 0,75 0,75 KKSNKASNFDSDD
MAK21 878 0,75 0,75 KASNFDSDDEMDE
MAK21 1024 QYLDQDSD
MAK5 678 0,70 1,07 0,64 0,61 0,62 0,93 0,82 1,43 0,96 LGIDVDSDEDDIS
MCM1 2 0,54 0,48 0,60 MSDIEEGT
MDN1 2124 1,01 1,01 SMNMKLSPNATAI
MDN1 2128 1,01 1,01 KLSPNATAIMEGL
MDN1 4353 0,35 0,35 PEEQAMSDEEELK
MDN1 4555 0,66 0,66 DEEEMLSDIDAHD
MEP2 490 0,92 0,45 1,03 0,81 0,45 STPSDASSTKNTD
MEP2 491 0,92 0,45 1,03 0,81 0,45 TPSDASSTKNTDH
MEP2 492 0,92 0,45 1,03 0,81 0,45 PSDASSTKNTDHI
MFT1 264 0,85 0,85 DNIDEDYESDEDE
MFT1 266 0,85 0,85 IDEDYESDEDEER
MHR1 224 TEQTEVSSQ
MHR1 225 EQTEVSSQ
MRD1 264 0,31 0,61 0,31 0,50 0,71 VNDDANSDEKENE
MRT4 181 0,67 0,67 IKAGKITIDSPYL
MRT4 184 0,67 0,67 GKITIDSPYLVCT
MSH6 145 1,07 0,78 1,37 RVNYAESDDDDSD
MSH6 150 1,07 0,78 1,37 ESDDDDSDTTFTA
MSH6 209 4,01 0,98 5,15 2,87 0,84 1,12 DDDDLISLAETTS
MSH6 213 4,01 0,98 5,15 2,87 0,84 1,12 LISLAETTSKKKF
MSH6 214 4,01 0,98 5,15 2,87 0,84 1,12 ISLAETTSKKKFS
MSH6 215 4,01 0,98 5,15 2,87 0,84 1,12 SLAETTSKKKFSY
MUP1 31 1,54 1,84 1,54 1,33 2,36 TTKKEVSNSTVDA
NCL1 667 EKETTESPAETTT
NEW1 107 0,51 0,19 0,83 KSTYKQSAVTPNQ
NEW1 120 0,51 0,19 0,83 SGTPTPSASTTSL
NEW1 124 0,51 0,19 0,83 TPSASTTSLTSLN
NEW1 125 0,51 0,19 0,83 PSASTTSLTSLNE
NEW1 127 0,51 0,19 0,83 ASTTSLTSLNEKL
NEW1 128 0,51 0,19 0,83 STTSLTSLNEKLS
NEW1 1191 1,27 0,66 1,19 0,92 1,01 1,97 0,34 0,51 0,94 0,86 TPKPVDTDDEED
NOC2 70 0,62 0,62 EVFKDMSVETFFE
NOC2 97 0,40 0,40 KTTKEQSDEDSSS
NOC2 101 0,40 0,40 EQSDEDSSSSEEE
NOC2 102 0,40 0,40 QSDEDSSSSEEEE
NOC2 103 0,40 0,40 SDEDSSSSEEEED
NOC2 104 0,40 0,40 DEDSSSSEEEEDM
NOC2 149 0,45 1,10 0,45 1,10 PLDGIDSQDEGED
NOC2 160 0,45 1,10 0,45 1,10 EDAERNSNIEEKS




NOG1 352 13,37 13,37 NKLKSQSRINNVL
NOP12 70 0,23 0,23 ASKPDVSDEQTEE
NOP12 175 0,56 0,80 0,54 0,60 0,39 0,72 0,79 0,90 0,63 0,90 FKKLFGTNPIAET
NOP12 184 0,56 0,80 0,54 0,57 0,39 0,75 0,79 0,90 0,63 0,90 IAETEESGNEKEE
NOP12 192 0,71 0,71 NEKEEESSKKSDN
NOP12 193 0,71 0,71 EKEEESSKKSDNN
NOP13 2 0,32 0,32 MSETELSK
NOP13 105 0,90 1,18 0,71 0,81 1,18 1,34 1,24 0,97 EESTINTPTGDES
NOP7 288 0,28 0,34 0,23 EDVKVESLDASTL
NOP7 292 0,45 0,53 0,36 VESLDASTLKSAL
NOP7 308 0,59 0,68 0,51 EANTDETEKEEEQ



























NOP8 234 0,27 0,70 0,16 0,38 0,70 CSGEMDSDENMSE
NOP8 239 0,27 0,70 0,16 0,38 0,70 DSDENMSEEEKEK
NOP8 268 0,23 0,22 0,23 PMTLNDSDEELLT
NOP8 370 0,21 1,33 0,22 0,20 0,21 0,70 1,97 FKLIEDSDNDIDH
NPL6 2 0,71 0,92 0,42 0,49 0,36 1,58 0,57 1,60 0,61 0,91 MSDSEGGL
NPL6 4 0,71 0,92 0,42 0,49 0,36 1,58 0,57 1,60 0,61 0,91 MSDSEGGLAS
PFK1 895 1,62 1,62 NKKNEASPNTDAK
PFK2 163 5,42 5,83 0,26 18,31 1,14 1,99 9,68 8,86 0,73 4,06 PEASAESGLSSKV
PFK2 166 5,50 5,83 0,56 18,31 1,14 1,99 9,68 8,86 0,73 4,06 SAESGLSSKVHSY
PFK2 167 5,40 6,32 0,15 18,31 1,14 1,99 9,68 8,86 2,68 4,06 AESGLSSKVHSYT
PFK2 171 1,18 1,33 1,02 LSSKVHSYTDLAY
PHO84 316 1,42 1,28 1,42 1,21 1,36 NGLERASTAVESL
PHO84 317 1,42 1,28 1,42 1,21 1,36 GLERASTAVESLD





POP1 524 1,88 1,71 2,04 YKLLTATPNSINK
POP1 527 1,88 1,71 2,04 LTATPNSINKTTV
PRP20 135 0,76 0,76 0,56 0,95 0,66 0,86 0,77 DMDADDSSDDEDG
PRP20 136 0,76 0,76 0,56 0,95 0,66 0,86 0,77 MDADDSSDDEDGD
PRP20 149 0,76 0,76 0,56 0,96 0,66 0,83 0,77 LNELESTPAKIPR
PTR2 6 1,71 1,71 MLNHPSQGSDDA
PTR2 9 2,41 2,41 NHPSQGSDDAQDE
PTR2 594 1,68 1,33 1,30 2,07 0,94 1,72 ILEPMESLRSTTK
PTR2 597 1,73 1,36 1,30 2,15 1,00 1,72 PMESLRSTTKY
PTR2 598 1,73 1,36 1,30 2,15 1,00 1,72 MESLRSTTKY
PTR2 599 1,68 1,36 1,30 2,07 1,00 1,72 ESLRSTTKY
PTR2 601 1,73 1,37 1,30 2,15 1,01 1,72 LRSTTKY
PUF6 31 0,84 1,03 0,84 0,77 1,29 AKKPRISIDSSDE
PUF6 34 0,84 1,03 0,84 0,77 1,29 PRISIDSSDEESE
PUF6 35 0,84 1,03 0,84 0,77 1,29 RISIDSSDEESEL
PUP2 251 EKEAAESPEEADV
PWP1 44 0,58 1,00 0,57 0,67 0,49 0,58 0,93 1,23 1,12 0,72 LDDAKATLEEAEG
PWP1 52 0,58 1,00 0,57 0,67 0,49 0,58 0,93 1,23 1,12 0,72 EEAEGESGVEDDA
PWP1 131 0,67 0,67 LPNQEDSQEEKQE
PWP2 232 0,75 0,85 0,41 0,53 1,30 0,82 0,92 0,82 DDDDNESEDDDKQ
PWP2 907 1,75 0,85 0,62 4,85 0,51 1,02 0,83 0,89 0,60 1,07 DNKLPLSNENDSS
PWP2 912 1,76 0,90 0,66 4,85 0,51 1,02 0,83 0,96 0,75 1,07 LSNENDSSDEEEN
PWP2 913 1,76 0,90 0,66 4,85 0,51 1,02 0,83 0,96 0,75 1,07 SNENDSSDEEENE
PYK1 257 0,85 0,85 DEILKVTDGVMVA
RCN2 160 0,39 0,39 DKSSLESPTMLKL
RCO1 683 ENPENQSE
REI1 106 1,04 1,44 0,64 LENMQKSQEGNTP
REI1 111 0,58 0,53 0,64 KSQEGNTPDLSKL
REI1 118 3,33 3,51 3,15 PDLSKLSLQENEE
RLP24 154 0,55 0,87 0,55 0,75 1,09 0,77 0,86 EQERAESVSEQEE
RLP24 156 0,41 0,86 0,41 0,92 1,09 0,68 0,76 ERAESVSEQEESE
RLP24 161 0,30 0,89 0,30 1,05 1,06 0,68 0,76 VSEQEESEEEEED
RLP24 172 0,30 0,89 0,30 1,05 1,06 0,68 0,76 EDMEIDSDEEEEE
RLP7 120 0,75 0,75 SVDLEETEEEEDD
RNR2 15 0,74 0,74 AAADALSDLEIKD
RPA34 8 1,27 1,01 1,27 0,80 1,22 SKLSKDYVSDSDS
RPA34 10 1,27 1,01 1,27 0,80 1,22 LSKDYVSDSDSDD
RPA34 12 1,27 1,01 1,27 0,80 1,22 KDYVSDSDSDDEV
RPA34 14 1,27 1,01 1,27 0,80 1,22 YVSDSDSDDEVIS
RPC19 33 1,12 1,12 EQDVDMTGDEEQE
RPC31 189 0,90 0,80 1,00 EDVDDASTGDGAA
RPC31 190 0,99 0,80 1,18 DVDDASTGDGAAK
RPL11B 44 1,14 1,11 1,16 EQLSGQTPVQSKA
RPL11B 161 1,00 1,13 0,91 0,96 1,17 0,96 1,08 1,22 1,09 TKEDTVSWFKQKY
RPL12A 38 1,91 0,83 1,89 1,94 0,90 0,77 IGPLGLSPKKVGE
RPL14B 3 1,09 0,94 1,19 1,08 1,15 MSTDSIVKA
RPL14B 5 1,10 0,98 1,19 1,08 1,15 MSTDSIVKASN



























RPL16A 188 1,07 1,12 1,00 1,14 1,12 NATAAESDVAKQL
RPL16B 2 1,07 1,18 1,03 1,11 1,05 1,09 1,36 1,10 1,18 MSQPVVVI
RPL16B 181 1,10 1,24 1,00 1,27 1,02 0,99 1,71 1,08 1,20 KKVSSASAAASES
RPL16B 185 1,08 1,25 1,01 1,27 0,96 1,02 1,71 1,08 1,20 SASAAASESDVAK
RPL16B 187 1,10 1,23 0,96 1,27 1,08 0,95 1,71 1,06 1,20 SAAASESDVAKQL
RPL19A 59 1,10 1,10 KAVTVHSKSRTRA
RPL1A 79 1,13 1,21 1,06 DVDRAKSCGVDAM
RPL1A 86 1,12 1,18 1,06 CGVDAMSVDDLKK
RPL20A 169 FSYKRPSTFY
RPL21A 70 1,16 1,00 1,31 1,18 VYNVTKSSVGVII
RPL22B 111 LVFYQVTPEDADE
RPL24A 7 1,08 1,01 1,03 1,19 1,04 0,90 1,18 0,86 1,10 MKVEIDSFSGAKI
RPL24A 9 0,95 1,23 0,94 0,87 1,04 1,22 1,18 1,44 1,09 VEIDSFSGAKIYP
RPL24A 86 0,59 1,15 0,82 0,50 0,51 0,53 1,31 1,38 1,19 0,74 RPITGASLDLIKE
RPL24A 153 FQKVAATSR
RPL24A 154 QKVAATSR
RPL24B 7 1,06 1,12 1,01 1,23 0,94 1,03 1,11 1,29 1,04 1,05 MKVEVDSFSGAKI
RPL24B 9 1,06 1,13 1,01 1,23 0,94 1,03 1,11 1,34 1,04 1,05 VEVDSFSGAKIYP
RPL24B 130 KAEKAKSAGVQGS
RPL24B 136 SAGVQGSKVSKQQ
RPL26B 74 0,92 0,92 GKISSVYRLKFAV
RPL27A 33 1,58 1,58 KPHDEGSKSHPFG
RPL27A 97 1,06 1,30 1,05 1,06 1,30 AFKSVVSTETFEQ
RPL27A 98 1,08 1,30 1,10 1,06 1,30 FKSVVSTETFEQP
RPL27A 100 1,06 1,30 1,05 1,06 1,30 SVVSTETFEQPSQ
RPL27A 105 0,97 1,30 1,00 0,95 1,30 ETFEQPSQREEAK
RPL2A 195 1,02 1,02 YRLKRNSWPKTRG
RPL3 187 1,25 1,25 IQLNGGSISEKVD
RPL3 296 1,08 1,04 1,01 1,14 1,04 DEANGATSFDRTK
RPL3 297 1,08 1,04 1,01 1,14 1,04 EANGATSFDRTKK
RPL3 301 1,08 1,04 1,01 1,14 1,04 ATSFDRTKKTITP
RPL3 355 1,08 1,04 0,97 1,19 1,06 1,15 1,06 0,86 KALEEVSLKWIDT
RPL30 6 0,99 0,93 0,96 1,03 0,93 MAPVKSQESINQ
RPL31A 100 EPVLVASAKGLQT
RPL32 67 1,08 1,00 1,16 0,99 1,00 KKTKFLSPSGHKT
RPL37A 80 0,99 0,99 0,99 1,02 0,97 FKNGFQTGSASKA
RPL37A 82 0,99 0,99 0,99 1,02 0,97 NGFQTGSASKASA
RPL37A 84 0,99 0,99 0,99 1,02 0,97 FQTGSASKASA
RPL37B 7 MGKGTPSFGKRHN
RPL37B 80 0,79 0,79 FKNGFQTGSAKAT
RPL37B 82 0,79 0,79 NGFQTGSAKATSA
RPL4A 158 0,87 0,87 VSTDLESIQKTKE
RPL4A 269 1,48 1,48 GSETVASSKVGYT
RPL4A 270 1,48 1,48 SETVASSKVGYTL
RPL6A 12 1,43 1,05 1,48 1,39 1,03 1,17 0,96 APKWYPSEDVAAL
RPL7A 8 1,18 1,18 1,22 1,43 1,13 0,94 0,73 1,37 0,92 1,69 AAEKILTPESQLK,
STEKILTPESQLK
RPL7A 11 1,00 1,18 1,20 0,74 1,13 0,94 0,73 1,37 0,92 1,69 KILTPESQLKKSK,
KILTPESQLKKTK
RPL8A 126 2,52 0,27 4,77 KSKQDASPKPYAV
RPL8A 216 1,03 1,04 1,11 0,94 1,04 ALAKLVSTIDANF
RPN1 19 0,88 0,88 DEQSQISPEKQTP
RPN1 178 1,14 1,08 1,14 1,08 DAEDETSSDGSKS
RPN1 184 1,22 0,99 1,25 1,20 0,53 1,22 1,22 SSDGSKSDGSAAT
RPN1 187 1,22 0,99 1,25 1,20 0,53 1,22 1,22 GSKSDGSAATSGF
RPN1 196 1,21 0,99 1,25 1,17 0,53 1,22 1,22 TSGFEFSKEDTLR
RPN13 132 0,94 1,14 0,71 1,04 0,63 1,37 0,51 1,40 1,53 1,13 IGVLNNSSESDEE



































RPP1A 96 1,15 1,01 1,58 0,96 0,99 1,09 1,05 0,98 0,96 1,04 EEAKEESDDDMGF
RPP1B 58 0,98 0,99 0,91 1,06 0,86 1,08 0,97 1,05 DLKEILSGFHNAG
RPP1B 73 0,98 0,87 0,91 1,06 0,86 1,08 0,97 0,57 AGAGAASGAAAAG
RPP1B 96 0,99 0,96 0,91 1,06 0,86 1,08 0,94 0,96 EEAAEESDDDMGF
RPP2A 43 1,22 1,03 1,18 1,26 1,04 1,17 0,89 KVSSVLSALEGKS
RPP2A 49 1,22 1,08 1,14 1,28 0,94 1,51 0,93 1,21 1,13 1,04 SALEGKSVDELIT
RPP2A 71 1,15 0,98 1,24 1,38 0,90 1,07 0,93 1,08 0,93 0,97 PAAGPASAGGAAA
RPP2A 79 1,15 0,98 1,24 1,38 0,90 1,09 0,93 1,03 0,97 0,97 GGAAAASGDAAAE
RPP2A 96 0,99 0,96 0,90 1,09 0,90 1,03 0,98 0,94 EEAAEESDDDMGF
RPP2B 65 1,07 1,22 1,06 1,19 0,98 1,05 0,86 1,01 0,80 2,21 GQKKFATVPTGGA
RPP2B 68 1,07 1,22 1,06 1,19 0,98 1,05 0,86 1,01 0,80 2,21 KFATVPTGGASSA
RPP2B 72 1,07 1,22 1,06 1,19 0,98 1,05 0,86 1,01 0,80 2,21 VPTGGASSAAAGA
RPP2B 73 1,07 1,22 1,06 1,19 0,98 1,05 0,86 1,01 0,80 2,21 PTGGASSAAAGAA
RPP2B 100 1,05 1,05 0,99 1,11 1,07 1,05 0,99 1,07 EEAKEESDDDMGF
RPS10B 48 0,91 0,91 0,90 VIKALQSLTSKGY
RPS10B 50 0,91 0,91 0,90 KALQSLTSKGYVK
RPS11A 2 1,09 0,95 1,09 1,09 0,92 1,00 0,91 MSTELTVQ
RPS11A 3 1,05 0,95 1,02 1,09 0,92 1,00 0,91 MSTELTVQS
RPS11A 9 1,01 0,95 0,96 1,05 0,92 1,00 0,91 TELTVQSERAFQK
RPS12 2 1,05 1,07 1,07 1,07 1,04 1,02 1,05 0,96 1,15 1,11 MSDVEEVV




RPS15 2 1,48 1,69 1,28 MSQAVNAK
RPS15 29 1,13 1,05 1,13 1,13 1,09 1,00 EKLLEMSTEDFVK
RPS15 30 1,13 1,05 1,13 1,13 1,09 1,00 KLLEMSTEDFVKL
RPS16A 2 1,01 1,01 1,01 1,01 MSAVPSVQ
RPS16A 15 1,40 1,11 1,69 TFGKKKSATAVAH
RPS16A 37 0,72 0,72 VNGSPITLVEPEI
RPS17B 96 0,97 0,97 ALDLSRSNGVLNV
RPS18A 107 1,08 0,88 1,28 LANNVESKLRDDL
RPS19B 117 1,11 0,96 0,97 1,08 1,29 0,96 0,85 1,07 IGIVEISPKGGRR
RPS1A 254 KDEVLETV
RPS1B 254 1,29 1,29 KDEVLETV
RPS2 2 1,48 0,98 2,24 1,37 1,06 1,25 0,99 0,93 1,03 MSAPEAQQ
RPS20 2 1,37 0,94 1,80 MSDFQKEK
RPS20 38 1,05 1,05 KQLENVSSNIVKN





RPS28A 5 0,74 1,00 0,31 1,17 0,92 1,03 1,05 MDNKTPVTLAK
RPS28B 3 2,45 0,97 0,25 4,64 0,97 MDSKTPVTL
RPS28B 5 1,06 0,99 0,96 1,17 0,97 1,01 MDSKTPVTLAK
RPS3 207 1,27 1,17 1,16 1,21 1,43 1,10 1,40 0,52 1,68 ALPDAVTIIEPKE
RPS3 221 1,22 1,17 1,02 1,23 1,21 1,43 1,03 1,40 0,83 1,41 EPILAPSVKDYRP
RPS3 231 YRPAEETEAQAEP
RPS5 2 1,01 0,97 1,01 1,00 1,03 0,84 1,04 MSDTEAPV
RPS5 21 1,04 0,97 1,01 1,08 1,03 0,84 1,04 EVVEEFTPVVLAT
RPS5 27 1,01 0,97 1,01 1,00 1,03 0,84 1,04 TPVVLATPIPEEV
RPS5 38 1,01 0,97 1,01 1,01 1,03 0,84 1,04 EVQQAQTEIKLFN
RPS6A 232 0,32 0,33 0,17 0,20 0,23 0,67 0,35 0,36 0,36 0,25 IRKRRASSLKA
RPS6A 233 0,32 0,33 0,17 0,20 0,23 0,67 0,35 0,36 0,36 0,25 RKRRASSLKA
RPS7A 187 IVFEIPSETH
RPS7A 189 FEIPSETH
RPS7B 10 1,63 1,20 1,63 1,01 1,36 1,22 VQSKILSQAPSEL
RPS7B 14 1,63 1,20 1,63 1,01 1,36 1,22 ILSQAPSELELQV





RRP14 219 0,23 0,62 0,23 0,59 0,65 KRKRLESEQEQDQ



























RRP14 232 0,26 0,62 0,26 0,59 0,65 DEIASDSDMEDID
RRP14 239 0,23 0,62 0,23 0,59 0,65 DMEDIDSDLENNS
RRP14 245 0,23 0,62 0,23 0,59 0,65 SDLENNSKKRFKK
RRP15 69 0,43 0,48 0,30 0,57 0,52 0,44 IIDNEQSDAEEDD
RRP5 187 0,53 1,21 0,53 1,13 2,00 0,65 1,07 EDAEYESSDDEDE
RRP5 188 0,53 1,21 0,53 1,13 2,00 0,65 1,07 DAEYESSDDEDEK
RSN1 933 0,98 0,98 GEFDTASKENNPF
SAC3 1167 1,43 1,43 HSSQFKTPLASRL
SAC3 1176 1,43 1,43 ASRLNTSGSSTSP
SAC3 1178 1,43 1,43 RLNTSGSSTSPPL
SAC3 1179 1,43 1,43 LNTSGSSTSPPLP
SAC3 1180 1,43 1,43 NTSGSSTSPPLPS
SAC3 1186 1,43 1,43 TSPPLPSHLAMKF
SAS10 314 2,01 2,01 VNEGDGSESEETA
SAS10 316 2,01 2,01 EGDGSESEETANI
SAS10 319 2,01 2,01 GSESEETANIEAF
SAS10 533 ELAENVSGDGKRA
SDA1 591 0,05 0,86 0,04 0,04 0,03 0,10 0,63 1,21 0,95 0,65 DVDMEDSDDEKDN
SDA1 603 0,08 0,82 0,02 0,20 0,03 0,07 1,09 0,29 1,09 NAKGKESDSDLEL
SDA1 605 0,09 0,82 0,02 0,20 0,03 0,09 1,09 0,29 1,09 KGKESDSDLELSD
SDA1 610 0,09 0,82 0,02 0,20 0,03 0,09 1,09 0,29 1,09 DSDLELSDDDDEK
SEC4 10 0,24 0,83 0,22 0,22 0,29 1,14 0,69 0,66 LRTVSASSGNGKS
SEC4 11 0,24 0,83 0,22 0,22 0,29 1,14 0,69 0,66 RTVSASSGNGKSY
SKG1 276 0,67 1,56 0,58 0,75 1,53 1,58 VFATPKSAAQSQL
SKG1 280 0,67 1,56 0,58 0,75 1,53 1,58 PKSAAQSQLPNTF
SMC1 261 1,04 0,96 1,12 KLSALNSEISSLK
SMX3 2 0,85 0,85 MSESSDIS
SMX3 4 0,85 0,85 MSESSDISAM
SMX3 5 0,85 0,85 MSESSDISAMQ
SNU114 85 1,56 1,24 1,56 1,24 ETKNTQSPQTPLV
SNU114 88 1,56 1,24 1,56 1,24 NTQSPQTPLVEPV
SPB1 529 0,34 0,66 0,34 0,45 1,08 0,52 0,57 EGVEGDSDDDEAI
SPB1 799 0,88 0,88 VTLVVASGRNKGL
SPS1 282 0,99 1,14 0,99 1,14 TITNLKSDVDLIK
SPT8 385 1,00 1,20 0,48 1,52 1,29 1,10 ADDDMDSLFGDED
SRO9 422 QETKEDSAPVAAG
SSD1 491 1,47 1,47 NDSDSLSSPTKSG
SSD1 492 1,47 1,47 DSDSLSSPTKSGV
SSZ1 477 0,56 0,69 0,69 0,43 0,61 0,83 0,62 AEEDDESEWSDDE
SSZ1 480 0,56 0,69 0,69 0,43 0,61 0,83 0,62 DDESEWSDDEPEV
STE2 382 0,94 1,02 0,44 1,45 0,95 1,45 1,03 0,67 QFYQLPTPTSSKN
STE2 384 0,91 1,02 0,44 1,37 1,01 1,36 1,03 0,67 YQLPTPTSSKNTR
STE2 385 0,87 1,04 0,44 1,30 0,99 1,45 1,03 0,68 QLPTPTSSKNTRI
STE2 386 0,87 1,04 0,44 1,30 0,99 1,45 1,03 0,67 LPTPTSSKNTRIG
STE2 411 0,79 1,03 0,63 0,94 1,03 EPVDMYTPDTAAD
STE2 414 0,79 1,03 0,63 0,94 1,03 DMYTPDTAADEEA
STE20 169 0,77 0,92 0,77 0,92 KLSLTDSTETIEN
STE20 172 0,77 0,92 0,77 0,92 LTDSTETIENNAT
STE20 492 0,34 0,24 0,44 SAPIIKSPVMNSA
STE20 502 0,34 0,24 0,44 NSAANVSPLKQTH
STE6 623 0,47 1,15 0,47 1,35 1,48 0,90 0,88 TETEEKSIHTVES
STE6 626 0,47 1,15 0,47 1,35 1,48 0,90 0,88 EEKSIHTVESFNS
STE6 629 0,47 1,15 0,47 1,35 1,48 0,90 0,88 SIHTVESFNSQLE
STE6 632 0,47 1,15 0,47 1,35 1,48 0,90 0,88 TVESFNSQLETPK
STF2 69 3,62 3,62 KKDRRGSNLQSHE
SUB1 119 0,69 0,69 KMVRLLSDDEYED
SUB1 123 0,69 0,69 LLSDDEYEDDNNN
SUB2 13 0,87 0,65 1,24 0,73 EDLLEYSDNEQEI
SUI3 112 1,15 0,48 1,11 1,19 0,36 0,60 DNVDAESKEGTPS
SUR1 349 0,88 0,49 1,07 0,69 0,49 KRLRKDSNTNIVL




SWI3 229 2,17 1,40 1,11 3,22 1,40 SKQLGNTSSVANT



























SWI3 235 2,17 1,40 1,11 3,22 1,40 TSSVANTPSEIPD
TAF12 286 0,81 0,73 0,90 QNQRKISSSNSTE
TAF12 288 0,76 0,73 0,78 QRKISSSNSTEIP
TAF12 290 0,76 0,73 0,78 KISSSNSTEIPSV
TAF12 291 0,76 0,73 0,78 ISSSNSTEIPSVT
TAL1 148 0,36 0,36 LIKIASTWEGIQA
TGL1 538 2,00 2,00 QLDANSSTTALDA
TGL1 539 2,00 2,00 LDANSSTTALDAL




TOP1 14 0,84 0,87 0,73 0,94 0,70 1,05 KVNHELSSDDDDD
TOP1 15 0,84 0,87 0,73 0,94 0,70 1,05 VNHELSSDDDDDV
TOP1 24 0,84 0,87 0,73 0,94 0,70 1,05 DDDVPLSQTLKKR
TOP2 1314 1,17 1,17 ATSKENTPEQDDV
TPO5 569 0,75 1,30 0,71 0,78 1,30 ESVENNSEEGFIK
TPS2 888 2,04 0,25 3,84 AYVMKRSASYTGA
TPS2 890 2,04 0,25 3,84 VMKRSASYTGAKV
TRA1 172 1,03 0,80 1,26 EQGDLDSPKEPQA
TRA1 542 0,61 0,61 KEDINDSPDVEMT
TRA1 2442 MTILDNSLERDIK
TRX2 11 0,11 0,11 LKSASEYDSALAS
TRX2 13 0,11 0,11 SASEYDSALASGD
TY1B-PR2 1082 0,30 0,30 KTVPQISDQETEK
TY1B-PR2 1086 0,30 0,30 QISDQETEKRIIH
UBI1 86 1,07 0,96 1,02 1,13 0,97 0,95 RKKKVYTTPKKIK
UBI1 87 1,07 0,96 1,02 1,13 0,97 0,95 KKKVYTTPKKIKH
UBP1 530 0,86 0,86 KAAQQDSSEDENI
UBP1 531 0,86 0,86 AAQQDSSEDENIG
UBP1 618 1,23 0,92 1,53 KRIIEHSDVENEN
UBP1 755 1,09 1,09 DLEAIQSNNEEDD
UFD1 354 1,16 0,89 1,43 KSKAPKSPEVIEI
URA6 90 LLRNAISDNVKAN
UTP14 423 0,49 1,25 0,35 0,63 1,13 1,37 RELAAVSSDEDNE
UTP14 424 0,49 1,25 0,35 0,63 1,13 1,37 ELAAVSSDEDNED
UTP14 488 0,48 1,10 0,32 0,63 1,11 1,20 1,00 KMLDRNSDDEEDG
UTP14 498 0,48 1,10 0,32 0,63 1,11 1,20 1,00 EDGRVQTLSDVEN
UTP14 500 0,48 1,10 0,32 0,63 1,11 1,20 1,00 GRVQTLSDVENEE
UTP14 562 1,06 1,07 1,06 DIKLFESDEEETN
UTP14 668 0,31 1,59 0,31 1,48 1,70 PWLANESDEEHTV
UTP14 673 0,31 1,59 0,31 1,48 1,70 ESDEEHTVKKQSS
UTP14 738 1,18 1,07 1,18 1,29 VDPYGGSDDEQGD
UTP22 3 7,30 7,30 MATSVKRKA
UTP22 4 7,30 7,30 MATSVKRKAS
UTP22 10 3,88 7,30 0,46 SVKRKASETSDQN





UTP8 148 0,68 0,76 0,97 0,39 0,76 TSNDHLSESDIDN
UTP8 150 0,68 0,76 0,97 0,39 0,76 NDHLSESDIDNKA
VAN1 21 0,39 2,59 0,39 3,68 1,42 2,68 AMDNGLSLPISRN
VAN1 25 0,39 2,62 0,39 3,68 1,49 2,68 GLSLPISRNGSSN
VAN1 29 0,39 2,72 0,39 4,06 1,42 2,68 PISRNGSSNNIKD
VAN1 30 0,39 2,72 0,39 4,06 1,42 2,68 ISRNGSSNNIKDK
VTC3 621 0,85 0,83 0,87 DLEDHESSDEEGT
VTC3 622 0,85 0,83 0,87 LEDHESSDEEGTA
YAP1 528 0,86 0,86 KKAANMSDDESSL
YBL047C 1340 1,60 0,58 2,63 NRGVATTPKSLAV
YBT1 936 1,27 1,27 EDELVKSSILSRA
YBT1 940 1,27 1,27 VKSSILSRANSSA
YBT1 952 1,51 2,42 1,68 1,35 3,22 2,21 1,85 ANLAAKSSTSLSN
YBT1 954 1,51 2,42 1,68 1,35 3,22 2,21 1,85 LAAKSSTSLSNLP



























YDL109C 269 11,55 11,55 DSVGKISFIGHSL
YDL109C 274 11,55 11,55 ISFIGHSLGGLTQ
YDL109C 279 11,55 11,55 HSLGGLTQTFAIC
YDL109C 281 11,55 11,55 LGGLTQTFAICYI
YDL109C 286 11,55 11,55 QTFAICYIKTKYP
YDL109C 289 11,55 11,55 AICYIKTKYPYFF
YDL109C 291 11,55 11,55 CYIKTKYPYFFKK
YDL109C 293 11,55 11,55 IKTKYPYFFKKVE
YDR119W 106 0,79 0,60 0,99 PQDEVNSIKGKPA
YEF3 1015 1,03 1,03 KKKKKLSSAELRK
YEF3 1039 1,06 1,44 0,91 1,20 1,33 1,32 0,84 2,27 LGDAYVSSDEEF
YEF3 1040 1,06 1,44 0,91 1,20 1,33 1,32 0,84 2,27 GDAYVSSDEEF
YGL039W 2 0,44 0,44 MTTEKTVV
YGL039W 3 0,44 0,44 MTTEKTVVF
YGL039W 6 0,44 0,44 MTTEKTVVFVSG
YGL039W 11 0,44 0,44 KTVVFVSGATGFI
YGL039W 14 0,44 0,44 VFVSGATGFIALH
YGR130C 247 0,72 0,72 EDKVSESTSIGKG
YGR130C 248 0,72 0,72 DKVSESTSIGKGT
YGR130C 249 0,72 0,72 KVSESTSIGKGTA
YHR146W 343 1,06 0,83 1,29 LVEKRESTEGVLD
YHR146W 344 1,06 0,83 1,29 VEKRESTEGVLDG




YJL123C 340 1,32 0,71 1,94 DRSSISSNSNKIS
YKR018C 380 1,29 0,64 1,09 1,48 0,64 SSNSEDSEDEEMD
YKT6 20 EKALELSEVKDLS
YKU80 3 0,75 0,75 MSSESTTFI
YKU80 5 0,75 0,75 MSSESTTFIVD
YKU80 6 0,75 0,75 MSSESTTFIVDV
YKU80 7 0,75 0,75 MSSESTTFIVDVS
YKU80 13 0,75 0,75 TFIVDVSPSMMKN
YKU80 15 0,75 0,75 IVDVSPSMMKNNN
YKU80 23 0,75 0,75 MKNNNVSKSMAYL
YLR413W 652 2,46 2,75 3,87 1,04 1,14 6,17 0,95 EKAVQESDSTTSR
YLR413W 654 2,63 2,75 4,22 1,04 1,14 6,17 0,95 AVQESDSTTSRII
YLR413W 655 2,30 2,75 3,55 1,04 1,14 6,17 0,95 VQESDSTTSRIIE
YLR413W 656 2,30 2,75 3,55 1,04 1,14 6,17 0,95 QESDSTTSRIIEE
YLR413W 657 2,46 2,75 3,87 1,04 1,14 6,17 0,95 ESDSTTSRIIEEH
YMR086W 874 2,03 2,03 VVSPGVSSPNHTT
YMR086W 875 2,03 2,03 VSPGVSSPNHTTT
YMR086W 879 2,03 2,03 VSSPNHTTTDPAI
YMR086W 880 2,03 2,03 SSPNHTTTDPAIT
YMR086W 881 2,03 2,03 SPNHTTTDPAITS
YMR086W 887 2,03 2,03 TDPAITSKKVDKK
YMR209C 3 0,86 0,95 0,98 0,74 0,95 0,95 MVSSLASNI
YMR209C 4 0,86 0,95 0,98 0,74 0,95 0,95 MVSSLASNII
YMR209C 19 0,86 0,95 0,98 0,74 0,95 0,95 LVVVLMTLLRQNK
YMR295C 14 1,01 1,01 SSISNTSDHDGAN
YNL050C 23 0,46 0,65 0,32 0,60 0,66 0,69 0,61 EGLGEDYDSNSSS
YNL050C 25 0,46 0,66 0,32 0,59 0,68 0,70 0,61 LGEDYDSNSSSKN
YNL050C 27 0,46 0,66 0,32 0,60 0,66 0,69 0,61 EDYDSNSSSKNNS
YNL050C 28 0,46 0,66 0,32 0,60 0,66 0,69 0,61 DYDSNSSSKNNSE
YNL050C 29 0,46 0,66 0,32 0,60 0,66 0,69 0,61 YDSNSSSKNNSEH
YNL058C 145 0,47 0,55 0,47 0,55 HHKHSSSLQSNPF
YNL058C 148 0,47 0,55 0,47 0,55 HSSSLQSNPFDIN
YNL058C 277 1,34 1,16 1,34 1,16 HKRNQSSLGLIPV
YNL058C 285 2,30 1,16 2,30 1,16 GLIPVASATSNTS
YNL058C 287 1,75 1,16 1,75 1,16 IPVASATSNTSSP
YNL058C 290 1,75 1,16 1,75 1,16 ASATSNTSSPKKA
YNL058C 292 1,75 1,16 1,75 1,16 ATSNTSSPKKAHK
YNL110C 34 0,01 0,62 0,01 0,02 0,61 0,63 EELALETSSSSSD
YNL110C 35 0,01 0,62 0,01 0,02 0,61 0,63 ELALETSSSSSDE



























YNL110C 37 0,01 0,62 0,01 0,02 0,61 0,63 ALETSSSSSDEED
YNL110C 38 0,01 0,62 0,01 0,02 0,61 0,63 LETSSSSSDEEDE
YNL110C 39 0,01 0,62 0,01 0,02 0,61 0,63 ETSSSSSDEEDEK
YNL110C 56 0,17 0,56 0,17 0,12 0,16 0,23 0,61 0,61 0,51 0,53 IEGLAASDDEQSG
YNL110C 61 0,17 0,56 0,17 0,12 0,16 0,21 0,61 0,61 0,51 0,53 ASDDEQSGTHKIK
YNL110C 63 0,17 0,56 0,17 0,12 0,16 0,21 0,61 0,61 0,51 0,53 DDEQSGTHKIKRL
YNL149C 119 QGLDPDSDADIEE
YOR287C 41 0,72 0,70 0,78 0,69 EIDEQESSDDELK
YOR287C 42 0,72 0,70 0,78 0,69 IDEQESSDDELKT
YPL146C 31 0,20 0,33 0,22 0,11 0,16 0,30 0,30 0,42 0,31 0,29 RKNIDLSDVEQYM
YPL146C 363 0,28 0,57 0,28 0,18 0,38 0,47 0,67 EETEILSAIESDS
YPL146C 367 0,28 0,57 0,28 0,17 0,38 0,47 0,67 ILSAIESDSNKVK
YRB1 60 1,47 1,47 GDDAPESPDIHFE
YRB2 179 0,86 0,86 DKDKVHSGSEQLA
YRB2 181 0,86 0,86 DKVHSGSEQLANA
YVH1 212 4,26 4,26 MFKDSESSQDLDK
YVH1 213 4,26 4,26 FKDSESSQDLDKL
ZEO1 25 1,11 0,82 1,40 LEETKESLQNKGQ
ZEO1 40 1,25 0,84 1,66 KEQAEASIDNLKN
ZEO1 49 1,37 0,78 1,96 NLKNEATPEAEQV
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